{"subnetworks": [{"diseases": ["HEROIN DEPENDENCE", "PAIN", "OPIOID DEPENDENCE", "NEONATAL ABSTINENCE SYNDROME", "OSTEOARTHRITIS", "UNIPOLAR DEPRESSION", "DRUG DEPENDENCE", "HIV INFECTION", "COCAINE DEPENDENCE", "LUMBAR DISC DEGENERATION", "CONSTIPATION", "EPILEPSY", "EATING DISORDER", "PRURITUS", "OBESITY", "CHRONIC KIDNEY DISEASE", "LIVER DISEASE", "ALCOHOL DEPENDENCE", "GAMBLING BEHAVIOUR", "ALCOHOL DRINKING", "METAMPHETAMINE DEPENDENCE", "CROHN'S DISEASE", "OBSESSIVE-COMPULSIVE DISORDER", "NICOTINE DEPENDENCE", "HAIR-PULLING", "MARIJUANA DEPENDENCE", "MULTIPLE SCLEROSIS", "BORDERLINE PERSONALITY DISORDER SYMPTOM", "TYPE I DIABETES MELLITUS", "SCHIZOPHRENIA", "BREAST CARCINOMA", "COUGH", "NEUROPATHIC PAIN", "OSTEOARTHRITIS, KNEE", "DIABETIC NEUROPATHY", "CANCER", "OTITIS MEDIA", "ADENOMA", "SUBARACHNOID HEMORRHAGE", "MORBID OBESITY", "OBSTRUCTIVE SLEEP APNEA", "HYPOTENSION", "IMMUNE SYSTEM DISEASE", "OCCLUSIVE ARTERIAL DISEASE", "PARKINSON'S DISEASE", "KIDNEY STONE", "DYSPNEA", "DIGESTIVE SYSTEM DISEASE", "DIARRHEA", "SCOLIOSIS", "PREMATURE EJACULATION", "HALLUX VALGUS", "IRRITABLE BOWEL SYNDROME", "ACNE", "PYODERMA", "PSORIASIS", "TYPE II DIABETES MELLITUS", "HIDRADENITIS SUPPURATIVA", "DIABETES MELLITUS", "RHEUMATOID ARTHRITIS", "CINCA SYNDROME", "HEART FAILURE", "CHRONIC CHILDHOOD ARTHRITIS", "FAMILIAL MEDITERRANEAN FEVER", "MYOCARDIAL INFARCTION", "PULMONARY HYPERTENSION", "BLEPHARITIS", "MUCOCUTANEOUS LYMPH NODE SYNDROME", "CHRONIC FATIGUE SYNDROME", "INJURY", "METABOLIC SYNDROME", "UVEITIS", "PERIODONTITIS", "COLORECTAL ADENOCARCINOMA", "DIABETIC RETINOPATHY", "URETHRITIS", "HEMORRHAGE", "NEOPLASM OF MATURE B-CELLS", "ALZHEIMERS DISEASE", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "PLEURAL EFFUSION", "ABDOMINAL AORTIC ANEURYSM", "MARFAN SYNDROME", "PRIMARY SYSTEMIC AMYLOIDOSIS", "DRY EYE SYNDROME", "SEPTICEMIC PLAGUE", "POLYCYSTIC OVARY SYNDROME", "PANCREATIC CARCINOMA", "SEIZURES", "DIABETIC FOOT", "AGE-RELATED MACULAR DEGENERATION", "TUBERCULOSIS", "GOUT", "CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME", "FAMILIAL COLD URTICARIA", "MUCKLE-WELLS SYNDROME", "MEVALONATE KINASE DEFICIENCY", "FEVER", "URTICARIA", "ATHEROSCLEROSIS", "PERIPHERAL ARTERIAL DISEASE", "ATRIAL FIBRILLATION", "PULMONARY SARCOIDOSIS", "SCLERITIS", "BEHCET'S SYNDROME", "MIGRAINE DISORDER", "MIGRAINE WITH AURA", "CARDIOVASCULAR DISEASE", "GASTRIC CARCINOMA", "HYPERTENSION", "ARTHRITIS", "MYALGIA", "FROZEN SHOULDER", "TENDINOPATHY", "POST OPERATIVE NAUSEA AND VOMITING", "GASTROPARESIS", "GASTROESOPHAGEAL REFLUX DISEASE", "GLAUCOMA", "OPEN-ANGLE GLAUCOMA", "HEMANGIOMA", "OCULAR HYPERTENSION", "SKIN ULCER", "ASTHMA", "SMOKING CESSATION", "CONGESTIVE HEART FAILURE", "GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY", "CONGENITAL MYASTHENIC SYNDROME", "IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION", "MEMORY IMPAIRMENT", "IDIOPATHIC PULMONARY FIBROSIS", "OBSTRUCTIVE LUNG DISEASE", "FAMILIAL DYSAUTONOMIA", "RESPIRATORY FAILURE", "INFLAMMATION", "CUTANEOUS MELANOMA", "EMPHYSEMA", "CHRONIC BRONCHITIS", "ANTERIOR ISCHEMIC OPTIC NEUROPATHY", "ACUTE RESPIRATORY DISTRESS SYNDROME", "OVARIAN CYST", "POST-TRAUMATIC STRESS DISORDER", "PROSTATE CARCINOMA", "NASAL OBSTRUCTION", "SUDDEN CARDIAC ARREST", "BRONCHIOLITIS", "SEASONAL ALLERGIC RHINITIS", "ALLERGIC RHINITIS", "ANGIOEDEMA", "SINUSITIS", "PREECLAMPSIA", "RENAL INSUFFICIENCY", "ORTHOSTATIC HYPOTENSION", "FIBROMYALGIA", "MULTIPLE SYSTEM ATROPHY", "BENIGN PROSTATIC HYPERPLASIA", "CATARACT", "CARDIAC ARRHYTHMIA", "STROKE", "HYPERPLASIA", "POST-OPERATIVE SIGN OR SYMPTOM", "NEUROGENIC BLADDER", "EYE DISEASE", "ALLERGIC CONJUNCTIVITIS", "RHINITIS", "ROSACEA", "GRAVES OPHTHALMOPATHY", "HYPERHIDROSIS", "URINARY INCONTINENCE", "ENURESIS NOCTURNA", "OVERACTIVE BLADDER", "AMBLYOPIA", "HYPOGLYCEMIA", "MYOPIA", "PEPTIC ULCER", "DIABETIC NEPHROPATHY", "AMYOTROPHIC LATERAL SCLEROSIS", "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "OPTIC NEURITIS", "SARCOIDOSIS", "ADRENAL GLAND DISEASE", "LEFT VENTRICULAR HYPERTROPHY", "CHRONIC INTERSTITIAL CYSTITIS", "SJOGREN SYNDROME", "SEXUAL DYSFUNCTION", "ACUTE KIDNEY INJURY", "NEOPLASM", "MELANOMA", "DIFFUSE LARGE B-CELL LYMPHOMA", "ULCERATIVE COLITIS", "POSTERIOR UVEITIS", "ACUTE MYELOID LEUKEMIA", "LEUKEMIA", "RECTUM CANCER", "NON-SMALL CELL LUNG CARCINOMA", "CYSTIC FIBROSIS", "LYMPHOMA", "LYMPHOID NEOPLASM", "MULTIPLE MYELOMA", "CHRONIC LYMPHOCYTIC LEUKEMIA", "CARCINOMA", "MANTLE CELL LYMPHOMA", "SMALL CELL LUNG CARCINOMA", "SYSTEMIC LUPUS ERYTHEMATOSUS"], "links": [{"source": "ENSG00000082556", "target": "ENSG00000115138", "reverse": "rev-stimulatory"}, {"source": "ENSG00000112038", "target": "ENSG00000116329"}, {"source": "ENSG00000112038", "target": "ENSG00000116729"}, {"source": "ENSG00000112038", "type": "inhibitory", "target": "ENSG00000144481"}, {"source": "ENSG00000115008", "type": "stimulatory", "target": "ENSG00000115594", "reverse": "rev-directed"}, {"source": "ENSG00000115138", "type": "directed", "target": "ENSG00000116329"}, {"source": "ENSG00000115138", "type": "stimulatory", "target": "ENSG00000185231"}, {"source": "ENSG00000115138", "type": "stimulatory", "target": "ENSG00000258839"}, {"source": "ENSG00000115594", "type": "inhibitory", "target": "ENSG00000125538", "reverse": "rev-stimulatory"}, {"source": "ENSG00000115594", "type": "directed", "target": "ENSG00000136689", "reverse": "rev-inhibitory"}, {"source": "ENSG00000115594", "target": "ENSG00000136697"}, {"source": "ENSG00000116329", "target": "ENSG00000169252"}, {"source": "ENSG00000118113", "target": "ENSG00000169344"}, {"source": "ENSG00000125538", "target": "ENSG00000169252"}, {"source": "ENSG00000125538", "type": "directed", "target": "ENSG00000169344"}, {"source": "ENSG00000135312", "type": "stimulatory", "target": "ENSG00000144481"}, {"source": "ENSG00000164270", "target": "ENSG00000169252"}, {"source": "ENSG00000169252", "target": "ENSG00000188778"}, {"source": "ENSG00000169344", "target": "ENSG00000226979"}, {"source": "ENSG00000226979", "target": "ENSG00000227507"}, {"source": "ENSG00000170214", "type": "manual", "target": "ENSG00000092820"}, {"source": "ENSG00000092820", "type": "manual", "target": "ENSG00000109062"}, {"source": "ENSG00000109062", "type": "manual", "target": "ENSG00000082556"}, {"source": "ENSG00000170214", "type": "manual", "target": "ENSG00000115415"}, {"source": "ENSG00000115415", "type": "manual", "target": "ENSG00000100393"}, {"source": "ENSG00000100393", "type": "manual", "target": "ENSG00000169429"}, {"source": "ENSG00000169429", "type": "manual", "target": "ENSG00000118113"}, {"source": "ENSG00000170214", "type": "manual", "target": "ENSG00000154229"}, {"source": "ENSG00000154229", "type": "manual", "target": "ENSG00000109072"}, {"source": "ENSG00000109072", "type": "manual", "target": "ENSG00000115138"}, {"source": "ENSG00000170214", "type": "manual", "target": "ENSG00000130561"}, {"source": "ENSG00000130561", "type": "manual", "target": "ENSG00000163914"}, {"source": "ENSG00000163914", "type": "manual", "target": "ENSG00000198055"}, {"source": "ENSG00000198055", "type": "manual", "target": "ENSG00000258839"}, {"source": "ENSG00000170214", "type": "manual", "target": "ENSG00000156052"}, {"source": "ENSG00000156052", "type": "manual", "target": "ENSG00000144481"}, {"source": "ENSG00000181072", "type": "manual", "target": "ENSG00000087258"}, {"source": "ENSG00000087258", "type": "manual", "target": "ENSG00000082556"}, {"source": "ENSG00000181072", "type": "manual", "target": "ENSG00000170312"}, {"source": "ENSG00000170312", "type": "manual", "target": "ENSG00000066044"}, {"source": "ENSG00000066044", "type": "manual", "target": "ENSG00000169429"}, {"source": "ENSG00000181072", "type": "manual", "target": "ENSG00000060558"}, {"source": "ENSG00000060558", "type": "manual", "target": "ENSG00000116329"}, {"source": "ENSG00000181072", "type": "manual", "target": "ENSG00000173020"}, {"source": "ENSG00000173020", "type": "manual", "target": "ENSG00000107643"}, {"source": "ENSG00000107643", "type": "manual", "target": "ENSG00000115594"}, {"source": "ENSG00000181072", "type": "manual", "target": "ENSG00000198055"}], "drugs": [{"indications": [{"efo_term": "PERIODONTITIS", "stage": 3}, {"efo_term": "URETHRITIS", "stage": 3}, {"efo_term": "HEMORRHAGE", "stage": 3}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 3}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 3}, {"efo_term": "PLEURAL EFFUSION", "stage": 3}, {"efo_term": "POLYCYSTIC OVARY SYNDROME", "stage": 3}, {"efo_term": "BLEPHARITIS", "stage": 2}, {"efo_term": "COLORECTAL ADENOCARCINOMA", "stage": 2}, {"efo_term": "ACNE", "stage": 2}, {"efo_term": "DIABETIC RETINOPATHY", "stage": 2}, {"efo_term": "NEOPLASM OF MATURE B-CELLS", "stage": 2}, {"efo_term": "PAIN", "stage": 2}, {"efo_term": "ABDOMINAL AORTIC ANEURYSM", "stage": 2}, {"efo_term": "MARFAN SYNDROME", "stage": 2}, {"efo_term": "PRIMARY SYSTEMIC AMYLOIDOSIS", "stage": 2}, {"efo_term": "DRY EYE SYNDROME", "stage": 2}, {"efo_term": "SEPTICEMIC PLAGUE", "stage": 2}, {"efo_term": "MYOCARDIAL INFARCTION", "stage": 2}, {"efo_term": "PANCREATIC CARCINOMA", "stage": 2}, {"efo_term": "SEIZURES", "stage": 2}, {"efo_term": "DIABETIC FOOT", "stage": 2}, {"efo_term": "AGE-RELATED MACULAR DEGENERATION", "stage": 2}, {"efo_term": "TUBERCULOSIS", "stage": 2}], "max_phase": 4, "name": "DOXYCYCLINE HYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200699", "mechanisms": ["Matrix metalloproteinase 8 inhibitor"], "genes": ["MMP8"], "type": "Small molecule", "diseases": ["BLEPHARITIS", "COLORECTAL ADENOCARCINOMA", "PERIODONTITIS", "ACNE", "DIABETIC RETINOPATHY", "URETHRITIS", "HEMORRHAGE", "NEOPLASM OF MATURE B-CELLS", "ALZHEIMERS DISEASE", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "PAIN", "PLEURAL EFFUSION", "ABDOMINAL AORTIC ANEURYSM", "MARFAN SYNDROME", "PRIMARY SYSTEMIC AMYLOIDOSIS", "DRY EYE SYNDROME", "SEPTICEMIC PLAGUE", "POLYCYSTIC OVARY SYNDROME", "MYOCARDIAL INFARCTION", "PANCREATIC CARCINOMA", "SEIZURES", "DIABETIC FOOT", "AGE-RELATED MACULAR DEGENERATION", "TUBERCULOSIS"]}, {"indications": [{"efo_term": "CHRONIC CHILDHOOD ARTHRITIS", "stage": 4}, {"efo_term": "MEVALONATE KINASE DEFICIENCY", "stage": 4}, {"efo_term": "FAMILIAL MEDITERRANEAN FEVER", "stage": 4}, {"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "CINCA SYNDROME", "stage": 4}, {"efo_term": "CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME", "stage": 4}, {"efo_term": "GOUT", "stage": 3}, {"efo_term": "FEVER", "stage": 3}, {"efo_term": "ATHEROSCLEROSIS", "stage": 3}, {"efo_term": "URTICARIA", "stage": 2}, {"efo_term": "PYODERMA", "stage": 2}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 2}, {"efo_term": "ABDOMINAL AORTIC ANEURYSM", "stage": 2}, {"efo_term": "PERIPHERAL ARTERIAL DISEASE", "stage": 2}, {"efo_term": "OSTEOARTHRITIS", "stage": 2}, {"efo_term": "ATRIAL FIBRILLATION", "stage": 2}, {"efo_term": "DIABETES MELLITUS", "stage": 2}, {"efo_term": "PULMONARY SARCOIDOSIS", "stage": 2}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 2}, {"efo_term": "DRY EYE SYNDROME", "stage": 2}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 1}, {"efo_term": "DIABETIC RETINOPATHY", "stage": 1}], "max_phase": 4, "name": "CANAKINUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201834", "mechanisms": ["Interleukin-1 beta inhibitor"], "genes": ["IL1B"], "type": "Antibody", "diseases": ["CHRONIC CHILDHOOD ARTHRITIS", "MEVALONATE KINASE DEFICIENCY", "GOUT", "FEVER", "URTICARIA", "FAMILIAL MEDITERRANEAN FEVER", "PYODERMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "ATHEROSCLEROSIS", "RHEUMATOID ARTHRITIS", "IMMUNE SYSTEM DISEASE", "ABDOMINAL AORTIC ANEURYSM", "PERIPHERAL ARTERIAL DISEASE", "OSTEOARTHRITIS", "ATRIAL FIBRILLATION", "DIABETES MELLITUS", "CINCA SYNDROME", "CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME", "DIABETIC RETINOPATHY", "PULMONARY SARCOIDOSIS", "TYPE I DIABETES MELLITUS", "DRY EYE SYNDROME"]}, {"indications": [{"efo_term": "MULTIPLE SCLEROSIS", "stage": 4}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 3}, {"efo_term": "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "stage": 3}, {"efo_term": "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "stage": 3}, {"efo_term": "MIGRAINE DISORDER", "stage": 2}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 2}, {"efo_term": "DIABETIC NEPHROPATHY", "stage": 2}, {"efo_term": "AMYOTROPHIC LATERAL SCLEROSIS", "stage": 2}, {"efo_term": "AMYOTROPHIC LATERAL SCLEROSIS", "stage": 2}, {"efo_term": "DIABETIC NEPHROPATHY", "stage": 2}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 2}, {"efo_term": "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "MIGRAINE DISORDER", "stage": 2}, {"efo_term": "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "SARCOIDOSIS", "stage": 2}, {"efo_term": "SARCOIDOSIS", "stage": 2}, {"efo_term": "ACUTE RESPIRATORY DISTRESS SYNDROME", "stage": 2}, {"efo_term": "UVEITIS", "stage": 2}, {"efo_term": "ACUTE RESPIRATORY DISTRESS SYNDROME", "stage": 2}, {"efo_term": "UVEITIS", "stage": 2}, {"efo_term": "OPTIC NEURITIS", "stage": 0}, {"efo_term": "OPTIC NEURITIS", "stage": 0}], "max_phase": 4, "name": "CORTICOTROPIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201610", "mechanisms": ["Melanocortin receptor 2 agonist"], "genes": ["MC2R"], "type": "Protein", "diseases": ["MIGRAINE DISORDER", "MULTIPLE SCLEROSIS", "RHEUMATOID ARTHRITIS", "DIABETIC NEPHROPATHY", "AMYOTROPHIC LATERAL SCLEROSIS", "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "OPTIC NEURITIS", "SARCOIDOSIS", "ACUTE RESPIRATORY DISTRESS SYNDROME", "UVEITIS"]}, {"indications": [{"efo_term": "ALCOHOL DEPENDENCE", "stage": 4}, {"efo_term": "OPIOID DEPENDENCE", "stage": 4}, {"efo_term": "HIV INFECTION", "stage": 3}, {"efo_term": "HEROIN DEPENDENCE", "stage": 3}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 3}, {"efo_term": "BORDERLINE PERSONALITY DISORDER SYMPTOM", "stage": 3}, {"efo_term": "GAMBLING BEHAVIOUR", "stage": 2}, {"efo_term": "METAMPHETAMINE DEPENDENCE", "stage": 2}, {"efo_term": "CROHN'S DISEASE", "stage": 2}, {"efo_term": "OBSESSIVE-COMPULSIVE DISORDER", "stage": 2}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 2}, {"efo_term": "HAIR-PULLING", "stage": 2}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}, {"efo_term": "ALCOHOL DRINKING", "stage": 1}, {"efo_term": "OBESITY", "stage": 1}, {"efo_term": "PAIN", "stage": 1}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 1}, {"efo_term": "SCHIZOPHRENIA", "stage": 1}], "max_phase": 4, "name": "NALTREXONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19019", "mechanisms": ["Opioid receptors; mu/kappa/delta antagonist"], "genes": ["OPRK1", "OPRM1", "OPRD1"], "type": "Small molecule", "diseases": ["ALCOHOL DEPENDENCE", "GAMBLING BEHAVIOUR", "OPIOID DEPENDENCE", "ALCOHOL DRINKING", "HIV INFECTION", "OBESITY", "PAIN", "METAMPHETAMINE DEPENDENCE", "CROHN'S DISEASE", "HEROIN DEPENDENCE", "OBSESSIVE-COMPULSIVE DISORDER", "NICOTINE DEPENDENCE", "HAIR-PULLING", "MARIJUANA DEPENDENCE", "MULTIPLE SCLEROSIS", "COCAINE DEPENDENCE", "BORDERLINE PERSONALITY DISORDER SYMPTOM", "TYPE I DIABETES MELLITUS", "SCHIZOPHRENIA", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 4}, {"efo_term": "CINCA SYNDROME", "stage": 4}, {"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "FAMILIAL MEDITERRANEAN FEVER", "stage": 3}, {"efo_term": "MYOCARDIAL INFARCTION", "stage": 3}, {"efo_term": "METABOLIC SYNDROME", "stage": 3}, {"efo_term": "DIABETES MELLITUS", "stage": 2}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 2}, {"efo_term": "OSTEOARTHRITIS", "stage": 2}, {"efo_term": "HEART FAILURE", "stage": 2}, {"efo_term": "CHRONIC CHILDHOOD ARTHRITIS", "stage": 2}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 2}, {"efo_term": "MUCOCUTANEOUS LYMPH NODE SYNDROME", "stage": 2}, {"efo_term": "CHRONIC FATIGUE SYNDROME", "stage": 2}, {"efo_term": "HIDRADENITIS SUPPURATIVA", "stage": 2}, {"efo_term": "UVEITIS", "stage": 2}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 1}, {"efo_term": "BLEPHARITIS", "stage": 1}, {"efo_term": "INJURY", "stage": 1}], "max_phase": 4, "name": "ANAKINRA", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201570", "mechanisms": ["Interleukin-1 receptor antagonist"], "genes": ["IL1R1"], "type": "Protein", "diseases": ["DIABETES MELLITUS", "TYPE I DIABETES MELLITUS", "OSTEOARTHRITIS", "RHEUMATOID ARTHRITIS", "CINCA SYNDROME", "HEART FAILURE", "CHRONIC CHILDHOOD ARTHRITIS", "CHRONIC KIDNEY DISEASE", "FAMILIAL MEDITERRANEAN FEVER", "MYOCARDIAL INFARCTION", "PULMONARY HYPERTENSION", "BLEPHARITIS", "MUCOCUTANEOUS LYMPH NODE SYNDROME", "CHRONIC FATIGUE SYNDROME", "INJURY", "IMMUNE SYSTEM DISEASE", "METABOLIC SYNDROME", "HIDRADENITIS SUPPURATIVA", "UVEITIS"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}, {"efo_term": "OPIOID DEPENDENCE", "stage": 4}, {"efo_term": "DRUG DEPENDENCE", "stage": 4}, {"efo_term": "NEONATAL ABSTINENCE SYNDROME", "stage": 3}, {"efo_term": "OSTEOARTHRITIS", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "HIV INFECTION", "stage": 3}, {"efo_term": "LUMBAR DISC DEGENERATION", "stage": 3}, {"efo_term": "EPILEPSY", "stage": 3}, {"efo_term": "HEROIN DEPENDENCE", "stage": 2}, {"efo_term": "CONSTIPATION", "stage": 2}, {"efo_term": "EATING DISORDER", "stage": 2}, {"efo_term": "PRURITUS", "stage": 2}, {"efo_term": "OBESITY", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "BUPRENORPHINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL511142", "mechanisms": ["Kappa opioid receptor agonist", "Mu opioid receptor agonist"], "genes": ["OPRK1", "OPRM1"], "type": "Small molecule", "diseases": ["HEROIN DEPENDENCE", "PAIN", "OPIOID DEPENDENCE", "NEONATAL ABSTINENCE SYNDROME", "OSTEOARTHRITIS", "UNIPOLAR DEPRESSION", "DRUG DEPENDENCE", "HIV INFECTION", "COCAINE DEPENDENCE", "LUMBAR DISC DEGENERATION", "CONSTIPATION", "EPILEPSY", "EATING DISORDER", "PRURITUS", "OBESITY"]}, {"indications": [{"efo_term": "HEART FAILURE", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "CONGESTIVE HEART FAILURE", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "ATRIAL FIBRILLATION", "stage": 3}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 2}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "EPILEPSY", "stage": 2}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}], "max_phase": 4, "name": "CARVEDILOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL723", "mechanisms": ["Adrenergic receptor beta antagonist", "Adrenergic receptor alpha-1 antagonist"], "genes": ["ADRB2", "ADRA1B", "ADRB3"], "type": "Small molecule", "diseases": ["HEART FAILURE", "HYPERTENSION", "PULMONARY HYPERTENSION", "CANCER", "EPILEPSY", "ATRIAL FIBRILLATION", "CONGESTIVE HEART FAILURE", "POST-TRAUMATIC STRESS DISORDER", "BREAST CARCINOMA", "CARDIOVASCULAR DISEASE", "COCAINE DEPENDENCE", "NICOTINE DEPENDENCE", "PROSTATE CARCINOMA"]}, {"indications": [{"efo_term": "NASAL OBSTRUCTION", "stage": 4}, {"efo_term": "GLAUCOMA", "stage": 4}, {"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "HEMORRHAGE", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "SEASONAL ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "URTICARIA", "stage": 4}, {"efo_term": "SUDDEN CARDIAC ARREST", "stage": 4}, {"efo_term": "ANGIOEDEMA", "stage": 4}, {"efo_term": "SINUSITIS", "stage": 4}, {"efo_term": "ASTHMA", "stage": 3}, {"efo_term": "SUDDEN CARDIAC ARREST", "stage": 3}, {"efo_term": "BRONCHIOLITIS", "stage": 3}], "max_phase": 4, "name": "EPINEPHRINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL679", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB2", "ADRA1B", "ADRB3"], "type": "Small molecule", "diseases": ["ASTHMA", "NASAL OBSTRUCTION", "SUDDEN CARDIAC ARREST", "BRONCHIOLITIS", "GLAUCOMA", "OBSTRUCTIVE LUNG DISEASE", "HEMORRHAGE", "CARDIOVASCULAR DISEASE", "SEASONAL ALLERGIC RHINITIS", "ALLERGIC RHINITIS", "URTICARIA", "ANGIOEDEMA", "SINUSITIS"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CONGESTIVE HEART FAILURE", "stage": 3}, {"efo_term": "FAMILIAL DYSAUTONOMIA", "stage": 3}, {"efo_term": "IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION", "stage": 2}, {"efo_term": "MEMORY IMPAIRMENT", "stage": 2}, {"efo_term": "RESPIRATORY FAILURE", "stage": 2}, {"efo_term": "GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY", "stage": 1}, {"efo_term": "CONGENITAL MYASTHENIC SYNDROME", "stage": 1}, {"efo_term": "IDIOPATHIC PULMONARY FIBROSIS", "stage": 1}, {"efo_term": "INFLAMMATION", "stage": 1}], "max_phase": 4, "name": "ALBUTEROL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL714", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "CONGESTIVE HEART FAILURE", "GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY", "CONGENITAL MYASTHENIC SYNDROME", "IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION", "MEMORY IMPAIRMENT", "IDIOPATHIC PULMONARY FIBROSIS", "OBSTRUCTIVE LUNG DISEASE", "FAMILIAL DYSAUTONOMIA", "RESPIRATORY FAILURE", "INFLAMMATION"]}, {"indications": [{"efo_term": "CANCER", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "ADENOMA", "stage": 3}, {"efo_term": "MORBID OBESITY", "stage": 3}, {"efo_term": "OBSTRUCTIVE SLEEP APNEA", "stage": 3}, {"efo_term": "OCCLUSIVE ARTERIAL DISEASE", "stage": 3}, {"efo_term": "OTITIS MEDIA", "stage": 2}, {"efo_term": "SUBARACHNOID HEMORRHAGE", "stage": 2}, {"efo_term": "HYPOTENSION", "stage": 2}, {"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 1}, {"efo_term": "OPIOID DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "FENTANYL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL596", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["CANCER", "OTITIS MEDIA", "PAIN", "ADENOMA", "SUBARACHNOID HEMORRHAGE", "MORBID OBESITY", "OBSTRUCTIVE SLEEP APNEA", "HYPOTENSION", "IMMUNE SYSTEM DISEASE", "OPIOID DEPENDENCE", "OCCLUSIVE ARTERIAL DISEASE"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "ARTHRITIS", "stage": 4}, {"efo_term": "MYALGIA", "stage": 4}, {"efo_term": "FROZEN SHOULDER", "stage": 4}, {"efo_term": "TENDINOPATHY", "stage": 4}, {"efo_term": "GASTRIC CARCINOMA", "stage": 3}, {"efo_term": "HYPERTENSION", "stage": 2}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 1}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "MENTHOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL256087", "mechanisms": ["Transient receptor potential cation channel subfamily M member 8 opener"], "genes": ["TRPM8"], "type": "Small molecule", "diseases": ["PAIN", "GASTRIC CARCINOMA", "HYPERTENSION", "ARTHRITIS", "MYALGIA", "FROZEN SHOULDER", "TENDINOPATHY", "DIABETIC NEUROPATHY", "NICOTINE DEPENDENCE"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}, {"efo_term": "CANCER", "stage": 3}, {"efo_term": "OSTEOARTHRITIS", "stage": 3}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 3}, {"efo_term": "KIDNEY STONE", "stage": 3}, {"efo_term": "PRURITUS", "stage": 3}, {"efo_term": "OSTEOARTHRITIS, KNEE", "stage": 2}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "OPIOID DEPENDENCE", "stage": 2}], "max_phase": 4, "name": "OXYCODONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL656", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["PAIN", "CANCER", "OSTEOARTHRITIS", "OSTEOARTHRITIS, KNEE", "PARKINSON'S DISEASE", "DIABETIC NEUROPATHY", "KIDNEY STONE", "PRURITUS", "OPIOID DEPENDENCE"]}, {"indications": [{"efo_term": "BEHCET'S SYNDROME", "stage": 3}, {"efo_term": "PYODERMA", "stage": 3}, {"efo_term": "UVEITIS", "stage": 3}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 2}, {"efo_term": "OSTEOARTHRITIS", "stage": 2}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 2}, {"efo_term": "ACNE", "stage": 2}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 2}, {"efo_term": "SCLERITIS", "stage": 1}], "max_phase": 3, "name": "GEVOKIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743026", "mechanisms": ["Interleukin-1 beta negative allosteric modulator"], "genes": ["IL1B"], "type": "Antibody", "diseases": ["TYPE I DIABETES MELLITUS", "OSTEOARTHRITIS", "SCLERITIS", "TYPE II DIABETES MELLITUS", "BEHCET'S SYNDROME", "ACNE", "PYODERMA", "RHEUMATOID ARTHRITIS", "UVEITIS"]}, {"indications": [{"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME", "stage": 4}, {"efo_term": "FAMILIAL COLD URTICARIA", "stage": 4}, {"efo_term": "MUCKLE-WELLS SYNDROME", "stage": 4}, {"efo_term": "GOUT", "stage": 3}, {"efo_term": "CHRONIC CHILDHOOD ARTHRITIS", "stage": 2}, {"efo_term": "FAMILIAL MEDITERRANEAN FEVER", "stage": 2}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 1}], "max_phase": 4, "name": "RILONACEPT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201830", "mechanisms": ["Interleukin-1 beta inhibitor"], "genes": ["IL1B"], "type": "Protein", "diseases": ["GOUT", "CHRONIC CHILDHOOD ARTHRITIS", "FAMILIAL MEDITERRANEAN FEVER", "TYPE I DIABETES MELLITUS", "IMMUNE SYSTEM DISEASE", "CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME", "FAMILIAL COLD URTICARIA", "MUCKLE-WELLS SYNDROME"]}, {"indications": [{"efo_term": "ORTHOSTATIC HYPOTENSION", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "HYPOTENSION", "stage": 2}, {"efo_term": "FIBROMYALGIA", "stage": 2}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "MULTIPLE SYSTEM ATROPHY", "stage": 2}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 1}], "max_phase": 4, "name": "DROXIDOPA", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103827", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB2", "ADRA1B", "ADRB3"], "type": "Small molecule", "diseases": ["HYPOTENSION", "ORTHOSTATIC HYPOTENSION", "FIBROMYALGIA", "CARDIOVASCULAR DISEASE", "CHRONIC KIDNEY DISEASE", "PARKINSON'S DISEASE", "MULTIPLE SYSTEM ATROPHY"]}, {"indications": [{"efo_term": "OVERACTIVE BLADDER", "stage": 4}, {"efo_term": "CHRONIC INTERSTITIAL CYSTITIS", "stage": 3}, {"efo_term": "HEART FAILURE", "stage": 2}, {"efo_term": "PAIN", "stage": 2}, {"efo_term": "NEUROGENIC BLADDER", "stage": 2}, {"efo_term": "LEFT VENTRICULAR HYPERTROPHY", "stage": 2}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 4, "name": "MIRABEGRON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2095212", "mechanisms": ["Beta-3 adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": ["HEART FAILURE", "PAIN", "LIVER DISEASE", "OVERACTIVE BLADDER", "NEUROGENIC BLADDER", "LEFT VENTRICULAR HYPERTROPHY", "CHRONIC INTERSTITIAL CYSTITIS"]}, {"indications": [{"efo_term": "ACNE", "stage": 2}, {"efo_term": "PYODERMA", "stage": 2}, {"efo_term": "PSORIASIS", "stage": 2}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 2}, {"efo_term": "HIDRADENITIS SUPPURATIVA", "stage": 2}, {"efo_term": "CANCER", "stage": 1}], "max_phase": 3, "name": "RA-18C3", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109653", "mechanisms": ["Interleukin-1 alpha inhibitor"], "genes": ["IL1A"], "type": "Antibody", "diseases": ["ACNE", "PYODERMA", "PSORIASIS", "CANCER", "TYPE II DIABETES MELLITUS", "HIDRADENITIS SUPPURATIVA"]}, {"indications": [{"efo_term": "GLAUCOMA", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "OCULAR HYPERTENSION", "stage": 4}, {"efo_term": "OPEN-ANGLE GLAUCOMA", "stage": 2}, {"efo_term": "HEMANGIOMA", "stage": 2}, {"efo_term": "SKIN ULCER", "stage": 2}], "max_phase": 4, "name": "TIMOLOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL499", "mechanisms": ["Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["GLAUCOMA", "OPEN-ANGLE GLAUCOMA", "CARDIOVASCULAR DISEASE", "HEMANGIOMA", "OCULAR HYPERTENSION", "SKIN ULCER"]}, {"indications": [{"efo_term": "EYE DISEASE", "stage": 3}, {"efo_term": "RHINITIS", "stage": 3}, {"efo_term": "ROSACEA", "stage": 3}, {"efo_term": "ALLERGIC CONJUNCTIVITIS", "stage": 2}, {"efo_term": "GRAVES OPHTHALMOPATHY", "stage": 2}, {"efo_term": "ALLERGIC RHINITIS", "stage": 1}], "max_phase": 4, "name": "OXYMETAZOLINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200791", "mechanisms": ["Adrenergic receptor alpha agonist"], "genes": ["ADRA1B"], "type": "Small molecule", "diseases": ["ALLERGIC RHINITIS", "EYE DISEASE", "ALLERGIC CONJUNCTIVITIS", "RHINITIS", "ROSACEA", "GRAVES OPHTHALMOPATHY"]}, {"indications": [{"efo_term": "OVERACTIVE BLADDER", "stage": 4}, {"efo_term": "NEUROGENIC BLADDER", "stage": 3}, {"efo_term": "HYPERHIDROSIS", "stage": 3}, {"efo_term": "URINARY INCONTINENCE", "stage": 3}, {"efo_term": "ENURESIS NOCTURNA", "stage": 3}, {"efo_term": "SEASONAL ALLERGIC RHINITIS", "stage": 2}], "max_phase": 4, "name": "OXYBUTYNIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1231", "mechanisms": ["Muscarinic acetylcholine receptor M2 antagonist"], "genes": ["CHRM2"], "type": "Small molecule", "diseases": ["NEUROGENIC BLADDER", "HYPERHIDROSIS", "URINARY INCONTINENCE", "ENURESIS NOCTURNA", "OVERACTIVE BLADDER", "SEASONAL ALLERGIC RHINITIS"]}, {"indications": [{"efo_term": "DIGESTIVE SYSTEM DISEASE", "stage": 4}, {"efo_term": "AMBLYOPIA", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "MYOPIA", "stage": 3}, {"efo_term": "SEASONAL ALLERGIC RHINITIS", "stage": 2}, {"efo_term": "HYPOGLYCEMIA", "stage": 0}], "max_phase": 4, "name": "ATROPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL517712", "mechanisms": ["Muscarinic acetylcholine receptor M2 antagonist"], "genes": ["CHRM2"], "type": "Small molecule", "diseases": ["AMBLYOPIA", "SEASONAL ALLERGIC RHINITIS", "PAIN", "DIGESTIVE SYSTEM DISEASE", "HYPOGLYCEMIA", "MYOPIA"]}, {"indications": [{"efo_term": "LYMPHOMA", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "MULTIPLE MYELOMA", "stage": 2}, {"efo_term": "CHRONIC LYMPHOCYTIC LEUKEMIA", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 1}, {"efo_term": "LYMPHOID NEOPLASM", "stage": 1}], "max_phase": 3, "name": "ALVOCIDIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL428690", "mechanisms": ["Cyclin-dependent kinase 1 inhibitor"], "genes": ["CDK1"], "type": "Small molecule", "diseases": ["LYMPHOMA", "PROSTATE CARCINOMA", "NEOPLASM", "LYMPHOID NEOPLASM", "MULTIPLE MYELOMA", "CHRONIC LYMPHOCYTIC LEUKEMIA"]}, {"indications": [{"efo_term": "PAIN", "stage": 3}, {"efo_term": "PRURITUS", "stage": 3}, {"efo_term": "NEONATAL ABSTINENCE SYNDROME", "stage": 2}, {"efo_term": "HALLUX VALGUS", "stage": 2}, {"efo_term": "OSTEOARTHRITIS, KNEE", "stage": 2}], "max_phase": 4, "name": "MORPHINE SULFATE HYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103744", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["NEONATAL ABSTINENCE SYNDROME", "PAIN", "HALLUX VALGUS", "PRURITUS", "OSTEOARTHRITIS, KNEE"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "EMPHYSEMA", "stage": 4}, {"efo_term": "CHRONIC BRONCHITIS", "stage": 4}, {"efo_term": "OBESITY", "stage": 2}], "max_phase": 4, "name": "SALMETEROL XINAFOATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1082607", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "OBESITY", "EMPHYSEMA", "CHRONIC BRONCHITIS"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "ACUTE RESPIRATORY DISTRESS SYNDROME", "stage": 2}], "max_phase": 4, "name": "ALBUTEROL SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201026", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "ACUTE RESPIRATORY DISTRESS SYNDROME"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 2}, {"efo_term": "LEUKEMIA", "stage": 2}, {"efo_term": "LIVER DISEASE", "stage": 1}, {"efo_term": "RECTUM CANCER", "stage": 1}], "max_phase": 3, "name": "MIDOSTAURIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533", "mechanisms": ["Protein kinase C (PKC) inhibitor"], "genes": ["PRKCA"], "type": "Small molecule", "diseases": ["ACUTE MYELOID LEUKEMIA", "LEUKEMIA", "LIVER DISEASE", "NEOPLASM", "RECTUM CANCER"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}, {"efo_term": "NEUROPATHIC PAIN", "stage": 3}, {"efo_term": "OSTEOARTHRITIS", "stage": 2}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 4, "name": "HYDROCODONE BITARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062267", "mechanisms": ["Opioid receptors; mu/kappa/delta agonist"], "genes": ["OPRK1", "OPRM1", "OPRD1"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN", "PAIN", "LIVER DISEASE", "OSTEOARTHRITIS"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "NEUROPATHIC PAIN", "stage": 4}, {"efo_term": "PAIN", "stage": 4}], "max_phase": 4, "name": "TAPENTADOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201777", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["PAIN", "NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "HEMANGIOMA", "stage": 3}, {"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "SMOKING CESSATION", "stage": 2}], "max_phase": 4, "name": "NADOLOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL649", "mechanisms": ["Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CARDIOVASCULAR DISEASE", "SMOKING CESSATION", "HEMANGIOMA"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "EMPHYSEMA", "stage": 4}, {"efo_term": "CHRONIC BRONCHITIS", "stage": 4}], "max_phase": 4, "name": "VILANTEROL TRIFENATATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1084172", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "EMPHYSEMA", "CHRONIC BRONCHITIS"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "EMPHYSEMA", "stage": 4}, {"efo_term": "CHRONIC BRONCHITIS", "stage": 4}, {"efo_term": "ASTHMA", "stage": 2}], "max_phase": 4, "name": "INDACATEROL MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789842", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "ASTHMA", "EMPHYSEMA", "CHRONIC BRONCHITIS"]}, {"indications": [{"efo_term": "BENIGN PROSTATIC HYPERPLASIA", "stage": 4}, {"efo_term": "POST-OPERATIVE SIGN OR SYMPTOM", "stage": 3}, {"efo_term": "HYPERPLASIA", "stage": 2}, {"efo_term": "NEUROGENIC BLADDER", "stage": 2}], "max_phase": 4, "name": "TAMSULOSIN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200914", "mechanisms": ["Adrenergic receptor alpha-1 antagonist"], "genes": ["ADRA1B"], "type": "Small molecule", "diseases": ["BENIGN PROSTATIC HYPERPLASIA", "HYPERPLASIA", "POST-OPERATIVE SIGN OR SYMPTOM", "NEUROGENIC BLADDER"]}, {"indications": [{"efo_term": "SEASONAL ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "PEPTIC ULCER", "stage": 4}, {"efo_term": "PARKINSON'S DISEASE", "stage": 4}], "max_phase": 4, "name": "ATROPINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2146146", "mechanisms": ["Muscarinic acetylcholine receptor M2 antagonist"], "genes": ["CHRM2"], "type": "Small molecule", "diseases": ["SEASONAL ALLERGIC RHINITIS", "ALLERGIC RHINITIS", "PEPTIC ULCER", "PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "ULCERATIVE COLITIS", "stage": 2}, {"efo_term": "POSTERIOR UVEITIS", "stage": 2}, {"efo_term": "PSORIASIS", "stage": 2}, {"efo_term": "DIFFUSE LARGE B-CELL LYMPHOMA", "stage": 1}], "max_phase": 2, "name": "SOTRASTAURIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL565612", "mechanisms": ["Protein kinase C (PKC) inhibitor"], "genes": ["PRKCA"], "type": "Small molecule", "diseases": ["DIFFUSE LARGE B-CELL LYMPHOMA", "ULCERATIVE COLITIS", "POSTERIOR UVEITIS", "PSORIASIS"]}, {"indications": [{"efo_term": "CHRONIC LYMPHOCYTIC LEUKEMIA", "stage": 3}, {"efo_term": "MELANOMA", "stage": 2}, {"efo_term": "MULTIPLE MYELOMA", "stage": 2}, {"efo_term": "CUTANEOUS MELANOMA", "stage": 2}], "max_phase": 3, "name": "DINACICLIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103840", "mechanisms": ["Cyclin-dependent kinase 1 inhibitor"], "genes": ["CDK1"], "type": "Small molecule", "diseases": ["MELANOMA", "CHRONIC LYMPHOCYTIC LEUKEMIA", "MULTIPLE MYELOMA", "CUTANEOUS MELANOMA"]}, {"indications": [{"efo_term": "OSTEOARTHRITIS, KNEE", "stage": 2}, {"efo_term": "PAIN", "stage": 2}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 2}], "max_phase": 3, "name": "CEBRANOPADOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2364605", "mechanisms": ["Opioid receptors; mu/kappa/delta agonist"], "genes": ["OPRK1", "OPRM1", "OPRD1"], "type": "Small molecule", "diseases": ["OSTEOARTHRITIS, KNEE", "PAIN", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}, {"efo_term": "CANCER", "stage": 4}, {"efo_term": "DYSPNEA", "stage": 0}], "max_phase": 4, "name": "FENTANYL CITRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL688", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["PAIN", "CANCER", "DYSPNEA"]}, {"indications": [{"efo_term": "CONSTIPATION", "stage": 3}, {"efo_term": "DIGESTIVE SYSTEM DISEASE", "stage": 3}, {"efo_term": "CANCER", "stage": 2}], "max_phase": 4, "name": "ALVIMOPAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL270190", "mechanisms": ["Mu opioid receptor antagonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["CONSTIPATION", "CANCER", "DIGESTIVE SYSTEM DISEASE"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}, {"efo_term": "PREMATURE EJACULATION", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 2}], "max_phase": 4, "name": "TRAMADOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237065", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["PAIN", "PREMATURE EJACULATION", "BREAST CARCINOMA"]}, {"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 2}, {"efo_term": "OSTEOARTHRITIS", "stage": 2}, {"efo_term": "DIABETES MELLITUS", "stage": 2}], "max_phase": 2, "name": "AMG-108", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109458", "mechanisms": ["Interleukin-1 receptor antagonist"], "genes": ["IL1R1"], "type": "Antibody", "diseases": ["RHEUMATOID ARTHRITIS", "OSTEOARTHRITIS", "DIABETES MELLITUS"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "CUTANEOUS MELANOMA", "stage": 2}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 1}], "max_phase": 4, "name": "PROPRANOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1671", "mechanisms": ["Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["TYPE II DIABETES MELLITUS", "HYPERTENSION", "CUTANEOUS MELANOMA"]}, {"indications": [{"efo_term": "GLAUCOMA", "stage": 3}, {"efo_term": "HEMANGIOMA", "stage": 3}, {"efo_term": "ANTERIOR ISCHEMIC OPTIC NEUROPATHY", "stage": 1}], "max_phase": 4, "name": "TIMOLOL MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200870", "mechanisms": ["Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["GLAUCOMA", "HEMANGIOMA", "ANTERIOR ISCHEMIC OPTIC NEUROPATHY"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "BREAST CARCINOMA", "stage": 2}], "max_phase": 4, "name": "CARVEDILOL PHOSPHATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201167", "mechanisms": ["Adrenergic receptor beta antagonist", "Adrenergic receptor alpha-1 antagonist"], "genes": ["ADRB2", "ADRA1B", "ADRB3"], "type": "Small molecule", "diseases": ["HYPERTENSION", "BREAST CARCINOMA"]}, {"indications": [{"efo_term": "MANTLE CELL LYMPHOMA", "stage": 2}, {"efo_term": "CHRONIC LYMPHOCYTIC LEUKEMIA", "stage": 2}, {"efo_term": "LYMPHOMA", "stage": 1}], "max_phase": 2, "name": "AT-7519", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL445813", "mechanisms": ["Cyclin-dependent kinase inhibitor"], "genes": ["CDK1"], "type": "Small molecule", "diseases": ["MANTLE CELL LYMPHOMA", "CHRONIC LYMPHOCYTIC LEUKEMIA", "LYMPHOMA"]}, {"indications": [{"efo_term": "LIVER DISEASE", "stage": 2}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 1}], "max_phase": 3, "name": "NALFURAFINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL490665", "mechanisms": ["Kappa opioid receptor agonist"], "genes": ["OPRK1"], "type": "Small molecule", "diseases": ["CHRONIC KIDNEY DISEASE", "LIVER DISEASE"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}, {"efo_term": "OPIOID DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "NALOXONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1718", "mechanisms": ["Opioid receptors; mu/kappa/delta antagonist"], "genes": ["OPRK1", "OPRM1", "OPRD1"], "type": "Small molecule", "diseases": ["OPIOID DEPENDENCE", "PAIN"]}, {"indications": [{"efo_term": "EATING DISORDER", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 1}], "max_phase": 2, "name": "SAMIDORPHAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL426084", "mechanisms": ["Mu opioid receptor antagonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["COCAINE DEPENDENCE", "EATING DISORDER"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}, {"efo_term": "OPIOID DEPENDENCE", "stage": 2}], "max_phase": 4, "name": "OXYCODONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200890", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["PAIN", "OPIOID DEPENDENCE"]}, {"indications": [{"efo_term": "ACNE", "stage": 4}, {"efo_term": "PERIODONTITIS", "stage": 3}], "max_phase": 4, "name": "DOXYCYCLINE HYCLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200567", "mechanisms": ["Matrix metalloproteinase 8 inhibitor"], "genes": ["MMP8"], "type": "Small molecule", "diseases": ["ACNE", "PERIODONTITIS"]}, {"indications": [{"efo_term": "MIGRAINE WITH AURA", "stage": 2}, {"efo_term": "MIGRAINE DISORDER", "stage": 1}], "max_phase": 4, "name": "SUMATRIPTAN SUCCINATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201150", "mechanisms": ["Serotonin 1b (5-HT1b) receptor agonist"], "genes": ["HTR1B"], "type": "Small molecule", "diseases": ["MIGRAINE DISORDER", "MIGRAINE WITH AURA"]}, {"indications": [{"efo_term": "CONSTIPATION", "stage": 3}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 4, "name": "PRUCALOPRIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL117287", "mechanisms": ["Serotonin 4 (5-HT4) receptor agonist"], "genes": ["HTR4"], "type": "Small molecule", "diseases": ["CONSTIPATION", "LIVER DISEASE"]}, {"indications": [{"efo_term": "GASTROPARESIS", "stage": 2}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 1}], "max_phase": 2, "name": "VELUSETRAG", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2087337", "mechanisms": ["Serotonin 4 (5-HT4) receptor agonist"], "genes": ["HTR4"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE", "GASTROPARESIS"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 4, "name": "PINDOLOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL500", "mechanisms": ["Beta-2 adrenergic receptor partial agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["CARDIOVASCULAR DISEASE", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 3}], "max_phase": 4, "name": "TERBUTALINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1160544", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "DRUG DEPENDENCE", "stage": 2}], "max_phase": 4, "name": "METAPROTERENOL SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200812", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "DRUG DEPENDENCE"]}, {"indications": [{"efo_term": "OVARIAN CYST", "stage": 1}, {"efo_term": "DIABETIC FOOT", "stage": 1}], "max_phase": 4, "name": "ESMOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201115", "mechanisms": ["Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["OVARIAN CYST", "DIABETIC FOOT"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "EMPHYSEMA", "stage": 4}], "max_phase": 4, "name": "ARFORMOTEROL TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1951071", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "EMPHYSEMA"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "EMPHYSEMA", "stage": 4}], "max_phase": 4, "name": "OLODATEROL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105743", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "EMPHYSEMA"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 1}], "max_phase": 2, "name": "BEDORADRINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2218893", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "ASTHMA"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}], "max_phase": 4, "name": "FORMOTEROL FUMARATE DIHYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2303638", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}], "max_phase": 2, "name": "ABEDITEROL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3039530", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}], "max_phase": 2, "name": "AZD3199", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545103", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "BENIGN PROSTATIC HYPERPLASIA", "stage": 4}, {"efo_term": "KIDNEY STONE", "stage": 3}], "max_phase": 4, "name": "ALFUZOSIN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1723", "mechanisms": ["Adrenergic receptor alpha-1 agonist"], "genes": ["ADRA1B"], "type": "Small molecule", "diseases": ["KIDNEY STONE", "BENIGN PROSTATIC HYPERPLASIA"]}, {"indications": [{"efo_term": "CATARACT", "stage": 3}, {"efo_term": "CARDIAC ARRHYTHMIA", "stage": 1}], "max_phase": 4, "name": "PHENYLEPHRINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200339", "mechanisms": ["Adrenergic receptor alpha-1 agonist"], "genes": ["ADRA1B"], "type": "Small molecule", "diseases": ["CATARACT", "CARDIAC ARRHYTHMIA"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}, {"efo_term": "ASTHMA", "stage": 2}], "max_phase": 2, "name": "ASM-024", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707249", "mechanisms": ["Muscarinic acetylcholine receptor M2 antagonist"], "genes": ["CHRM2"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "ASTHMA"]}, {"indications": [{"efo_term": "SJOGREN SYNDROME", "stage": 2}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 2}], "max_phase": 2, "name": "BAMINERCEPT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1742988", "mechanisms": ["Heterotrimeric lymphotoxin LTa1b2 inhibitor"], "genes": ["LTA", "LTB"], "type": "Protein", "diseases": ["SJOGREN SYNDROME", "RHEUMATOID ARTHRITIS"]}, {"indications": [{"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "CYSTIC FIBROSIS", "stage": 2}], "max_phase": 2, "name": "SELICICLIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14762", "mechanisms": ["Cyclin-dependent kinase 1 inhibitor"], "genes": ["CDK1"], "type": "Small molecule", "diseases": ["NON-SMALL CELL LUNG CARCINOMA", "CYSTIC FIBROSIS"]}, {"indications": [{"efo_term": "SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 2}], "max_phase": 2, "name": "Roniciclib", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544942", "mechanisms": ["Cyclin-dependent kinase inhibitor"], "genes": ["CDK1"], "type": "Small molecule", "diseases": ["SMALL CELL LUNG CARCINOMA", "NEOPLASM"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}], "max_phase": 4, "name": "DEZOCINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1685", "mechanisms": ["Kappa opioid receptor antagonist", "Mu opioid receptor partial agonist"], "genes": ["OPRK1", "OPRM1"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "PAIN", "stage": 2}], "max_phase": 2, "name": "AXOMADOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107731", "mechanisms": ["Kappa opioid receptor agonist", "Mu opioid receptor agonist", "Delta opioid receptor agonist"], "genes": ["OPRK1", "OPRM1", "OPRD1"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "OPIOID DEPENDENCE", "stage": 4}], "max_phase": 4, "name": "Buprenorphine Hydrochloride", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2368861", "mechanisms": ["Kappa opioid receptor agonist", "Mu opioid receptor agonist"], "genes": ["OPRK1", "OPRM1"], "type": "Small molecule", "diseases": ["OPIOID DEPENDENCE"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}], "max_phase": 4, "name": "CODEINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL284671", "mechanisms": ["Opioid receptors; mu/kappa/delta agonist"], "genes": ["OPRK1", "OPRM1", "OPRD1"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}], "max_phase": 4, "name": "OXYMORPHONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200794", "mechanisms": ["Opioid receptors; mu/kappa/delta agonist"], "genes": ["OPRK1", "OPRM1", "OPRD1"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}], "max_phase": 4, "name": "CODEINE PHOSPHATE HYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201099", "mechanisms": ["Opioid receptors; mu/kappa/delta agonist"], "genes": ["OPRK1", "OPRM1", "OPRD1"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "PAIN", "stage": 2}], "max_phase": 4, "name": "NALBUPHINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201132", "mechanisms": ["Opioid receptors; mu/kappa/delta agonist"], "genes": ["OPRK1", "OPRM1", "OPRD1"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "BREAST CARCINOMA", "stage": 2}], "max_phase": 4, "name": "NALTREXONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201149", "mechanisms": ["Opioid receptors; mu/kappa/delta antagonist"], "genes": ["OPRK1", "OPRM1", "OPRD1"], "type": "Small molecule", "diseases": ["BREAST CARCINOMA"]}, {"indications": [{"efo_term": "ALCOHOL DEPENDENCE", "stage": 3}], "max_phase": 4, "name": "NALMEFENE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201152", "mechanisms": ["Opioid receptors; mu/kappa/delta antagonist"], "genes": ["OPRK1", "OPRM1", "OPRD1"], "type": "Small molecule", "diseases": ["ALCOHOL DEPENDENCE"]}, {"indications": [{"efo_term": "COUGH", "stage": 4}], "max_phase": 4, "name": "CODEINE POLISTIREX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201463", "mechanisms": ["Opioid receptors; mu/kappa/delta agonist"], "genes": ["OPRK1", "OPRM1", "OPRD1"], "type": "Small molecule", "diseases": ["COUGH"]}, {"indications": [{"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}], "max_phase": 2, "name": "ODELEPRAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103878", "mechanisms": ["Opioid receptors; mu/kappa/delta antagonist"], "genes": ["OPRK1", "OPRM1", "OPRD1"], "type": "Small molecule", "diseases": ["ALCOHOL DEPENDENCE"]}, {"indications": [{"efo_term": "PAIN", "stage": 2}], "max_phase": 4, "name": "MEPERIDINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1701", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "DIARRHEA", "stage": 3}], "max_phase": 4, "name": "LOPERAMIDE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1707", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["DIARRHEA"]}, {"indications": [{"efo_term": "SCOLIOSIS", "stage": 2}], "max_phase": 4, "name": "METHADONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200825", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["SCOLIOSIS"]}, {"indications": [{"efo_term": "CONSTIPATION", "stage": 4}], "max_phase": 4, "name": "METHYLNALTREXONE BROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201770", "mechanisms": ["Mu opioid receptor antagonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["CONSTIPATION"]}, {"indications": [{"efo_term": "PAIN", "stage": 3}], "max_phase": 4, "name": "HYDROMORPHONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237055", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "CONSTIPATION", "stage": 3}], "max_phase": 4, "name": "NALDEMEDINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105755", "mechanisms": ["Mu opioid receptor antagonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["CONSTIPATION"]}, {"indications": [{"efo_term": "IRRITABLE BOWEL SYNDROME", "stage": 4}], "max_phase": 4, "name": "ELUXADOLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2159122", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["IRRITABLE BOWEL SYNDROME"]}, {"indications": [{"efo_term": "CONSTIPATION", "stage": 2}], "max_phase": 2, "name": "METHYLSAMIDORPHAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2364619", "mechanisms": ["Mu opioid receptor antagonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["CONSTIPATION"]}, {"indications": [{"efo_term": "PAIN", "stage": 3}], "max_phase": 3, "name": "OLICERIDINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2443262", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "CONSTIPATION", "stage": 4}], "max_phase": 4, "name": "NALDEMEDINE TOSYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3039508", "mechanisms": ["Mu opioid receptor antagonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["CONSTIPATION"]}, {"indications": [{"efo_term": "CONSTIPATION", "stage": 2}], "max_phase": 2, "name": "AXELOPRAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3137313", "mechanisms": ["Mu opioid receptor antagonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["CONSTIPATION"]}, {"indications": [{"efo_term": "MIGRAINE DISORDER", "stage": 4}], "max_phase": 4, "name": "SUMATRIPTAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL128", "mechanisms": ["Serotonin 1b (5-HT1b) receptor agonist"], "genes": ["HTR1B"], "type": "Small molecule", "diseases": ["MIGRAINE DISORDER"]}, {"indications": [{"efo_term": "MIGRAINE DISORDER", "stage": 4}], "max_phase": 4, "name": "ZOLMITRIPTAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1185", "mechanisms": ["Serotonin 1b (5-HT1b) receptor agonist"], "genes": ["HTR1B"], "type": "Small molecule", "diseases": ["MIGRAINE DISORDER"]}, {"indications": [{"efo_term": "MIGRAINE DISORDER", "stage": 4}], "max_phase": 4, "name": "ALMOTRIPTAN MALATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200521", "mechanisms": ["Serotonin 1b (5-HT1b) receptor agonist"], "genes": ["HTR1B"], "type": "Small molecule", "diseases": ["MIGRAINE DISORDER"]}, {"indications": [{"efo_term": "MIGRAINE DISORDER", "stage": 4}], "max_phase": 4, "name": "RIZATRIPTAN BENZOATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201032", "mechanisms": ["Serotonin 1b (5-HT1b) receptor agonist"], "genes": ["HTR1B"], "type": "Small molecule", "diseases": ["MIGRAINE DISORDER"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 1}], "max_phase": 2, "name": "GSK163090", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1631540", "mechanisms": ["Serotonin 1b (5-HT1b) receptor antagonist"], "genes": ["HTR1B"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}], "max_phase": 4, "name": "ERGOLOID MESYLATES", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2311030", "mechanisms": ["Serotonin 1b (5-HT1b) receptor agonist", "Adrenergic receptor alpha antagonist"], "genes": ["HTR1B", "ADRA1B"], "type": "Small molecule", "diseases": ["CARDIOVASCULAR DISEASE"]}, {"indications": [{"efo_term": "DIGESTIVE SYSTEM DISEASE", "stage": 4}], "max_phase": 4, "name": "CISAPRIDE MONOHYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200788", "mechanisms": ["Serotonin 4 (5-HT4) receptor agonist"], "genes": ["HTR4"], "type": "Small molecule", "diseases": ["DIGESTIVE SYSTEM DISEASE"]}, {"indications": [{"efo_term": "POST OPERATIVE NAUSEA AND VOMITING", "stage": 4}], "max_phase": 4, "name": "METOCLOPRAMIDE HYDROCHLORIDE HYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200940", "mechanisms": ["Serotonin 4 (5-HT4) receptor agonist"], "genes": ["HTR4"], "type": "Small molecule", "diseases": ["POST OPERATIVE NAUSEA AND VOMITING"]}, {"indications": [{"efo_term": "CONSTIPATION", "stage": 2}], "max_phase": 2, "name": "NARONAPRIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103858", "mechanisms": ["Serotonin 4 (5-HT4) receptor agonist"], "genes": ["HTR4"], "type": "Small molecule", "diseases": ["CONSTIPATION"]}, {"indications": [{"efo_term": "GASTROESOPHAGEAL REFLUX DISEASE", "stage": 2}], "max_phase": 2, "name": "Revexepride", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545035", "mechanisms": ["Serotonin 4 (5-HT4) receptor agonist"], "genes": ["HTR4"], "type": "Small molecule", "diseases": ["GASTROESOPHAGEAL REFLUX DISEASE"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}], "max_phase": 2, "name": "CARMOTEROL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1094785", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}], "max_phase": 4, "name": "PIRBUTEROL ACETATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200444", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}], "max_phase": 4, "name": "NEBIVOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201731", "mechanisms": ["Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["HYPERTENSION"]}, {"indications": [{"efo_term": "OBESITY", "stage": 2}], "max_phase": 2, "name": "LY377604", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2012520", "mechanisms": ["Beta-2 adrenergic receptor antagonist", "Beta-3 adrenergic receptor agonist"], "genes": ["ADRB2", "ADRB3"], "type": "Small molecule", "diseases": ["OBESITY"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 3}], "max_phase": 4, "name": "LEVALBUTEROL TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062258", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}], "max_phase": 2, "name": "BATEFENTEROL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3039518", "mechanisms": ["Beta-2 adrenergic receptor agonist", "Muscarinic acetylcholine receptor M2 antagonist"], "genes": ["ADRB2", "CHRM2"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}], "max_phase": 4, "name": "ISOPROTERENOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1711", "mechanisms": ["Adrenergic receptor beta agonist"], "genes": ["ADRB2", "ADRB3"], "type": "Small molecule", "diseases": ["ASTHMA"]}, {"indications": [{"efo_term": "OPEN-ANGLE GLAUCOMA", "stage": 4}], "max_phase": 4, "name": "CARTEOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201002", "mechanisms": ["Adrenergic receptor beta antagonist"], "genes": ["ADRB2", "ADRB3"], "type": "Small molecule", "diseases": ["OPEN-ANGLE GLAUCOMA"]}, {"indications": [{"efo_term": "PREECLAMPSIA", "stage": 2}], "max_phase": 4, "name": "LABETALOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200323", "mechanisms": ["Adrenergic receptor antagonist"], "genes": ["ADRB2", "ADRA1B", "ADRB3"], "type": "Small molecule", "diseases": ["PREECLAMPSIA"]}, {"indications": [{"efo_term": "RENAL INSUFFICIENCY", "stage": 0}], "max_phase": 4, "name": "NORADRENALINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1356607", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB2", "ADRA1B", "ADRB3"], "type": "Small molecule", "diseases": ["RENAL INSUFFICIENCY"]}, {"indications": [{"efo_term": "STROKE", "stage": 1}], "max_phase": 4, "name": "MIDODRINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200461", "mechanisms": ["Adrenergic receptor alpha-1 agonist"], "genes": ["ADRA1B"], "type": "Small molecule", "diseases": ["STROKE"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}], "max_phase": 4, "name": "PHENYLEPHRINE BITARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062264", "mechanisms": ["Adrenergic receptor alpha-1 agonist"], "genes": ["ADRA1B"], "type": "Small molecule", "diseases": ["ASTHMA"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}], "max_phase": 4, "name": "RAUWOLFIA SERPENTINA", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3559672", "mechanisms": ["Adrenergic receptor alpha antagonist"], "genes": ["ADRA1B"], "type": "Small molecule", "diseases": ["HYPERTENSION"]}, {"indications": [{"efo_term": "OVERACTIVE BLADDER", "stage": 1}], "max_phase": 4, "name": "PROPANTHELINE BROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1240", "mechanisms": ["Muscarinic acetylcholine receptor M2 antagonist"], "genes": ["CHRM2"], "type": "Small molecule", "diseases": ["OVERACTIVE BLADDER"]}, {"indications": [{"efo_term": "OVERACTIVE BLADDER", "stage": 4}], "max_phase": 4, "name": "SOLIFENACIN SUCCINATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200803", "mechanisms": ["Muscarinic acetylcholine receptor M2 antagonist"], "genes": ["CHRM2"], "type": "Small molecule", "diseases": ["OVERACTIVE BLADDER"]}, {"indications": [{"efo_term": "OVERACTIVE BLADDER", "stage": 4}], "max_phase": 4, "name": "FESOTERODINE FUMARATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201765", "mechanisms": ["Muscarinic acetylcholine receptor M2 antagonist"], "genes": ["CHRM2"], "type": "Small molecule", "diseases": ["OVERACTIVE BLADDER"]}, {"indications": [{"efo_term": "OVERACTIVE BLADDER", "stage": 4}], "max_phase": 4, "name": "TOLTERODINE TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1722209", "mechanisms": ["Muscarinic acetylcholine receptor M2 antagonist"], "genes": ["CHRM2"], "type": "Small molecule", "diseases": ["OVERACTIVE BLADDER"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 1}], "max_phase": 4, "name": "TROSPIUM CHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3084748", "mechanisms": ["Muscarinic acetylcholine receptor M2 antagonist"], "genes": ["CHRM2"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "ADRENAL GLAND DISEASE", "stage": 1}], "max_phase": 4, "name": "COSYNTROPIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103784", "mechanisms": ["Melanocortin receptor 2 agonist"], "genes": ["MC2R"], "type": "Protein", "diseases": ["ADRENAL GLAND DISEASE"]}, {"indications": [{"efo_term": "NEUROGENIC BLADDER", "stage": 1}], "max_phase": 3, "name": "RITOBEGRON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107773", "mechanisms": ["Beta-3 adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": ["NEUROGENIC BLADDER"]}, {"indications": [{"efo_term": "OVERACTIVE BLADDER", "stage": 2}], "max_phase": 2, "name": "VIBEGRON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107826", "mechanisms": ["Beta-3 adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": ["OVERACTIVE BLADDER"]}, {"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 1}], "max_phase": 2, "name": "PATECLIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743056", "mechanisms": ["TNF-beta inhibitor"], "genes": ["LTA"], "type": "Antibody", "diseases": ["RHEUMATOID ARTHRITIS"]}, {"indications": [{"efo_term": "SEXUAL DYSFUNCTION", "stage": 3}], "max_phase": 3, "name": "BREMELANOTIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2070241", "mechanisms": ["Melanocortin receptor 1 agonist"], "genes": ["MC1R"], "type": "Protein", "diseases": ["SEXUAL DYSFUNCTION"]}, {"indications": [{"efo_term": "ACUTE KIDNEY INJURY", "stage": 2}], "max_phase": 2, "name": "Modimelanotide", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545104", "mechanisms": ["Melanocortin receptor 1 agonist"], "genes": ["MC1R"], "type": "Protein", "diseases": ["ACUTE KIDNEY INJURY"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 1}], "max_phase": 2, "name": "HuMax-IL8", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109617", "mechanisms": ["Interleukin-8 inhibitor"], "genes": ["CXCL8"], "type": "Antibody", "diseases": ["NEOPLASM"]}, {"indications": [{"efo_term": "CANCER", "stage": 1}], "max_phase": 1, "name": "GSK-690693", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL494089", "mechanisms": ["Protein kinase C (PKC) inhibitor"], "genes": ["PRKCA"], "type": "Small molecule", "diseases": ["CANCER"]}, {"indications": [{"efo_term": "MELANOMA", "stage": 2}], "max_phase": 2, "name": "(7S)-HYDROXYL-STAUROSPORINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL574737", "mechanisms": ["Protein kinase C (PKC) inhibitor"], "genes": ["PRKCA"], "type": "Small molecule", "diseases": ["MELANOMA"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 1}], "max_phase": 2, "name": "RG-547", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL384304", "mechanisms": ["Cyclin-dependent kinase 1 inhibitor"], "genes": ["CDK1"], "type": "Small molecule", "diseases": ["NEOPLASM"]}, {"indications": [{"efo_term": "CARCINOMA", "stage": 2}], "max_phase": 2, "name": "MILCICLIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL564829", "mechanisms": ["Cyclin-dependent kinase 1 inhibitor"], "genes": ["CDK1"], "type": "Small molecule", "diseases": ["CARCINOMA"]}, {"indications": [{"efo_term": "CHRONIC LYMPHOCYTIC LEUKEMIA", "stage": 1}], "max_phase": 1, "name": "TG-02", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1944698", "mechanisms": ["Cyclin-dependent kinase 1 inhibitor"], "genes": ["CDK1"], "type": "Small molecule", "diseases": ["CHRONIC LYMPHOCYTIC LEUKEMIA"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 1}], "max_phase": 1, "name": "PHA-793887", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1230607", "mechanisms": ["Cyclin-dependent kinase inhibitor"], "genes": ["CDK1"], "type": "Small molecule", "diseases": ["NEOPLASM"]}, {"indications": [{"efo_term": "SYSTEMIC LUPUS ERYTHEMATOSUS", "stage": 2}], "max_phase": 2, "name": "TANZISERTIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1950289", "mechanisms": ["c-Jun N-terminal kinase 1 inhibitor"], "genes": ["MAPK8"], "type": "Small molecule", "diseases": ["SYSTEMIC LUPUS ERYTHEMATOSUS"]}, {"indications": [], "max_phase": 4, "name": "BUTORPHANOL TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL299400", "mechanisms": ["Kappa opioid receptor partial agonist", "Mu opioid receptor partial agonist"], "genes": ["OPRK1", "OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ANILERIDINE PHOSPHATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200543", "mechanisms": ["Kappa opioid receptor agonist", "Mu opioid receptor agonist"], "genes": ["OPRK1", "OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ANILERIDINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201047", "mechanisms": ["Kappa opioid receptor agonist", "Mu opioid receptor agonist"], "genes": ["OPRK1", "OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LEVALLORPHAN TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062276", "mechanisms": ["Kappa opioid receptor partial agonist", "Mu opioid receptor antagonist"], "genes": ["OPRK1", "OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "HYDROCODONE POLISTIREX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201470", "mechanisms": ["Opioid receptors; mu/kappa/delta agonist"], "genes": ["OPRK1", "OPRM1", "OPRD1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ALFENTANIL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200531", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIFENOXIN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200599", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "OXYCODONE TEREPHTHALATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200611", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIPHENOXYLATE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200665", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LEVOMETHADYL ACETATE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200817", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "REMIFENTANIL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201120", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "FENTANYL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201159", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "SUFENTANIL CITRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201163", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROPOXYPHENE NAPSYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237085", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROPOXYPHENE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237104", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LEVORPHANOL TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062261", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIHYDROCODEINE BITARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062266", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "FAXELADOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103829", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "FRAKEFAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105081", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "NALOXEGOL OXALATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2219416", "mechanisms": ["Mu opioid receptor antagonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "BEVENOPRAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3039511", "mechanisms": ["Mu opioid receptor antagonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "Naltalimide", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545408", "mechanisms": ["Mu opioid receptor partial agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DOXYCYCLINE CALCIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2364574", "mechanisms": ["Matrix metalloproteinase 8 inhibitor"], "genes": ["MMP8"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "FROVATRIPTAN SUCCINATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200371", "mechanisms": ["Serotonin 1b (5-HT1b) receptor agonist"], "genes": ["HTR1B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "NARATRIPTAN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200601", "mechanisms": ["Serotonin 1b (5-HT1b) receptor agonist"], "genes": ["HTR1B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ELETRIPTAN HYDROBROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201003", "mechanisms": ["Serotonin 1b (5-HT1b) receptor agonist"], "genes": ["HTR1B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "DONITRIPTAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1742428", "mechanisms": ["Serotonin 1b (5-HT1b) receptor agonist"], "genes": ["HTR1B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "ELZASONAN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2106698", "mechanisms": ["Serotonin 1b (5-HT1b) receptor antagonist"], "genes": ["HTR1B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "Trelanserin", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3183740", "mechanisms": ["Serotonin 1b (5-HT1b) receptor antagonist"], "genes": ["HTR1B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "D-3263", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707315", "mechanisms": ["Transient receptor potential cation channel subfamily M member 8 agonist"], "genes": ["TRPM8"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TEGASEROD MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1516474", "mechanisms": ["Serotonin 4 (5-HT4) receptor partial agonist"], "genes": ["HTR4"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "Capeserod", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2027925", "mechanisms": ["Serotonin 4 (5-HT4) receptor partial agonist"], "genes": ["HTR4"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "SOTALOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1700", "mechanisms": ["Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PENBUTOLOL SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200363", "mechanisms": ["Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BITOLTEROL MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200405", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DOBUTAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200418", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "OXPRENOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200745", "mechanisms": ["Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROTOKYLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200893", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ISOETHARINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200920", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "METIPRANOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200947", "mechanisms": ["Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LEVALBUTEROL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201061", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROPAFENONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201063", "mechanisms": ["Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ISOETHARINE MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201153", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "RITODRINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201160", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LEVOBUNOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201177", "mechanisms": ["Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "MILVETEROL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1940832", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "GSK159802", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545087", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "LAS190792", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545272", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ISOPROTERENOL SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200447", "mechanisms": ["Adrenergic receptor beta agonist"], "genes": ["ADRB2", "ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "HYDROXYAMPHETAMINE HYDROBROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200705", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB2", "ADRA1B", "ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIPIVEFRIN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200833", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB2", "ADRA1B", "ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MEPHENTERMINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200996", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB2", "ADRA1B", "ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "EPINEPHRINE BITARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256958", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB2", "ADRA1B", "ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PRAZOSIN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1558", "mechanisms": ["Adrenergic receptor alpha-1 antagonist"], "genes": ["ADRA1B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DOXAZOSIN MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200561", "mechanisms": ["Adrenergic receptor alpha-1 antagonist"], "genes": ["ADRA1B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TRIMIPRAMINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200948", "mechanisms": ["Adrenergic receptor alpha-1 antagonist"], "genes": ["ADRA1B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TERAZOSIN HYDROCHLORIDE HYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201091", "mechanisms": ["Adrenergic receptor alpha-1 antagonist"], "genes": ["ADRA1B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "METHOXAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201103", "mechanisms": ["Adrenergic receptor alpha-1 agonist"], "genes": ["ADRA1B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "METARAMINOL BITARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062262", "mechanisms": ["Adrenergic receptor alpha-1 agonist"], "genes": ["ADRA1B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TOLAZOLINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1689", "mechanisms": ["Adrenergic receptor alpha antagonist"], "genes": ["ADRA1B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "NAPHAZOLINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1706", "mechanisms": ["Adrenergic receptor alpha agonist"], "genes": ["ADRA1B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TETRAHYDROZOLINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200413", "mechanisms": ["Adrenergic receptor alpha agonist"], "genes": ["ADRA1B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PHENOXYBENZAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200787", "mechanisms": ["Adrenergic receptor alpha antagonist"], "genes": ["ADRA1B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PHENTOLAMINE MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200873", "mechanisms": ["Adrenergic receptor alpha antagonist"], "genes": ["ADRA1B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ALSEROXYLON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201454", "mechanisms": ["Adrenergic receptor alpha antagonist"], "genes": ["ADRA1B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ERGOTAMINE TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062265", "mechanisms": ["Adrenergic receptor alpha agonist"], "genes": ["ADRA1B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "OXYBUTYNIN CHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1133", "mechanisms": ["Muscarinic acetylcholine receptor M2 antagonist"], "genes": ["CHRM2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BETHANECHOL CHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1768", "mechanisms": ["Muscarinic acetylcholine receptor M2 agonist"], "genes": ["CHRM2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DARIFENACIN HYDROBROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200935", "mechanisms": ["Muscarinic acetylcholine receptor M2 antagonist"], "genes": ["CHRM2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "DAROTROPIUM BROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103803", "mechanisms": ["Muscarinic acetylcholine receptor antagonist"], "genes": ["CHRM2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "Afacifenacin", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545165", "mechanisms": ["Muscarinic acetylcholine receptor antagonist"], "genes": ["CHRM2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CORTICOTROPIN ZINC HYDROXIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201609", "mechanisms": ["Melanocortin receptor 2 agonist"], "genes": ["MC2R"], "type": "Protein", "diseases": []}, {"indications": [], "max_phase": 4, "name": "SERACTIDE ACETATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201489", "mechanisms": ["Melanocortin receptor 2 agonist"], "genes": ["MC2R"], "type": "Protein", "diseases": []}, {"indications": [], "max_phase": 2, "name": "RAFABEGRON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL279260", "mechanisms": ["Beta-3 adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "SOLABEGRON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL208427", "mechanisms": ["Beta-3 adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "AMIBEGRON HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL545437", "mechanisms": ["Beta-3 adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "ABX-IL8", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109616", "mechanisms": ["Interleukin-8 inhibitor"], "genes": ["CXCL8"], "type": "Antibody", "diseases": []}, {"indications": [], "max_phase": 1, "name": "CEP-2563", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545332", "mechanisms": ["Protein kinase C (PKC) inhibitor"], "genes": ["PRKCA"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "RGB-286638", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545083", "mechanisms": ["Cyclin-dependent kinase 1 inhibitor"], "genes": ["CDK1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "Riviciclib", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545283", "mechanisms": ["Cyclin-dependent kinase 1 inhibitor"], "genes": ["CDK1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "AG-24322", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545420", "mechanisms": ["Cyclin-dependent kinase 1 inhibitor"], "genes": ["CDK1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "AZD-5438", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL488436", "mechanisms": ["Cyclin-dependent kinase inhibitor"], "genes": ["CDK1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "CC-401", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1614713", "mechanisms": ["c-Jun N-terminal kinase 1 inhibitor"], "genes": ["MAPK8"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "Bentamapimod", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545213", "mechanisms": ["c-Jun N-terminal kinase, JNK inhibitor"], "genes": ["MAPK8"], "type": "Small molecule", "diseases": []}], "heat": 0.26566826197963755, "nodes": [{"assoc": 1.0, "id": "ENSG00000082556", "label": "OPRK1"}, {"assoc": 1.0, "id": "ENSG00000112038", "label": "OPRM1"}, {"assoc": 0.0953904246226, "id": "ENSG00000115008", "label": "IL1A"}, {"assoc": 0.0882393396175, "id": "ENSG00000115138", "label": "POMC"}, {"assoc": 0.228518732862, "id": "ENSG00000115594", "label": "IL1R1"}, {"assoc": 1.0, "id": "ENSG00000116329", "label": "OPRD1"}, {"assoc": 0.018706, "id": "ENSG00000116729", "label": "WLS"}, {"assoc": 0.26309452875, "id": "ENSG00000118113", "label": "MMP8"}, {"assoc": 0.201858736014, "id": "ENSG00000125538", "label": "IL1B"}, {"assoc": 1.0, "id": "ENSG00000135312", "label": "HTR1B"}, {"assoc": 0.112125856494, "id": "ENSG00000136689", "label": "IL1RN"}, {"assoc": 0.051216, "id": "ENSG00000136697", "label": "IL1F10"}, {"assoc": 1.0, "id": "ENSG00000144481", "label": "TRPM8"}, {"assoc": 0.214656697009, "id": "ENSG00000164270", "label": "HTR4"}, {"assoc": 1.0, "id": "ENSG00000169252", "label": "ADRB2"}, {"assoc": 0.138377069406, "id": "ENSG00000169344", "label": "UMOD"}, {"assoc": 1.0, "id": "ENSG00000170214", "label": "ADRA1B"}, {"assoc": 1.0, "id": "ENSG00000181072", "label": "CHRM2"}, {"assoc": 0.014356, "id": "ENSG00000185231", "label": "MC2R"}, {"assoc": 1.0, "id": "ENSG00000188778", "label": "ADRB3"}, {"assoc": 0.0943788761213, "id": "ENSG00000226979", "label": "LTA"}, {"assoc": 0.0200108333333, "id": "ENSG00000227507", "label": "LTB"}, {"assoc": 0.0858013849558, "id": "ENSG00000258839", "label": "MC1R"}, {"assoc": 0, "id": "ENSG00000092820", "label": "EZR"}, {"assoc": 0, "id": "ENSG00000109062", "label": "SLC9A3R1"}, {"assoc": 0, "id": "ENSG00000115415", "label": "STAT1"}, {"assoc": 0, "id": "ENSG00000100393", "label": "EP300"}, {"assoc": 0, "id": "ENSG00000169429", "label": "CXCL8"}, {"assoc": 0, "id": "ENSG00000154229", "label": "PRKCA"}, {"assoc": 0, "id": "ENSG00000109072", "label": "VTN"}, {"assoc": 0, "id": "ENSG00000130561", "label": "SAG"}, {"assoc": 0, "id": "ENSG00000163914", "label": "RHO"}, {"assoc": 0, "id": "ENSG00000198055", "label": "GRK6"}, {"assoc": 0, "id": "ENSG00000156052", "label": "GNAQ"}, {"assoc": 0, "id": "ENSG00000087258", "label": "GNAO1"}, {"assoc": 0, "id": "ENSG00000170312", "label": "CDK1"}, {"assoc": 0, "id": "ENSG00000066044", "label": "ELAVL1"}, {"assoc": 0, "id": "ENSG00000060558", "label": "GNA15"}, {"assoc": 0, "id": "ENSG00000173020", "label": "GRK2"}, {"assoc": 0, "id": "ENSG00000107643", "label": "MAPK8"}], "size": 40}, {"diseases": ["PAIN", "GASTRIC CARCINOMA", "HYPERTENSION", "ARTHRITIS", "MYALGIA", "FROZEN SHOULDER", "TENDINOPATHY", "DIABETIC NEUROPATHY", "NICOTINE DEPENDENCE", "IRRITABLE BOWEL SYNDROME", "MARIJUANA DEPENDENCE", "SCHIZOPHRENIA", "CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING", "OBSTRUCTIVE SLEEP APNEA", "ANOREXIA NERVOSA", "DRUG DEPENDENCE", "NAUSEA", "ALCOHOL DEPENDENCE", "ALZHEIMERS DISEASE", "SMOKING CESSATION", "ACUTE GRAFT VS. HOST DISEASE", "ANXIETY", "EPILEPSY", "NEOPLASM", "SEIZURES", "PARKINSON'S DISEASE", "LENNOX-GASTAUT SYNDROME", "POST-TRAUMATIC STRESS DISORDER", "PRADER-WILLI SYNDROME", "LUNG CARCINOMA", "DRAVET SYNDROME", "HEPATIC STEATOSIS", "ULCERATIVE COLITIS", "COCAINE DEPENDENCE", "OPIOID DEPENDENCE", "OBESITY", "TYPE II DIABETES MELLITUS", "POST OPERATIVE NAUSEA AND VOMITING", "SPASTICITY", "OBSESSIVE-COMPULSIVE DISORDER", "CACHEXIA", "LIVER DISEASE", "CORONARY ARTERY DISEASE", "SICKLE CELL ANEMIA", "CORONARY HEART DISEASE", "CARDIOVASCULAR DISEASE", "MYOCARDIAL ISCHEMIA", "DIABETIC FOOT", "HUNTINGTON DISEASE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "NEUROPATHIC PAIN", "NON-SMALL CELL LUNG CARCINOMA", "BILIARY ATRESIA", "DUCHENNE MUSCULAR DYSTROPHY", "CUTANEOUS LEISHMANIASIS", "ENDOMETRIOSIS", "NECROTIZING ENTEROCOLITIS", "PATENT DUCTUS ARTERIOSUS", "HEPATITIS, ALCOHOLIC", "ACUTE KIDNEY INJURY", "MYOCARDIAL INFARCTION", "ACUTE MYELOID LEUKEMIA", "CHRONIC LYMPHOCYTIC LEUKEMIA", "ATRIAL FIBRILLATION", "CARDIOMYOPATHY", "WOLFF-PARKINSON-WHITE SYNDROME", "CORONARY STENOSIS", "ANGINA PECTORIS", "DYSPNEA", "MIGRAINE DISORDER", "AMBLYOPIA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "OBSTRUCTIVE LUNG DISEASE", "ASTHMA", "PREMATURE BIRTH", "CHRONIC KIDNEY DISEASE", "RETINOPATHY OF PREMATURITY", "BLADDER CARCINOMA", "PULMONARY HYPERTENSION", "EMPHYSEMA", "ALTITUDE SICKNESS", "CHRONIC BRONCHITIS", "CARCINOMA", "DIABETIC RETINOPATHY", "PROSTATE CARCINOMA", "BREAST CARCINOMA", "CONGENITAL ISOLATED HYPERINSULINISM", "CANCER", "ACROMEGALY", "INSOMNIA", "SLEEP APNEA", "PANIC DISORDER", "PSYCHOSIS", "BIPOLAR DISORDER", "AUTISM", "DIABETES MELLITUS", "UNIPOLAR DEPRESSION", "FISH-EYE DISEASE", "INJURY", "NAUSEA AND VOMITING", "MENTAL OR BEHAVIOURAL DISORDER", "TOURETTE SYNDROME", "AGGRESSIVE BEHAVIOR", "AGITATION", "AUTISM SPECTRUM DISORDER", "POSTPARTUM DEPRESSION", "SCHIZOAFFECTIVE DISORDER", "PSORIASIS", "BORDERLINE PERSONALITY DISORDER SYMPTOM", "MULTIPLE SCLEROSIS", "INFERTILITY", "RESTLESS LEGS SYNDROME", "OVARIAN HYPERSTIMULATION SYNDROME", "AMYOTROPHIC LATERAL SCLEROSIS", "POST-OPERATIVE SIGN OR SYMPTOM", "CONDUCT DISORDER", "NEONATAL ABSTINENCE SYNDROME", "EATING DISORDER", "GAMBLING BEHAVIOUR", "HIV INFECTION", "VOMITING", "INSULIN RESISTANCE", "LYMPHOID NEOPLASM", "FIBROMYALGIA", "HYPERPROLACTINEMIA", "HYPOGONADISM", "GROWTH HORMONE EXCESS", "HEART FAILURE", "CONGESTIVE HEART FAILURE", "OCULAR HYPERTENSION", "FEVER", "OSTEOARTHRITIS", "OSTEOARTHRITIS, KNEE", "DIGESTIVE SYSTEM DISEASE", "CLEFT PALATE", "INFLUENZA INFECTION", "SEPSIS", "ABDOMINAL PAIN", "DYSMENORRHEA", "COMMON COLD", "HEMORRHAGE", "BACTERIAL MENINGITIS", "CERVICAL ADENOCARCINOMA", "GLAUCOMA", "TONSILLITIS", "BRAIN DISEASE", "PULPITIS", "TYPE I DIABETES MELLITUS", "OSTEOARTHRITIS, HIP", "RENAL COLIC", "ARTHRALGIA", "COUGH", "CYSTINOSIS", "DISORDER OF LIPID METABOLISM", "PRURITUS", "RHINITIS", "ATOPIC ECZEMA", "NEUROGENIC BLADDER", "ROSACEA", "SEBORRHEIC DERMATITIS", "MESOTHELIOMA", "CENTRAL NERVOUS SYSTEM CANCER", "PANCREATIC CARCINOMA", "THYROID CARCINOMA", "OVARIAN CARCINOMA", "GASTROINTESTINAL STROMAL TUMOR", "THYROID NEOPLASM", "HEPATOCELLULAR CARCINOMA", "CLEAR CELL RENAL CARCINOMA", "NEUROBLASTOMA", "GLIOBLASTOMA MULTIFORME", "CHRONIC MYELOGENOUS LEUKEMIA", "BREAST NEOPLASM", "LEUKEMIA", "LYMPHANGIOLEIOMYOMATOSIS", "OSTEOSARCOMA", "MALE BREAST CARCINOMA", "MELANOMA", "ALCOHOL DRINKING", "ACTINIC KERATOSIS", "ABNORMALITY OF BLOOD AND BLOOD-FORMING TISSUES", "MULTIPLE MYELOMA", "NON-HODGKINS LYMPHOMA", "SQUAMOUS CELL LUNG CARCINOMA", "ACUTE LYMPHOBLASTIC LEUKEMIA", "METASTATIC MELANOMA", "SYSTEMIC SCLERODERMA", "MALIGNANT PLEURAL MESOTHELIOMA", "DIFFUSE LARGE B-CELL LYMPHOMA", "POLYCYTHEMIA VERA", "LYMPHOMA", "SMALL CELL LUNG CARCINOMA", "PROSTATE ADENOCARCINOMA", "CHOLANGIOCARCINOMA", "GLIOSARCOMA"], "links": [{"source": "ENSG00000104321", "target": "ENSG00000196689"}, {"source": "ENSG00000118432", "target": "ENSG00000128271"}, {"source": "ENSG00000118432", "type": "inhibitory", "target": "ENSG00000196689"}, {"source": "ENSG00000121853", "target": "ENSG00000241563", "reverse": "rev-stimulatory"}, {"source": "ENSG00000128271", "target": "ENSG00000149295"}, {"source": "ENSG00000128271", "target": "ENSG00000163485"}, {"source": "ENSG00000132671", "target": "ENSG00000157005", "reverse": "rev-stimulatory"}, {"source": "ENSG00000132671", "target": "ENSG00000241563", "reverse": "rev-stimulatory"}, {"source": "ENSG00000137252", "target": "ENSG00000161610", "reverse": "rev-stimulatory"}, {"source": "ENSG00000139874", "target": "ENSG00000157005", "reverse": "rev-stimulatory"}, {"source": "ENSG00000139874", "target": "ENSG00000162009"}, {"source": "ENSG00000139874", "target": "ENSG00000241563", "reverse": "rev-stimulatory"}, {"source": "ENSG00000149295", "target": "ENSG00000162009"}, {"source": "ENSG00000157005", "type": "stimulatory", "target": "ENSG00000162009"}, {"source": "ENSG00000157005", "type": "stimulatory", "target": "ENSG00000180616"}, {"source": "ENSG00000157005", "type": "stimulatory", "target": "ENSG00000278195"}, {"source": "ENSG00000162009", "target": "ENSG00000241563", "reverse": "rev-stimulatory"}, {"source": "ENSG00000162105", "target": "ENSG00000180616"}, {"source": "ENSG00000163485", "target": "ENSG00000169860"}, {"source": "ENSG00000163485", "target": "ENSG00000196839"}, {"source": "ENSG00000167723", "target": "ENSG00000196689"}, {"source": "ENSG00000169241", "type": "stimulatory", "target": "ENSG00000187688"}, {"source": "ENSG00000180616", "target": "ENSG00000241563", "reverse": "rev-stimulatory"}, {"source": "ENSG00000180616", "target": "ENSG00000278195"}, {"source": "ENSG00000183695", "target": "ENSG00000241563", "reverse": "rev-stimulatory"}, {"source": "ENSG00000187688", "target": "ENSG00000196689"}, {"source": "ENSG00000241563", "type": "stimulatory", "target": "ENSG00000278195"}, {"source": "ENSG00000137252", "type": "manual", "target": "ENSG00000161610"}, {"source": "ENSG00000161610", "type": "manual", "target": "ENSG00000121764"}, {"source": "ENSG00000121764", "type": "manual", "target": "ENSG00000197122"}, {"source": "ENSG00000197122", "type": "manual", "target": "ENSG00000085733"}, {"source": "ENSG00000085733", "type": "manual", "target": "ENSG00000162105"}], "drugs": [{"indications": [{"efo_term": "ACUTE LYMPHOBLASTIC LEUKEMIA", "stage": 4}, {"efo_term": "CANCER", "stage": 4}, {"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "LEUKEMIA", "stage": 3}, {"efo_term": "CHRONIC MYELOGENOUS LEUKEMIA", "stage": 3}, {"efo_term": "ABNORMALITY OF BLOOD AND BLOOD-FORMING TISSUES", "stage": 2}, {"efo_term": "CHRONIC LYMPHOCYTIC LEUKEMIA", "stage": 2}, {"efo_term": "MULTIPLE MYELOMA", "stage": 2}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "PANCREATIC CARCINOMA", "stage": 2}, {"efo_term": "SQUAMOUS CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "LUNG CARCINOMA", "stage": 2}, {"efo_term": "METASTATIC MELANOMA", "stage": 2}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 2}, {"efo_term": "MALIGNANT PLEURAL MESOTHELIOMA", "stage": 2}, {"efo_term": "DIFFUSE LARGE B-CELL LYMPHOMA", "stage": 2}, {"efo_term": "MELANOMA", "stage": 2}, {"efo_term": "MESOTHELIOMA", "stage": 2}, {"efo_term": "POLYCYTHEMIA VERA", "stage": 2}, {"efo_term": "BREAST NEOPLASM", "stage": 2}, {"efo_term": "HEPATOCELLULAR CARCINOMA", "stage": 2}, {"efo_term": "LYMPHOMA", "stage": 2}, {"efo_term": "SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "PROSTATE ADENOCARCINOMA", "stage": 2}, {"efo_term": "CHOLANGIOCARCINOMA", "stage": 2}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 2}, {"efo_term": "GLIOSARCOMA", "stage": 2}, {"efo_term": "NON-HODGKINS LYMPHOMA", "stage": 1}, {"efo_term": "GLIOBLASTOMA MULTIFORME", "stage": 1}, {"efo_term": "SYSTEMIC SCLERODERMA", "stage": 1}], "max_phase": 4, "name": "DASATINIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421", "mechanisms": ["SRC inhibitor"], "genes": ["SRC"], "type": "Small molecule", "diseases": ["ABNORMALITY OF BLOOD AND BLOOD-FORMING TISSUES", "CHRONIC LYMPHOCYTIC LEUKEMIA", "LEUKEMIA", "MULTIPLE MYELOMA", "NON-HODGKINS LYMPHOMA", "NON-SMALL CELL LUNG CARCINOMA", "PANCREATIC CARCINOMA", "SQUAMOUS CELL LUNG CARCINOMA", "BREAST CARCINOMA", "CHRONIC MYELOGENOUS LEUKEMIA", "PROSTATE CARCINOMA", "ACUTE LYMPHOBLASTIC LEUKEMIA", "GLIOBLASTOMA MULTIFORME", "LUNG CARCINOMA", "METASTATIC MELANOMA", "SYSTEMIC SCLERODERMA", "ACUTE MYELOID LEUKEMIA", "CANCER", "MALIGNANT PLEURAL MESOTHELIOMA", "NEOPLASM", "DIFFUSE LARGE B-CELL LYMPHOMA", "MELANOMA", "MESOTHELIOMA", "POLYCYTHEMIA VERA", "BREAST NEOPLASM", "HEPATOCELLULAR CARCINOMA", "LYMPHOMA", "SMALL CELL LUNG CARCINOMA", "PROSTATE ADENOCARCINOMA", "CHOLANGIOCARCINOMA", "CHRONIC KIDNEY DISEASE", "GLIOSARCOMA"]}, {"indications": [{"efo_term": "FEVER", "stage": 4}, {"efo_term": "MIGRAINE DISORDER", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "ARTHRITIS", "stage": 4}, {"efo_term": "INFLUENZA INFECTION", "stage": 4}, {"efo_term": "DYSMENORRHEA", "stage": 4}, {"efo_term": "COMMON COLD", "stage": 4}, {"efo_term": "OSTEOARTHRITIS", "stage": 3}, {"efo_term": "OSTEOARTHRITIS, KNEE", "stage": 3}, {"efo_term": "ABDOMINAL PAIN", "stage": 3}, {"efo_term": "BACTERIAL MENINGITIS", "stage": 3}, {"efo_term": "OSTEOARTHRITIS, HIP", "stage": 3}, {"efo_term": "DIGESTIVE SYSTEM DISEASE", "stage": 2}, {"efo_term": "CLEFT PALATE", "stage": 2}, {"efo_term": "PATENT DUCTUS ARTERIOSUS", "stage": 2}, {"efo_term": "HYPERTENSION", "stage": 2}, {"efo_term": "BORDERLINE PERSONALITY DISORDER SYMPTOM", "stage": 2}, {"efo_term": "SEPSIS", "stage": 2}, {"efo_term": "INJURY", "stage": 2}, {"efo_term": "HEMORRHAGE", "stage": 2}, {"efo_term": "CERVICAL ADENOCARCINOMA", "stage": 2}, {"efo_term": "TONSILLITIS", "stage": 2}, {"efo_term": "BRAIN DISEASE", "stage": 2}, {"efo_term": "PULPITIS", "stage": 2}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 2}, {"efo_term": "RENAL COLIC", "stage": 2}, {"efo_term": "GLAUCOMA", "stage": 0}], "max_phase": 4, "name": "ACETAMINOPHEN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL112", "mechanisms": ["Vanilloid receptor opener"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": ["FEVER", "MIGRAINE DISORDER", "OSTEOARTHRITIS", "OSTEOARTHRITIS, KNEE", "PAIN", "DIGESTIVE SYSTEM DISEASE", "ARTHRITIS", "CLEFT PALATE", "PATENT DUCTUS ARTERIOSUS", "HYPERTENSION", "INFLUENZA INFECTION", "BORDERLINE PERSONALITY DISORDER SYMPTOM", "SEPSIS", "INJURY", "ABDOMINAL PAIN", "DYSMENORRHEA", "COMMON COLD", "HEMORRHAGE", "BACTERIAL MENINGITIS", "CERVICAL ADENOCARCINOMA", "GLAUCOMA", "TONSILLITIS", "BRAIN DISEASE", "PULPITIS", "TYPE I DIABETES MELLITUS", "OSTEOARTHRITIS, HIP", "RENAL COLIC"]}, {"indications": [{"efo_term": "ARTHRALGIA", "stage": 4}, {"efo_term": "MYALGIA", "stage": 4}, {"efo_term": "ARTHRITIS", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "FROZEN SHOULDER", "stage": 4}, {"efo_term": "TENDINOPATHY", "stage": 4}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "OSTEOARTHRITIS", "stage": 3}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 3}, {"efo_term": "ANGINA PECTORIS", "stage": 3}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "DISORDER OF LIPID METABOLISM", "stage": 2}, {"efo_term": "COUGH", "stage": 1}, {"efo_term": "PARKINSON'S DISEASE", "stage": 1}, {"efo_term": "PRURITUS", "stage": 1}, {"efo_term": "AMYOTROPHIC LATERAL SCLEROSIS", "stage": 0}, {"efo_term": "MIGRAINE DISORDER", "stage": 0}, {"efo_term": "CYSTINOSIS", "stage": 0}, {"efo_term": "INJURY", "stage": 0}], "max_phase": 4, "name": "CAPSAICIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL294199", "mechanisms": ["Vanilloid receptor opener"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": ["PAIN", "ARTHRALGIA", "MYALGIA", "AMYOTROPHIC LATERAL SCLEROSIS", "OSTEOARTHRITIS", "COUGH", "PULMONARY HYPERTENSION", "ARTHRITIS", "FROZEN SHOULDER", "TENDINOPATHY", "PARKINSON'S DISEASE", "MIGRAINE DISORDER", "CYSTINOSIS", "PROSTATE CARCINOMA", "DIABETIC NEUROPATHY", "DISORDER OF LIPID METABOLISM", "PRURITUS", "INJURY", "ANGINA PECTORIS"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 3}, {"efo_term": "SEIZURES", "stage": 3}, {"efo_term": "LENNOX-GASTAUT SYNDROME", "stage": 3}, {"efo_term": "DRAVET SYNDROME", "stage": 3}, {"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 2}, {"efo_term": "ANXIETY", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 2}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "DRUG DEPENDENCE", "stage": 2}, {"efo_term": "PRADER-WILLI SYNDROME", "stage": 2}, {"efo_term": "HEPATIC STEATOSIS", "stage": 2}, {"efo_term": "ULCERATIVE COLITIS", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "OPIOID DEPENDENCE", "stage": 2}, {"efo_term": "PAIN", "stage": 1}, {"efo_term": "ACUTE GRAFT VS. HOST DISEASE", "stage": 1}, {"efo_term": "LUNG CARCINOMA", "stage": 1}], "max_phase": 3, "name": "CANNABIDIOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL190461", "mechanisms": ["Cannabinoid CB1 receptor Negative allosteric modulator"], "genes": ["CNR1"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "PAIN", "MARIJUANA DEPENDENCE", "ACUTE GRAFT VS. HOST DISEASE", "ANXIETY", "EPILEPSY", "NEOPLASM", "SEIZURES", "PARKINSON'S DISEASE", "LENNOX-GASTAUT SYNDROME", "POST-TRAUMATIC STRESS DISORDER", "DRUG DEPENDENCE", "PRADER-WILLI SYNDROME", "LUNG CARCINOMA", "DRAVET SYNDROME", "HEPATIC STEATOSIS", "ULCERATIVE COLITIS", "COCAINE DEPENDENCE", "OPIOID DEPENDENCE"]}, {"indications": [{"efo_term": "AUTISM", "stage": 4}, {"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "AGGRESSIVE BEHAVIOR", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "AGITATION", "stage": 4}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 3}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 3}, {"efo_term": "MENTAL OR BEHAVIOURAL DISORDER", "stage": 3}, {"efo_term": "TOURETTE SYNDROME", "stage": 3}, {"efo_term": "ANOREXIA NERVOSA", "stage": 3}, {"efo_term": "POSTPARTUM DEPRESSION", "stage": 3}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 2}, {"efo_term": "DIABETES MELLITUS", "stage": 2}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "AUTISM SPECTRUM DISORDER", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "ARIPIPRAZOLE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1112", "mechanisms": ["Dopamine D2 receptor partial agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["ALCOHOL DEPENDENCE", "ALZHEIMERS DISEASE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "AUTISM", "BIPOLAR DISORDER", "SCHIZOPHRENIA", "UNIPOLAR DEPRESSION", "MENTAL OR BEHAVIOURAL DISORDER", "PSYCHOSIS", "TOURETTE SYNDROME", "DIABETES MELLITUS", "POST-TRAUMATIC STRESS DISORDER", "ANOREXIA NERVOSA", "AGGRESSIVE BEHAVIOR", "AGITATION", "AUTISM SPECTRUM DISORDER", "POSTPARTUM DEPRESSION", "COCAINE DEPENDENCE"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "EATING DISORDER", "stage": 3}, {"efo_term": "HUNTINGTON DISEASE", "stage": 3}, {"efo_term": "GAMBLING BEHAVIOUR", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 3}, {"efo_term": "LYMPHOID NEOPLASM", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "DIABETES MELLITUS", "stage": 2}, {"efo_term": "CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING", "stage": 2}, {"efo_term": "AUTISM", "stage": 2}, {"efo_term": "VOMITING", "stage": 2}, {"efo_term": "INSULIN RESISTANCE", "stage": 2}, {"efo_term": "POST OPERATIVE NAUSEA AND VOMITING", "stage": 2}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}, {"efo_term": "HIV INFECTION", "stage": 1}], "max_phase": 4, "name": "OLANZAPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL715", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "EATING DISORDER", "HUNTINGTON DISEASE", "SCHIZOPHRENIA", "DIABETES MELLITUS", "GAMBLING BEHAVIOUR", "UNIPOLAR DEPRESSION", "CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING", "FISH-EYE DISEASE", "HIV INFECTION", "ALCOHOL DEPENDENCE", "AUTISM", "PSYCHOSIS", "VOMITING", "INSULIN RESISTANCE", "POST OPERATIVE NAUSEA AND VOMITING", "CANCER", "LYMPHOID NEOPLASM", "BREAST CARCINOMA"]}, {"indications": [{"efo_term": "THYROID CARCINOMA", "stage": 4}, {"efo_term": "THYROID NEOPLASM", "stage": 4}, {"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "CANCER", "stage": 4}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 3}, {"efo_term": "MESOTHELIOMA", "stage": 2}, {"efo_term": "PANCREATIC CARCINOMA", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "GASTROINTESTINAL STROMAL TUMOR", "stage": 2}, {"efo_term": "HEPATOCELLULAR CARCINOMA", "stage": 2}, {"efo_term": "CLEAR CELL RENAL CARCINOMA", "stage": 2}, {"efo_term": "LUNG CARCINOMA", "stage": 2}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "CENTRAL NERVOUS SYSTEM CANCER", "stage": 1}, {"efo_term": "OVARIAN CARCINOMA", "stage": 1}, {"efo_term": "NEUROBLASTOMA", "stage": 1}], "max_phase": 4, "name": "VANDETANIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828", "mechanisms": ["Tyrosine-protein kinase SRC inhibitor"], "genes": ["SRC"], "type": "Small molecule", "diseases": ["MESOTHELIOMA", "CENTRAL NERVOUS SYSTEM CANCER", "PANCREATIC CARCINOMA", "THYROID CARCINOMA", "NON-SMALL CELL LUNG CARCINOMA", "OVARIAN CARCINOMA", "PROSTATE CARCINOMA", "GASTROINTESTINAL STROMAL TUMOR", "THYROID NEOPLASM", "HEPATOCELLULAR CARCINOMA", "NEOPLASM", "CLEAR CELL RENAL CARCINOMA", "NEUROBLASTOMA", "CANCER", "LUNG CARCINOMA", "BREAST CARCINOMA"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "WOLFF-PARKINSON-WHITE SYNDROME", "stage": 4}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 3}, {"efo_term": "ATRIAL FIBRILLATION", "stage": 3}, {"efo_term": "CORONARY STENOSIS", "stage": 3}, {"efo_term": "ANGINA PECTORIS", "stage": 3}, {"efo_term": "PAIN", "stage": 2}, {"efo_term": "MYOCARDIAL INFARCTION", "stage": 2}, {"efo_term": "CARDIOMYOPATHY", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 1}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 1}, {"efo_term": "CHRONIC LYMPHOCYTIC LEUKEMIA", "stage": 1}], "max_phase": 4, "name": "ADENOSINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477", "mechanisms": ["Adenosine receptor agonist"], "genes": ["ADORA2A", "ADORA1"], "type": "Small molecule", "diseases": ["CORONARY ARTERY DISEASE", "PAIN", "NEOPLASM", "MYOCARDIAL INFARCTION", "CARDIOVASCULAR DISEASE", "ACUTE MYELOID LEUKEMIA", "CHRONIC LYMPHOCYTIC LEUKEMIA", "ATRIAL FIBRILLATION", "CARDIOMYOPATHY", "WOLFF-PARKINSON-WHITE SYNDROME", "CORONARY STENOSIS", "ANGINA PECTORIS"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "ENDOMETRIOSIS", "stage": 3}, {"efo_term": "HEPATITIS, ALCOHOLIC", "stage": 3}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "BILIARY ATRESIA", "stage": 2}, {"efo_term": "CUTANEOUS LEISHMANIASIS", "stage": 2}, {"efo_term": "NECROTIZING ENTEROCOLITIS", "stage": 2}, {"efo_term": "PATENT DUCTUS ARTERIOSUS", "stage": 2}, {"efo_term": "ACUTE KIDNEY INJURY", "stage": 2}, {"efo_term": "HEPATIC STEATOSIS", "stage": 2}, {"efo_term": "DUCHENNE MUSCULAR DYSTROPHY", "stage": 1}], "max_phase": 4, "name": "PENTOXIFYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL628", "mechanisms": ["Adenosine A2 receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["NON-SMALL CELL LUNG CARCINOMA", "BILIARY ATRESIA", "DUCHENNE MUSCULAR DYSTROPHY", "CUTANEOUS LEISHMANIASIS", "ENDOMETRIOSIS", "NECROTIZING ENTEROCOLITIS", "PATENT DUCTUS ARTERIOSUS", "CARDIOVASCULAR DISEASE", "HEPATITIS, ALCOHOLIC", "ACUTE KIDNEY INJURY", "HEPATIC STEATOSIS"]}, {"indications": [{"efo_term": "LYMPHANGIOLEIOMYOMATOSIS", "stage": 2}, {"efo_term": "OSTEOSARCOMA", "stage": 2}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "MALE BREAST CARCINOMA", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 2}, {"efo_term": "MELANOMA", "stage": 2}, {"efo_term": "ALCOHOL DRINKING", "stage": 2}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 1}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 1}], "max_phase": 3, "name": "SARACATINIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL217092", "mechanisms": ["Tyrosine-protein kinase SRC inhibitor"], "genes": ["SRC"], "type": "Small molecule", "diseases": ["LYMPHANGIOLEIOMYOMATOSIS", "OSTEOSARCOMA", "NON-SMALL CELL LUNG CARCINOMA", "CANCER", "PROSTATE CARCINOMA", "MALE BREAST CARCINOMA", "NEOPLASM", "MELANOMA", "ALCOHOL DRINKING", "ALZHEIMERS DISEASE", "ALCOHOL DEPENDENCE"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "ARTHRITIS", "stage": 4}, {"efo_term": "MYALGIA", "stage": 4}, {"efo_term": "FROZEN SHOULDER", "stage": 4}, {"efo_term": "TENDINOPATHY", "stage": 4}, {"efo_term": "GASTRIC CARCINOMA", "stage": 3}, {"efo_term": "HYPERTENSION", "stage": 2}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 1}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "MENTHOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL256087", "mechanisms": ["Transient receptor potential cation channel subfamily A member 1 opener"], "genes": ["TRPA1"], "type": "Small molecule", "diseases": ["PAIN", "GASTRIC CARCINOMA", "HYPERTENSION", "ARTHRITIS", "MYALGIA", "FROZEN SHOULDER", "TENDINOPATHY", "DIABETIC NEUROPATHY", "NICOTINE DEPENDENCE"]}, {"indications": [{"efo_term": "CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING", "stage": 4}, {"efo_term": "NAUSEA", "stage": 4}, {"efo_term": "ANOREXIA NERVOSA", "stage": 3}, {"efo_term": "IRRITABLE BOWEL SYNDROME", "stage": 2}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 2}, {"efo_term": "OBSTRUCTIVE SLEEP APNEA", "stage": 2}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 2}, {"efo_term": "SCHIZOPHRENIA", "stage": 1}, {"efo_term": "DRUG DEPENDENCE", "stage": 1}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "DRONABINOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL465", "mechanisms": ["Cannabinoid CB1 receptor agonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": ["IRRITABLE BOWEL SYNDROME", "MARIJUANA DEPENDENCE", "SCHIZOPHRENIA", "CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING", "OBSTRUCTIVE SLEEP APNEA", "ANOREXIA NERVOSA", "DRUG DEPENDENCE", "NAUSEA", "ALCOHOL DEPENDENCE", "ALZHEIMERS DISEASE"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 3}, {"efo_term": "MIGRAINE DISORDER", "stage": 3}, {"efo_term": "PARKINSON'S DISEASE", "stage": 3}, {"efo_term": "ATRIAL FIBRILLATION", "stage": 3}, {"efo_term": "DYSPNEA", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "AMBLYOPIA", "stage": 1}, {"efo_term": "PAIN", "stage": 1}], "max_phase": 4, "name": "CAFFEINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL113", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA2A", "ADORA1"], "type": "Small molecule", "diseases": ["CORONARY ARTERY DISEASE", "DYSPNEA", "MIGRAINE DISORDER", "PARKINSON'S DISEASE", "ATRIAL FIBRILLATION", "COCAINE DEPENDENCE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "AMBLYOPIA", "PAIN"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "AUTISM", "stage": 4}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "DIABETES MELLITUS", "stage": 2}, {"efo_term": "INJURY", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 1}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}], "max_phase": 4, "name": "RISPERIDONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL85", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "PSYCHOSIS", "SCHIZOPHRENIA", "AUTISM", "COCAINE DEPENDENCE", "DIABETES MELLITUS", "UNIPOLAR DEPRESSION", "FISH-EYE DISEASE", "INJURY"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "BORDERLINE PERSONALITY DISORDER SYMPTOM", "stage": 3}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 3}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 1}], "max_phase": 4, "name": "QUETIAPINE FUMARATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200911", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "BORDERLINE PERSONALITY DISORDER SYMPTOM", "FISH-EYE DISEASE", "POST-TRAUMATIC STRESS DISORDER", "SCHIZOPHRENIA", "UNIPOLAR DEPRESSION", "MULTIPLE SCLEROSIS", "ALCOHOL DEPENDENCE"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}, {"efo_term": "RESTLESS LEGS SYNDROME", "stage": 3}, {"efo_term": "OVARIAN HYPERSTIMULATION SYNDROME", "stage": 3}, {"efo_term": "INFERTILITY", "stage": 2}, {"efo_term": "ENDOMETRIOSIS", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 1}, {"efo_term": "OBESITY", "stage": 1}, {"efo_term": "BREAST CARCINOMA", "stage": 0}], "max_phase": 4, "name": "CABERGOLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201087", "mechanisms": ["Dopamine D2 receptor agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "INFERTILITY", "RESTLESS LEGS SYNDROME", "OVARIAN HYPERSTIMULATION SYNDROME", "COCAINE DEPENDENCE", "BREAST CARCINOMA", "OBESITY", "ENDOMETRIOSIS"]}, {"indications": [{"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "EMPHYSEMA", "stage": 4}, {"efo_term": "CHRONIC BRONCHITIS", "stage": 4}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 1}, {"efo_term": "ALTITUDE SICKNESS", "stage": 1}, {"efo_term": "BLADDER CARCINOMA", "stage": 0}], "max_phase": 4, "name": "AMINOPHYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1370561", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA2A", "ADORA1"], "type": "Small molecule", "diseases": ["OBSTRUCTIVE LUNG DISEASE", "ASTHMA", "BLADDER CARCINOMA", "PULMONARY HYPERTENSION", "EMPHYSEMA", "ALTITUDE SICKNESS", "CHRONIC BRONCHITIS"]}, {"indications": [{"efo_term": "ACROMEGALY", "stage": 4}, {"efo_term": "DIABETIC RETINOPATHY", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "CANCER", "stage": 3}, {"efo_term": "CARCINOMA", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "CONGENITAL ISOLATED HYPERINSULINISM", "stage": 2}], "max_phase": 4, "name": "OCTREOTIDE ACETATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200480", "mechanisms": ["Somatostatin receptor agonist"], "genes": ["SSTR4", "SSTR1", "SSTR5", "SSTR2", "SSTR3"], "type": "Protein", "diseases": ["CARCINOMA", "DIABETIC RETINOPATHY", "PROSTATE CARCINOMA", "BREAST CARCINOMA", "CONGENITAL ISOLATED HYPERINSULINISM", "CANCER", "ACROMEGALY"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "TOURETTE SYNDROME", "stage": 4}, {"efo_term": "CONDUCT DISORDER", "stage": 4}, {"efo_term": "BIPOLAR DISORDER", "stage": 3}, {"efo_term": "AGITATION", "stage": 3}, {"efo_term": "POST-OPERATIVE SIGN OR SYMPTOM", "stage": 3}], "max_phase": 4, "name": "HALOPERIDOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54", "mechanisms": ["D2-like dopamine receptor inverse agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "PSYCHOSIS", "SCHIZOPHRENIA", "AGITATION", "POST-OPERATIVE SIGN OR SYMPTOM", "TOURETTE SYNDROME", "CONDUCT DISORDER"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 3}, {"efo_term": "BIPOLAR DISORDER", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 2}, {"efo_term": "ASTHMA", "stage": 1}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 1}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 1}], "max_phase": 4, "name": "LOXAPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL831", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["ASTHMA", "NICOTINE DEPENDENCE", "PSYCHOSIS", "SCHIZOPHRENIA", "BIPOLAR DISORDER", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 4}, {"efo_term": "INFERTILITY", "stage": 4}, {"efo_term": "HYPERPROLACTINEMIA", "stage": 4}, {"efo_term": "HYPOGONADISM", "stage": 4}, {"efo_term": "GROWTH HORMONE EXCESS", "stage": 4}, {"efo_term": "ACROMEGALY", "stage": 4}], "max_phase": 4, "name": "BROMOCRIPTINE MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200503", "mechanisms": ["D2-like dopamine receptor agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "TYPE II DIABETES MELLITUS", "INFERTILITY", "HYPERPROLACTINEMIA", "HYPOGONADISM", "GROWTH HORMONE EXCESS", "ACROMEGALY"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "SCHIZOAFFECTIVE DISORDER", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "BIPOLAR DISORDER", "stage": 3}, {"efo_term": "AUTISM", "stage": 3}, {"efo_term": "OBSESSIVE-COMPULSIVE DISORDER", "stage": 2}], "max_phase": 4, "name": "PALIPERIDONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1621", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "SCHIZOPHRENIA", "SCHIZOAFFECTIVE DISORDER", "OBSESSIVE-COMPULSIVE DISORDER", "PSYCHOSIS", "AUTISM"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "INSOMNIA", "stage": 3}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 3}], "max_phase": 4, "name": "BREXPIPRAZOLE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105760", "mechanisms": ["Dopamine D2 receptor partial agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "UNIPOLAR DEPRESSION", "INSOMNIA", "PSYCHOSIS", "POST-TRAUMATIC STRESS DISORDER"]}, {"indications": [{"efo_term": "NAUSEA", "stage": 4}, {"efo_term": "POST OPERATIVE NAUSEA AND VOMITING", "stage": 2}, {"efo_term": "SPASTICITY", "stage": 2}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 2}, {"efo_term": "OBSESSIVE-COMPULSIVE DISORDER", "stage": 1}], "max_phase": 4, "name": "NABILONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2218896", "mechanisms": ["Cannabinoid CB1 receptor agonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": ["NAUSEA", "POST OPERATIVE NAUSEA AND VOMITING", "SPASTICITY", "MARIJUANA DEPENDENCE", "OBSESSIVE-COMPULSIVE DISORDER"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 3}, {"efo_term": "SICKLE CELL ANEMIA", "stage": 2}, {"efo_term": "MYOCARDIAL ISCHEMIA", "stage": 2}, {"efo_term": "CORONARY HEART DISEASE", "stage": 0}], "max_phase": 4, "name": "REGADENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL317052", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["CORONARY ARTERY DISEASE", "SICKLE CELL ANEMIA", "CORONARY HEART DISEASE", "CARDIOVASCULAR DISEASE", "MYOCARDIAL ISCHEMIA"]}, {"indications": [{"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 3}, {"efo_term": "PREMATURE BIRTH", "stage": 2}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 2}], "max_phase": 4, "name": "THEOPHYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL190", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA2A", "ADORA1"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "OBSTRUCTIVE LUNG DISEASE", "ASTHMA", "PREMATURE BIRTH", "CHRONIC KIDNEY DISEASE"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "CHRONIC MYELOGENOUS LEUKEMIA", "stage": 4}, {"efo_term": "GLIOBLASTOMA MULTIFORME", "stage": 2}, {"efo_term": "BREAST NEOPLASM", "stage": 2}, {"efo_term": "LEUKEMIA", "stage": 2}], "max_phase": 4, "name": "BOSUTINIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441", "mechanisms": ["Tyrosine-protein kinase SRC inhibitor"], "genes": ["SRC"], "type": "Small molecule", "diseases": ["GLIOBLASTOMA MULTIFORME", "NEOPLASM", "CHRONIC MYELOGENOUS LEUKEMIA", "BREAST NEOPLASM", "LEUKEMIA"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 4, "name": "ILOPERIDONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14376", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "LIVER DISEASE", "POST-TRAUMATIC STRESS DISORDER", "PSYCHOSIS"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "MIGRAINE DISORDER", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "NAUSEA AND VOMITING", "stage": 2}], "max_phase": 4, "name": "PROCHLORPERAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL728", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["MIGRAINE DISORDER", "NAUSEA AND VOMITING", "PSYCHOSIS", "PAIN"]}, {"indications": [{"efo_term": "ATOPIC ECZEMA", "stage": 3}, {"efo_term": "ROSACEA", "stage": 2}, {"efo_term": "PRURITUS", "stage": 2}, {"efo_term": "SEBORRHEIC DERMATITIS", "stage": 2}], "max_phase": 3, "name": "PAC-14028", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707398", "mechanisms": ["Vanilloid receptor antagonist"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": ["ATOPIC ECZEMA", "ROSACEA", "PRURITUS", "SEBORRHEIC DERMATITIS"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 3}, {"efo_term": "LIVER DISEASE", "stage": 1}, {"efo_term": "DRUG DEPENDENCE", "stage": 1}], "max_phase": 3, "name": "ISTRADEFYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL431770", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "LIVER DISEASE", "DRUG DEPENDENCE"]}, {"indications": [{"efo_term": "PREMATURE BIRTH", "stage": 3}, {"efo_term": "RETINOPATHY OF PREMATURITY", "stage": 2}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 4, "name": "CAFFEINE, CITRATED", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200569", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA2A", "ADORA1"], "type": "Small molecule", "diseases": ["PREMATURE BIRTH", "LIVER DISEASE", "RETINOPATHY OF PREMATURITY"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 4}, {"efo_term": "SLEEP APNEA", "stage": 1}, {"efo_term": "PANIC DISORDER", "stage": 0}], "max_phase": 4, "name": "SUVOREXANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1083659", "mechanisms": ["Orexin receptor antagonist"], "genes": ["HCRTR2", "HCRTR1"], "type": "Small molecule", "diseases": ["INSOMNIA", "SLEEP APNEA", "PANIC DISORDER"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 3}], "max_phase": 4, "name": "ASENAPINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544974", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "SCHIZOPHRENIA", "PSYCHOSIS"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 3}, {"efo_term": "SCHIZOPHRENIA", "stage": 3}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 1}], "max_phase": 3, "name": "ITI-007", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545044", "mechanisms": ["Dopamine D2 receptor partial agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE", "BIPOLAR DISORDER", "SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "AMYOTROPHIC LATERAL SCLEROSIS", "stage": 2}], "max_phase": 4, "name": "PIMOZIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1423", "mechanisms": ["Dopamine receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PSYCHOSIS", "SCHIZOPHRENIA", "AMYOTROPHIC LATERAL SCLEROSIS"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 3}, {"efo_term": "NEONATAL ABSTINENCE SYNDROME", "stage": 3}], "max_phase": 4, "name": "CHLORPROMAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL71", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PSYCHOSIS", "SCHIZOPHRENIA", "NEONATAL ABSTINENCE SYNDROME"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}, {"efo_term": "RESTLESS LEGS SYNDROME", "stage": 4}, {"efo_term": "FIBROMYALGIA", "stage": 2}], "max_phase": 4, "name": "ROTIGOTINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1303", "mechanisms": ["D2-like dopamine receptor agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["FIBROMYALGIA", "PARKINSON'S DISEASE", "RESTLESS LEGS SYNDROME"]}, {"indications": [{"efo_term": "COUGH", "stage": 2}, {"efo_term": "RHINITIS", "stage": 2}, {"efo_term": "ATOPIC ECZEMA", "stage": 1}], "max_phase": 2, "name": "SB-705498", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL207433", "mechanisms": ["Vanilloid receptor antagonist"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": ["COUGH", "RHINITIS", "ATOPIC ECZEMA"]}, {"indications": [{"efo_term": "CANCER", "stage": 4}, {"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "ACUTE GRAFT VS. HOST DISEASE", "stage": 2}], "max_phase": 4, "name": "PENTOSTATIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1580", "mechanisms": ["Adenosine deaminase inhibitor"], "genes": ["ADA"], "type": "Small molecule", "diseases": ["CANCER", "NEOPLASM", "ACUTE GRAFT VS. HOST DISEASE"]}, {"indications": [{"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "ACTINIC KERATOSIS", "stage": 2}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 1}], "max_phase": 2, "name": "KX2-391", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL571546", "mechanisms": ["Tyrosine-protein kinase SRC inhibitor"], "genes": ["SRC"], "type": "Small molecule", "diseases": ["PROSTATE CARCINOMA", "ACUTE MYELOID LEUKEMIA", "ACTINIC KERATOSIS"]}, {"indications": [{"efo_term": "OBESITY", "stage": 3}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 3}], "max_phase": 3, "name": "TARANABANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220360", "mechanisms": ["Cannabinoid CB1 receptor inverse agonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": ["OBESITY", "TYPE II DIABETES MELLITUS"]}, {"indications": [{"efo_term": "OBESITY", "stage": 2}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 2}], "max_phase": 2, "name": "IBIPINABANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL412262", "mechanisms": ["Cannabinoid CB1 receptor antagonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": ["OBESITY", "TYPE II DIABETES MELLITUS"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 3}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 3, "name": "PRELADENANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL240624", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "LIVER DISEASE"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 3}, {"efo_term": "COCAINE DEPENDENCE", "stage": 0}], "max_phase": 3, "name": "TOZADENANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105747", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "COCAINE DEPENDENCE"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 1}, {"efo_term": "PARKINSON'S DISEASE", "stage": 1}], "max_phase": 2, "name": "V81444", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545288", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}], "max_phase": 4, "name": "CLOZAPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "PSYCHOSIS"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 3}, {"efo_term": "SCHIZOPHRENIA", "stage": 3}], "max_phase": 3, "name": "BIFEPRUNOX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218166", "mechanisms": ["Dopamine D2 receptor partial agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE", "SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "PSORIASIS", "stage": 2}], "max_phase": 4, "name": "FLUPHENAZINE DECANOATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200854", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PSORIASIS", "PSYCHOSIS"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "PSORIASIS", "stage": 2}], "max_phase": 4, "name": "FLUPHENAZINE ENANTHATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200951", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PSYCHOSIS", "PSORIASIS"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "SCHIZOAFFECTIVE DISORDER", "stage": 4}], "max_phase": 4, "name": "PALIPERIDONE PALMITATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201732", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "SCHIZOAFFECTIVE DISORDER"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "BIPOLAR DISORDER", "stage": 4}], "max_phase": 4, "name": "LURASIDONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1615372", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "BIPOLAR DISORDER"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}], "max_phase": 4, "name": "CARIPRAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2024517", "mechanisms": ["Dopamine D2 receptor modulator"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 1}], "max_phase": 4, "name": "THIORIDAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL479", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PSYCHOSIS", "ACUTE MYELOID LEUKEMIA"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}, {"efo_term": "RESTLESS LEGS SYNDROME", "stage": 2}], "max_phase": 4, "name": "PRAMIPEXOLE DIHYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL542257", "mechanisms": ["D2-like dopamine receptor agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "RESTLESS LEGS SYNDROME"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "CANCER", "stage": 2}], "max_phase": 4, "name": "HALOPERIDOL DECANOATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200986", "mechanisms": ["D2-like dopamine receptor inverse agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["CANCER", "PSYCHOSIS"]}, {"indications": [{"efo_term": "HEART FAILURE", "stage": 3}, {"efo_term": "CONGESTIVE HEART FAILURE", "stage": 3}], "max_phase": 3, "name": "ROLOFYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103819", "mechanisms": ["Adenosine A1 receptor antagonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": ["HEART FAILURE", "CONGESTIVE HEART FAILURE"]}, {"indications": [{"efo_term": "ATRIAL FIBRILLATION", "stage": 2}, {"efo_term": "ANGINA PECTORIS", "stage": 2}], "max_phase": 2, "name": "Capadenoson", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3235279", "mechanisms": ["Adenosine A1 receptor partial agonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": ["ATRIAL FIBRILLATION", "ANGINA PECTORIS"]}, {"indications": [{"efo_term": "NEUROGENIC BLADDER", "stage": 2}, {"efo_term": "PAIN", "stage": 2}], "max_phase": 2, "name": "SAF312", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544953", "mechanisms": ["Vanilloid receptor inhibitor"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": ["NEUROGENIC BLADDER", "PAIN"]}, {"indications": [{"efo_term": "NEUROPATHIC PAIN", "stage": 2}, {"efo_term": "PAIN", "stage": 2}], "max_phase": 2, "name": "AZD1386", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545039", "mechanisms": ["Vanilloid receptor antagonist"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN", "PAIN"]}, {"indications": [{"efo_term": "COUGH", "stage": 2}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}], "max_phase": 2, "name": "XEN-D0501", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707293", "mechanisms": ["Vanilloid receptor antagonist"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": ["COUGH", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "CANCER", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 2}], "max_phase": 2, "name": "ILORASERTIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1980297", "mechanisms": ["SRC inhibitor"], "genes": ["SRC"], "type": "Small molecule", "diseases": ["CANCER", "NEOPLASM"]}, {"indications": [{"efo_term": "DIABETIC NEUROPATHY", "stage": 2}], "max_phase": 2, "name": "GRC-17536", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707318", "mechanisms": ["Transient receptor potential cation channel subfamily A member 1 antagonist"], "genes": ["TRPA1"], "type": "Small molecule", "diseases": ["DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "SMOKING CESSATION", "stage": 2}], "max_phase": 2, "name": "SURINABANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL189676", "mechanisms": ["Cannabinoid CB1 receptor antagonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": ["SMOKING CESSATION"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 2}], "max_phase": 2, "name": "Drinabant", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545166", "mechanisms": ["Cannabinoid CB1 receptor antagonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "CACHEXIA", "stage": 2}], "max_phase": 3, "name": "MACIMORELIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL278623", "mechanisms": ["Ghrelin receptor agonist"], "genes": ["GHSR"], "type": "Small molecule", "diseases": ["CACHEXIA"]}, {"indications": [{"efo_term": "CACHEXIA", "stage": 2}], "max_phase": 3, "name": "ANAMORELIN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103794", "mechanisms": ["Ghrelin receptor agonist"], "genes": ["GHSR"], "type": "Small molecule", "diseases": ["CACHEXIA"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 2}], "max_phase": 2, "name": "VIPADENANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL447664", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "DIABETIC FOOT", "stage": 2}], "max_phase": 2, "name": "SONEDENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1950553", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["DIABETIC FOOT"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 1}], "max_phase": 1, "name": "PBF-509", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545009", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "HUNTINGTON DISEASE", "stage": 1}], "max_phase": 1, "name": "PBF-999", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545271", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["HUNTINGTON DISEASE"]}, {"indications": [{"efo_term": "NEUROPATHIC PAIN", "stage": 2}], "max_phase": 2, "name": "BVT.115959", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545409", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}], "max_phase": 4, "name": "OXTRIPHYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200434", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA2A", "ADORA1"], "type": "Small molecule", "diseases": ["OBSTRUCTIVE LUNG DISEASE"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 2}], "max_phase": 2, "name": "SB-649868", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1272307", "mechanisms": ["Orexin receptor 2 antagonist", "Orexin receptor 1 antagonist"], "genes": ["HCRTR2", "HCRTR1"], "type": "Small molecule", "diseases": ["INSOMNIA"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 3}], "max_phase": 3, "name": "LEMBOREXANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545367", "mechanisms": ["Orexin receptor 2 antagonist", "Orexin receptor 1 antagonist"], "genes": ["HCRTR2", "HCRTR1"], "type": "Small molecule", "diseases": ["INSOMNIA"]}, {"indications": [{"efo_term": "ACROMEGALY", "stage": 4}], "max_phase": 4, "name": "PASIREOTIDE DIASPARTATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3039588", "mechanisms": ["Somatostatin receptor 1 agonist", "Somatostatin receptor 5 agonist", "Somatostatin receptor 2 agonist", "Somatostatin receptor 3 agonist"], "genes": ["SSTR1", "SSTR5", "SSTR2", "SSTR3"], "type": "Protein", "diseases": ["ACROMEGALY"]}, {"indications": [{"efo_term": "ACROMEGALY", "stage": 4}], "max_phase": 4, "name": "PASIREOTIDE PAMOATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545188", "mechanisms": ["Somatostatin receptor 1 agonist", "Somatostatin receptor 5 agonist", "Somatostatin receptor 2 agonist", "Somatostatin receptor 3 agonist"], "genes": ["SSTR1", "SSTR5", "SSTR2", "SSTR3"], "type": "Protein", "diseases": ["ACROMEGALY"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}], "max_phase": 4, "name": "PERPHENAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL567", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PSYCHOSIS"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}], "max_phase": 4, "name": "TRIFLUPROMAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL570", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PSYCHOSIS"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}], "max_phase": 4, "name": "CHLORPROTHIXENE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL908", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PSYCHOSIS"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}], "max_phase": 4, "name": "THIOTHIXENE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PSYCHOSIS"]}, {"indications": [{"efo_term": "HUNTINGTON DISEASE", "stage": 3}], "max_phase": 3, "name": "PRIDOPIDINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL596802", "mechanisms": ["Dopamine D2 receptor modulator"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["HUNTINGTON DISEASE"]}, {"indications": [{"efo_term": "POST OPERATIVE NAUSEA AND VOMITING", "stage": 4}], "max_phase": 4, "name": "METOCLOPRAMIDE HYDROCHLORIDE HYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200940", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["POST OPERATIVE NAUSEA AND VOMITING"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 3}], "max_phase": 4, "name": "ZIPRASIDONE MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200997", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}], "max_phase": 4, "name": "ARIPIPRAZOLE LAUROXIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2219425", "mechanisms": ["Dopamine D2 receptor partial agonist"], "genes": ["DRD2"], "type": "Unknown", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 3}], "max_phase": 3, "name": "PARDOPRUNOX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103832", "mechanisms": ["Dopamine receptors; D2 & D3 partial agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}], "max_phase": 4, "name": "AMOXAPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1113", "mechanisms": ["Dopamine receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}], "max_phase": 4, "name": "ERGOLOID MESYLATES", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2311030", "mechanisms": ["Dopamine receptor agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["CARDIOVASCULAR DISEASE"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}], "max_phase": 4, "name": "DROPERIDOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1108", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PSYCHOSIS"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}], "max_phase": 4, "name": "APOMORPHINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1616", "mechanisms": ["D2-like dopamine receptor agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}], "max_phase": 4, "name": "LEVOMEPROMAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1764", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PSYCHOSIS"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 3}], "max_phase": 4, "name": "ROPINIROLE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200411", "mechanisms": ["D2-like dopamine receptor agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 3}], "max_phase": 4, "name": "OLANZAPINE PAMOATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201741", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "ACROMEGALY", "stage": 4}], "max_phase": 4, "name": "LANREOTIDE ACETATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201184", "mechanisms": ["Somatostatin receptor 5 agonist", "Somatostatin receptor 2 agonist"], "genes": ["SSTR5", "SSTR2"], "type": "Protein", "diseases": ["ACROMEGALY"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 2}], "max_phase": 2, "name": "PBF-680", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545162", "mechanisms": ["Adenosine A1 receptor antagonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": ["ASTHMA"]}, {"indications": [{"efo_term": "HEART FAILURE", "stage": 2}], "max_phase": 2, "name": "BAY1067197", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545405", "mechanisms": ["Adenosine A1 receptor agonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": ["HEART FAILURE"]}, {"indications": [{"efo_term": "OCULAR HYPERTENSION", "stage": 3}], "max_phase": 3, "name": "Trabodenoson", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545407", "mechanisms": ["Adenosine A1 receptor agonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": ["OCULAR HYPERTENSION"]}, {"indications": [{"efo_term": "NEUROPATHIC PAIN", "stage": 2}], "max_phase": 2, "name": "GRC-15300", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707319", "mechanisms": ["Transient receptor potential cation channel subfamily V member 3 antagonist"], "genes": ["TRPV3"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "OSTEOARTHRITIS", "stage": 1}], "max_phase": 1, "name": "MAVATREP", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2364618", "mechanisms": ["Vanilloid receptor antagonist"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": ["OSTEOARTHRITIS"]}, {"indications": [{"efo_term": "LYMPHOMA", "stage": 1}], "max_phase": 1, "name": "XL-228", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545085", "mechanisms": ["SRC inhibitor"], "genes": ["SRC"], "type": "Small molecule", "diseases": ["LYMPHOMA"]}, {"indications": [], "max_phase": 0, "name": "CB-189625", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707378", "mechanisms": ["Transient receptor potential cation channel subfamily A member 1 antagonist"], "genes": ["TRPA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "OTENABANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL562668", "mechanisms": ["Cannabinoid CB1 receptor antagonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "NONABINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2106841", "mechanisms": ["Cannabinoid CB1 receptor agonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "AZD2207", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545289", "mechanisms": ["Cannabinoid CB1 receptor antagonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "SAD448", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545387", "mechanisms": ["Cannabinoid CB1 receptor agonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "TABIMORELIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL281764", "mechanisms": ["Ghrelin receptor agonist"], "genes": ["GHSR"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "ULIMORELIN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1923502", "mechanisms": ["Ghrelin receptor agonist"], "genes": ["GHSR"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "ST1535", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL197669", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "UK432097", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1096896", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "BINODENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1950554", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "APADENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1950649", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "EVODENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1950651", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "AMP579", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545163", "mechanisms": ["Adenosine A2a receptor agonist", "Adenosine A1 receptor agonist"], "genes": ["ADORA2A", "ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "THEOPHYLLINE SODIUM GLYCINATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200578", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA2A", "ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ZIPRASIDONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1712", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MOLINDONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200419", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROCHLORPERAZINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200587", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BENZQUINAMIDE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200707", "mechanisms": ["Dopamine D2 receptor modulator"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "FLUPHENAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200792", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "THIETHYLPERAZINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200856", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "THIOTHIXENE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200902", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TRIMIPRAMINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200948", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MESORIDAZINE BESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201052", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "THIETHYLPERAZINE MALATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201074", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TRIFLUPROMAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201102", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROCHLORPERAZINE EDISYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201154", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "APLINDORE FUMARATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104864", "mechanisms": ["Dopamine D2 receptor partial agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "SARIZOTAN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2146110", "mechanisms": ["Dopamine D2 receptor partial agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CARPHENAZINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2358147", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ACETOPHENAZINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2360079", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "Ordopidine", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545010", "mechanisms": ["Dopamine D2 receptor modulator"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "SB-773812", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545102", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "Seridopidine", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545388", "mechanisms": ["Dopamine D2 receptor modulator"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PERGOLIDE MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1275", "mechanisms": ["Dopamine receptor agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TRIFLUOPERAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1710", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CHLORPROMAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1713", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROMAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200469", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "THIORIDAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200916", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LOXAPINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201060", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LOXAPINE SUCCINATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201155", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "HALOPERIDOL LACTATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2096643", "mechanisms": ["D2-like dopamine receptor inverse agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "VAPREOTIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103975", "mechanisms": ["Somatostatin receptor 5 agonist", "Somatostatin receptor 2 agonist", "Somatostatin receptor 3 agonist"], "genes": ["SSTR5", "SSTR2", "SSTR3"], "type": "Protein", "diseases": []}, {"indications": [], "max_phase": 1, "name": "FK453", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL440115", "mechanisms": ["Adenosine A1 receptor antagonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "TONAPOFYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL414157", "mechanisms": ["Adenosine A1 receptor antagonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "TECADENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL392149", "mechanisms": ["Adenosine A1 receptor agonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "Derenofylline", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL592435", "mechanisms": ["Adenosine A1 receptor antagonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "SELODENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107371", "mechanisms": ["Adenosine A1 receptor agonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "NAXIFYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107805", "mechanisms": ["Adenosine A1 receptor antagonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "GS-9667", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545011", "mechanisms": ["Adenosine A1 receptor partial agonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "GW493838", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545223", "mechanisms": ["Adenosine A1 receptor agonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "RPR749", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545331", "mechanisms": ["Adenosine A1 receptor agonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "AMG-517", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL229430", "mechanisms": ["Vanilloid receptor antagonist"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "ABT-102", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL398338", "mechanisms": ["Vanilloid receptor antagonist"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "GRC-6211", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545107", "mechanisms": ["Vanilloid receptor antagonist"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "PHE377", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545148", "mechanisms": ["Vanilloid receptor antagonist"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "NGD-8243", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545227", "mechanisms": ["Vanilloid receptor antagonist"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "JTS-653", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545228", "mechanisms": ["Vanilloid receptor antagonist"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "DWP05195", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545229", "mechanisms": ["Vanilloid receptor antagonist"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "SYL-1001", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707356", "mechanisms": ["Vanilloid receptor antagonist"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "MR-1817", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707397", "mechanisms": ["Vanilloid receptor antagonist"], "genes": ["TRPV1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "JNJ-26483327", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545133", "mechanisms": ["Tyrosine-protein kinase SRC inhibitor"], "genes": ["SRC"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "AZM-475271", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545150", "mechanisms": ["Tyrosine-protein kinase SRC inhibitor"], "genes": ["SRC"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "AZD-0424", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545177", "mechanisms": ["Tyrosine-protein kinase SRC inhibitor"], "genes": ["SRC"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "PD-0166285", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545196", "mechanisms": ["Tyrosine-protein kinase SRC inhibitor"], "genes": ["SRC"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "ENMD-981693", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL52885", "mechanisms": ["SRC inhibitor"], "genes": ["SRC"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "TG100-801", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL403989", "mechanisms": ["SRC inhibitor"], "genes": ["SRC"], "type": "Small molecule", "diseases": []}], "heat": 0.3005740087626193, "nodes": [{"assoc": 1.0, "id": "ENSG00000104321", "label": "TRPA1"}, {"assoc": 1.0, "id": "ENSG00000118432", "label": "CNR1"}, {"assoc": 0.0557190355556, "id": "ENSG00000121853", "label": "GHSR"}, {"assoc": 1.0, "id": "ENSG00000128271", "label": "ADORA2A"}, {"assoc": 0.037036, "id": "ENSG00000132671", "label": "SSTR4"}, {"assoc": 0.014112, "id": "ENSG00000137252", "label": "HCRTR2"}, {"assoc": 0.203762, "id": "ENSG00000139874", "label": "SSTR1"}, {"assoc": 1.0, "id": "ENSG00000149295", "label": "DRD2"}, {"assoc": 0.0889065740039, "id": "ENSG00000157005", "label": "SST"}, {"assoc": 0.13269712712, "id": "ENSG00000161610", "label": "HCRT"}, {"assoc": 0.2, "id": "ENSG00000162009", "label": "SSTR5"}, {"assoc": 0.152944, "id": "ENSG00000162105", "label": "SHANK2"}, {"assoc": 1.0, "id": "ENSG00000163485", "label": "ADORA1"}, {"assoc": 0.217062163948, "id": "ENSG00000167723", "label": "TRPV3"}, {"assoc": 0.0363341055556, "id": "ENSG00000169241", "label": "SLC50A1"}, {"assoc": 0.0713270245797, "id": "ENSG00000169860", "label": "P2RY1"}, {"assoc": 0.204800875, "id": "ENSG00000180616", "label": "SSTR2"}, {"assoc": 0.0215824444444, "id": "ENSG00000183695", "label": "MRGPRX2"}, {"assoc": 0.0296588656974, "id": "ENSG00000187688", "label": "TRPV2"}, {"assoc": 1.0, "id": "ENSG00000196689", "label": "TRPV1"}, {"assoc": 0.0572733450151, "id": "ENSG00000196839", "label": "ADA"}, {"assoc": 0.0917086669084, "id": "ENSG00000241563", "label": "CORT"}, {"assoc": 0.2, "id": "ENSG00000278195", "label": "SSTR3"}, {"assoc": 0, "id": "ENSG00000121764", "label": "HCRTR1"}, {"assoc": 0, "id": "ENSG00000197122", "label": "SRC"}, {"assoc": 0, "id": "ENSG00000085733", "label": "CTTN"}], "size": 26}, {"diseases": ["DIABETES MELLITUS", "OBESITY", "TYPE II DIABETES MELLITUS", "BREAST CARCINOMA", "PROSTATE ADENOCARCINOMA", "PROSTATE CARCINOMA", "PANCREATIC CARCINOMA", "DIABETIC FOOT", "METABOLIC SYNDROME"], "links": [{"source": "ENSG00000023228", "target": "ENSG00000115286", "reverse": "rev-directed"}, {"source": "ENSG00000023228", "target": "ENSG00000139180", "reverse": "rev-directed"}, {"source": "ENSG00000023228", "target": "ENSG00000140990", "reverse": "rev-directed"}, {"source": "ENSG00000023228", "type": "directed", "target": "ENSG00000158864", "reverse": "rev-directed"}, {"source": "ENSG00000023228", "target": "ENSG00000164258", "reverse": "rev-directed"}, {"source": "ENSG00000023228", "target": "ENSG00000167792", "reverse": "rev-directed"}, {"source": "ENSG00000023228", "target": "ENSG00000178127", "reverse": "rev-directed"}, {"source": "ENSG00000023228", "target": "ENSG00000184752", "reverse": "rev-directed"}, {"source": "ENSG00000110717", "type": "directed", "target": "ENSG00000115286"}, {"source": "ENSG00000110717", "type": "directed", "target": "ENSG00000145494"}, {"source": "ENSG00000110717", "type": "directed", "target": "ENSG00000167792"}, {"source": "ENSG00000110717", "type": "directed", "target": "ENSG00000184752"}, {"source": "ENSG00000115286", "type": "directed", "target": "ENSG00000158864"}, {"source": "ENSG00000115286", "target": "ENSG00000198888", "reverse": "rev-directed"}, {"source": "ENSG00000128311", "target": "ENSG00000198888"}, {"source": "ENSG00000131495", "target": "ENSG00000147684", "reverse": "rev-directed"}, {"source": "ENSG00000131495", "target": "ENSG00000164258", "reverse": "rev-directed"}, {"source": "ENSG00000131495", "target": "ENSG00000167792", "reverse": "rev-directed"}, {"source": "ENSG00000131495", "type": "directed", "target": "ENSG00000184752"}, {"source": "ENSG00000139180", "type": "directed", "target": "ENSG00000140990"}, {"source": "ENSG00000139180", "type": "directed", "target": "ENSG00000166136"}, {"source": "ENSG00000139180", "type": "directed", "target": "ENSG00000167792"}, {"source": "ENSG00000139180", "type": "directed", "target": "ENSG00000184752"}, {"source": "ENSG00000139180", "type": "directed", "target": "ENSG00000184983"}, {"source": "ENSG00000145494", "type": "directed", "target": "ENSG00000158864"}, {"source": "ENSG00000147684", "type": "directed", "target": "ENSG00000184752"}, {"source": "ENSG00000158864", "target": "ENSG00000167792", "reverse": "rev-directed"}, {"source": "ENSG00000158864", "target": "ENSG00000178127", "reverse": "rev-directed"}, {"source": "ENSG00000160194", "target": "ENSG00000178127", "reverse": "rev-directed"}, {"source": "ENSG00000164258", "type": "directed", "target": "ENSG00000167792"}, {"source": "ENSG00000164258", "type": "directed", "target": "ENSG00000184752"}, {"source": "ENSG00000167792", "target": "ENSG00000178127", "reverse": "rev-directed"}, {"source": "ENSG00000184752", "target": "ENSG00000184983", "reverse": "rev-directed"}], "drugs": [{"indications": [{"efo_term": "TYPE II DIABETES MELLITUS", "stage": 4}, {"efo_term": "DIABETES MELLITUS", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "METABOLIC SYNDROME", "stage": 3}, {"efo_term": "OBESITY", "stage": 2}, {"efo_term": "PROSTATE ADENOCARCINOMA", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "DIABETIC FOOT", "stage": 2}, {"efo_term": "PANCREATIC CARCINOMA", "stage": 1}], "max_phase": 4, "name": "METFORMIN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1703", "mechanisms": ["Mitochondrial complex I (NADH dehydrogenase) inhibitor"], "genes": ["NDUFS1", "NDUFS8", "NDUFS7", "NDUFA2", "NDUFA9", "NDUFB10", "NDUFS6", "NDUFB9", "NDUFS2", "NDUFV3", "NDUFS4", "NDUFB8", "NDUFV1", "NDUFV2", "NDUFA12", "NDUFA6", "MT-ND1"], "type": "Small molecule", "diseases": ["DIABETES MELLITUS", "OBESITY", "TYPE II DIABETES MELLITUS", "BREAST CARCINOMA", "PROSTATE ADENOCARCINOMA", "PROSTATE CARCINOMA", "PANCREATIC CARCINOMA", "DIABETIC FOOT", "METABOLIC SYNDROME"]}, {"indications": [], "max_phase": 1, "name": "NV-128", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545135", "mechanisms": ["Mitochondrial complex I (NADH dehydrogenase) inhibitor"], "genes": ["NDUFS1", "NDUFS8", "NDUFS7", "NDUFA2", "NDUFA9", "NDUFB10", "NDUFS6", "NDUFB9", "NDUFS2", "NDUFV3", "NDUFS4", "NDUFB8", "NDUFV1", "NDUFV2", "NDUFA12", "NDUFA6", "MT-ND1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "ME-344", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545320", "mechanisms": ["Mitochondrial complex I (NADH dehydrogenase) inhibitor"], "genes": ["NDUFS1", "NDUFS8", "NDUFS7", "NDUFA2", "NDUFA9", "NDUFB10", "NDUFS6", "NDUFB9", "NDUFS2", "NDUFV3", "NDUFS4", "NDUFB8", "NDUFV1", "NDUFV2", "NDUFA12", "NDUFA6", "MT-ND1"], "type": "Small molecule", "diseases": []}], "heat": 0.10155552454188893, "nodes": [{"assoc": 0.1, "id": "ENSG00000023228", "label": "NDUFS1"}, {"assoc": 0.1, "id": "ENSG00000110717", "label": "NDUFS8"}, {"assoc": 0.1, "id": "ENSG00000115286", "label": "NDUFS7"}, {"assoc": 0.127999441754, "id": "ENSG00000128311", "label": "TST"}, {"assoc": 0.1, "id": "ENSG00000131495", "label": "NDUFA2"}, {"assoc": 0.1, "id": "ENSG00000139180", "label": "NDUFA9"}, {"assoc": 0.1, "id": "ENSG00000140990", "label": "NDUFB10"}, {"assoc": 0.1, "id": "ENSG00000145494", "label": "NDUFS6"}, {"assoc": 0.1, "id": "ENSG00000147684", "label": "NDUFB9"}, {"assoc": 0.1, "id": "ENSG00000158864", "label": "NDUFS2"}, {"assoc": 0.1, "id": "ENSG00000160194", "label": "NDUFV3"}, {"assoc": 0.1, "id": "ENSG00000164258", "label": "NDUFS4"}, {"assoc": 0.1, "id": "ENSG00000166136", "label": "NDUFB8"}, {"assoc": 0.1, "id": "ENSG00000167792", "label": "NDUFV1"}, {"assoc": 0.1, "id": "ENSG00000178127", "label": "NDUFV2"}, {"assoc": 0.1, "id": "ENSG00000184752", "label": "NDUFA12"}, {"assoc": 0.1, "id": "ENSG00000184983", "label": "NDUFA6"}, {"assoc": 0.1, "id": "ENSG00000198888", "label": "MT-ND1"}], "size": 18}, {"diseases": ["HYPOTENSION", "PAIN", "INGUINAL HERNIA", "OSTEOARTHRITIS", "BONE FRACTURE", "BREAST CARCINOMA", "INJURY", "PROSTATE CARCINOMA", "HALLUX VALGUS", "POST OPERATIVE NAUSEA AND VOMITING", "OSTEOARTHRITIS, HIP", "BREAST NEOPLASM", "CANCER", "CORONARY ARTERY DISEASE", "DILATED CARDIOMYOPATHY", "TYPE II DIABETES MELLITUS", "ATRIAL FIBRILLATION", "ACUTE CORONARY SYNDROME", "IRRITABLE BOWEL SYNDROME", "PROLONGED QT INTERVAL", "PULMONARY HYPERTENSION", "CARDIOVASCULAR DISEASE", "VASCULAR DISEASE", "ANGINA PECTORIS", "MYOCARDIAL ISCHEMIA", "DIASTOLIC HEART FAILURE", "PREGNANCY", "EPILEPSY", "SEIZURES", "OPTIC NEURITIS", "OSTEOARTHRITIS, KNEE", "PERIPHERAL NEUROPATHY", "SUDDEN CARDIAC ARREST", "SYSTEMIC SCLERODERMA", "CARCINOMA", "PREMATURE BIRTH", "URINARY TRACT INFECTION", "POST-OPERATIVE SIGN OR SYMPTOM", "CARPAL TUNNEL SYNDROME", "COUGH", "PRURITUS", "TINNITUS", "ANXIETY", "FIBROMYALGIA", "COCAINE DEPENDENCE", "DYSMENORRHEA", "NEUROPATHIC PAIN", "PARATHYROID DISEASE", "PREECLAMPSIA", "POSTMENOPAUSAL OSTEOPOROSIS", "PREMATURE EJACULATION", "TENDINOPATHY", "CARDIAC ARRHYTHMIA", "OBESITY", "UTERINE FIBROID", "AGE-RELATED MACULAR DEGENERATION", "FROZEN SHOULDER", "STROKE", "NUTRITIONAL DISORDER", "ARTHRITIS", "MYALGIA", "OVERACTIVE BLADDER", "CHRONIC INTERSTITIAL CYSTITIS", "PARTIAL EPILEPSY", "BIPOLAR DISORDER", "TRIGEMINAL NEURALGIA", "CATARACT", "FISH-EYE DISEASE", "MENTAL OR BEHAVIOURAL DISORDER", "MOOD DISORDER", "UNIPOLAR DEPRESSION", "NEUROFIBROMATOSIS TYPE 1", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "LENNOX-GASTAUT SYNDROME", "GENERALIZED TONIC-CLONIC SEIZURES", "DRUG DEPENDENCE", "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "POST-TRAUMATIC STRESS DISORDER", "ATAXIA", "AUTISM SPECTRUM DISORDER", "ALZHEIMERS DISEASE", "CUTANEOUS MELANOMA", "PROXIMAL SPINAL MUSCULAR ATROPHY", "AMYOTROPHIC LATERAL SCLEROSIS", "OBSESSIVE-COMPULSIVE DISORDER", "ALCOHOL DEPENDENCE", "PARKINSON'S DISEASE", "EATING DISORDER", "ESSENTIAL TREMOR", "NICOTINE DEPENDENCE", "MIGRAINE DISORDER", "NEUROPATHY", "DIABETIC NEUROPATHY", "MULTIPLE SCLEROSIS", "SCHIZOPHRENIA", "COMPLEX PARTIAL EPILEPSY", "ALCOHOL DRINKING", "CONGENITAL HEART DISEASE", "METAMPHETAMINE DEPENDENCE", "GAMBLING BEHAVIOUR", "SMOKING CESSATION", "MARIJUANA DEPENDENCE", "PRADER-WILLI SYNDROME", "CEREBRAL ISCHEMIA", "DYSURIA", "HIP FRACTURE"], "links": [{"source": "ENSG00000136531", "target": "ENSG00000151150"}, {"source": "ENSG00000196876", "type": "manual", "target": "ENSG00000161958"}, {"source": "ENSG00000161958", "type": "manual", "target": "ENSG00000136531"}, {"source": "ENSG00000169432", "type": "manual", "target": "ENSG00000129682"}, {"source": "ENSG00000129682", "type": "manual", "target": "ENSG00000136531"}, {"source": "ENSG00000185313", "type": "manual", "target": "ENSG00000161958"}, {"source": "ENSG00000007314", "type": "manual", "target": "ENSG00000161958"}, {"source": "ENSG00000168356", "type": "manual", "target": "ENSG00000129682"}, {"source": "ENSG00000144285", "type": "manual", "target": "ENSG00000129682"}, {"source": "ENSG00000153253", "type": "manual", "target": "ENSG00000129682"}, {"source": "ENSG00000183873", "type": "manual", "target": "ENSG00000161958"}], "drugs": [{"indications": [{"efo_term": "PRURITUS", "stage": 4}, {"efo_term": "TENDINOPATHY", "stage": 4}, {"efo_term": "CARDIAC ARRHYTHMIA", "stage": 4}, {"efo_term": "FROZEN SHOULDER", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "ARTHRITIS", "stage": 4}, {"efo_term": "MYALGIA", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "PERIPHERAL NEUROPATHY", "stage": 3}, {"efo_term": "SUDDEN CARDIAC ARREST", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "CARPAL TUNNEL SYNDROME", "stage": 3}, {"efo_term": "COUGH", "stage": 3}, {"efo_term": "FIBROMYALGIA", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 3}, {"efo_term": "PARATHYROID DISEASE", "stage": 3}, {"efo_term": "PREECLAMPSIA", "stage": 3}, {"efo_term": "POSTMENOPAUSAL OSTEOPOROSIS", "stage": 3}, {"efo_term": "PREMATURE EJACULATION", "stage": 3}, {"efo_term": "OBESITY", "stage": 3}, {"efo_term": "NUTRITIONAL DISORDER", "stage": 3}, {"efo_term": "PREGNANCY", "stage": 3}, {"efo_term": "OVERACTIVE BLADDER", "stage": 3}, {"efo_term": "OSTEOARTHRITIS, KNEE", "stage": 2}, {"efo_term": "SYSTEMIC SCLERODERMA", "stage": 2}, {"efo_term": "CARCINOMA", "stage": 2}, {"efo_term": "URINARY TRACT INFECTION", "stage": 2}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "ANXIETY", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "DYSMENORRHEA", "stage": 2}, {"efo_term": "OSTEOARTHRITIS", "stage": 2}, {"efo_term": "UTERINE FIBROID", "stage": 2}, {"efo_term": "AGE-RELATED MACULAR DEGENERATION", "stage": 2}, {"efo_term": "STROKE", "stage": 2}, {"efo_term": "CHRONIC INTERSTITIAL CYSTITIS", "stage": 2}, {"efo_term": "PREMATURE BIRTH", "stage": 1}, {"efo_term": "POST-OPERATIVE SIGN OR SYMPTOM", "stage": 1}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 1}, {"efo_term": "TINNITUS", "stage": 0}], "max_phase": 4, "name": "LIDOCAINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL79", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["OSTEOARTHRITIS, KNEE", "PAIN", "PERIPHERAL NEUROPATHY", "SUDDEN CARDIAC ARREST", "SYSTEMIC SCLERODERMA", "CARCINOMA", "PREMATURE BIRTH", "URINARY TRACT INFECTION", "BREAST CARCINOMA", "POST-OPERATIVE SIGN OR SYMPTOM", "CANCER", "CARPAL TUNNEL SYNDROME", "COUGH", "PRURITUS", "TINNITUS", "ANXIETY", "FIBROMYALGIA", "COCAINE DEPENDENCE", "DYSMENORRHEA", "NEUROPATHIC PAIN", "PARATHYROID DISEASE", "PREECLAMPSIA", "OSTEOARTHRITIS", "POSTMENOPAUSAL OSTEOPOROSIS", "PREMATURE EJACULATION", "TENDINOPATHY", "CARDIAC ARRHYTHMIA", "OBESITY", "UTERINE FIBROID", "AGE-RELATED MACULAR DEGENERATION", "FROZEN SHOULDER", "PULMONARY HYPERTENSION", "STROKE", "NUTRITIONAL DISORDER", "ARTHRITIS", "MYALGIA", "PREGNANCY", "OVERACTIVE BLADDER", "CHRONIC INTERSTITIAL CYSTITIS"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "MIGRAINE DISORDER", "stage": 3}, {"efo_term": "OBESITY", "stage": 3}, {"efo_term": "SMOKING CESSATION", "stage": 3}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 3}, {"efo_term": "PRADER-WILLI SYNDROME", "stage": 3}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "ALCOHOL DRINKING", "stage": 2}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "METAMPHETAMINE DEPENDENCE", "stage": 2}, {"efo_term": "GAMBLING BEHAVIOUR", "stage": 2}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 2}, {"efo_term": "CEREBRAL ISCHEMIA", "stage": 2}, {"efo_term": "BIPOLAR DISORDER", "stage": 1}, {"efo_term": "CONGENITAL HEART DISEASE", "stage": 1}], "max_phase": 4, "name": "TOPIRAMATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["COCAINE DEPENDENCE", "EPILEPSY", "ALCOHOL DRINKING", "BIPOLAR DISORDER", "MIGRAINE DISORDER", "ALCOHOL DEPENDENCE", "CONGENITAL HEART DISEASE", "METAMPHETAMINE DEPENDENCE", "GAMBLING BEHAVIOUR", "OBESITY", "SMOKING CESSATION", "NICOTINE DEPENDENCE", "MARIJUANA DEPENDENCE", "PRADER-WILLI SYNDROME", "CEREBRAL ISCHEMIA"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}, {"efo_term": "INGUINAL HERNIA", "stage": 3}, {"efo_term": "BONE FRACTURE", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "INJURY", "stage": 3}, {"efo_term": "HALLUX VALGUS", "stage": 3}, {"efo_term": "POST OPERATIVE NAUSEA AND VOMITING", "stage": 3}, {"efo_term": "BREAST NEOPLASM", "stage": 3}, {"efo_term": "CANCER", "stage": 3}, {"efo_term": "HYPOTENSION", "stage": 2}, {"efo_term": "OSTEOARTHRITIS", "stage": 2}, {"efo_term": "OSTEOARTHRITIS, HIP", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 1}], "max_phase": 4, "name": "BUPIVACAINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1098", "mechanisms": ["Sodium channel protein type IV alpha subunit blocker"], "genes": ["SCN4A"], "type": "Small molecule", "diseases": ["HYPOTENSION", "PAIN", "INGUINAL HERNIA", "OSTEOARTHRITIS", "BONE FRACTURE", "BREAST CARCINOMA", "INJURY", "PROSTATE CARCINOMA", "HALLUX VALGUS", "POST OPERATIVE NAUSEA AND VOMITING", "OSTEOARTHRITIS, HIP", "BREAST NEOPLASM", "CANCER"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "ANGINA PECTORIS", "stage": 4}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 3}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 3}, {"efo_term": "ATRIAL FIBRILLATION", "stage": 3}, {"efo_term": "MYOCARDIAL ISCHEMIA", "stage": 3}, {"efo_term": "DILATED CARDIOMYOPATHY", "stage": 2}, {"efo_term": "ACUTE CORONARY SYNDROME", "stage": 2}, {"efo_term": "IRRITABLE BOWEL SYNDROME", "stage": 2}, {"efo_term": "PROLONGED QT INTERVAL", "stage": 2}, {"efo_term": "VASCULAR DISEASE", "stage": 2}, {"efo_term": "DIASTOLIC HEART FAILURE", "stage": 2}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 1}], "max_phase": 4, "name": "RANOLAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1404", "mechanisms": ["Sodium channel protein type IV alpha subunit blocker", "Sodium channel protein type V alpha subunit blocker"], "genes": ["SCN4A", "SCN5A"], "type": "Small molecule", "diseases": ["CORONARY ARTERY DISEASE", "DILATED CARDIOMYOPATHY", "TYPE II DIABETES MELLITUS", "ATRIAL FIBRILLATION", "ACUTE CORONARY SYNDROME", "IRRITABLE BOWEL SYNDROME", "PROLONGED QT INTERVAL", "PULMONARY HYPERTENSION", "CARDIOVASCULAR DISEASE", "VASCULAR DISEASE", "ANGINA PECTORIS", "MYOCARDIAL ISCHEMIA", "DIASTOLIC HEART FAILURE"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "SEIZURES", "stage": 4}, {"efo_term": "LENNOX-GASTAUT SYNDROME", "stage": 4}, {"efo_term": "GENERALIZED TONIC-CLONIC SEIZURES", "stage": 4}, {"efo_term": "PARTIAL EPILEPSY", "stage": 4}, {"efo_term": "MOOD DISORDER", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "NEUROFIBROMATOSIS TYPE 1", "stage": 2}, {"efo_term": "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "DRUG DEPENDENCE", "stage": 2}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}, {"efo_term": "MENTAL OR BEHAVIOURAL DISORDER", "stage": 1}], "max_phase": 4, "name": "LAMOTRIGINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL741", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "EPILEPSY", "FISH-EYE DISEASE", "MENTAL OR BEHAVIOURAL DISORDER", "MOOD DISORDER", "UNIPOLAR DEPRESSION", "NEUROFIBROMATOSIS TYPE 1", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "SEIZURES", "LENNOX-GASTAUT SYNDROME", "GENERALIZED TONIC-CLONIC SEIZURES", "PARTIAL EPILEPSY", "DRUG DEPENDENCE"]}, {"indications": [{"efo_term": "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "ATAXIA", "stage": 2}, {"efo_term": "AUTISM SPECTRUM DISORDER", "stage": 2}, {"efo_term": "BIPOLAR DISORDER", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 2}, {"efo_term": "CUTANEOUS MELANOMA", "stage": 2}, {"efo_term": "PROXIMAL SPINAL MUSCULAR ATROPHY", "stage": 2}, {"efo_term": "AMYOTROPHIC LATERAL SCLEROSIS", "stage": 2}, {"efo_term": "OBSESSIVE-COMPULSIVE DISORDER", "stage": 2}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 1}, {"efo_term": "CANCER", "stage": 1}], "max_phase": 4, "name": "RILUZOLE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL744", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "POST-TRAUMATIC STRESS DISORDER", "ATAXIA", "AUTISM SPECTRUM DISORDER", "BIPOLAR DISORDER", "UNIPOLAR DEPRESSION", "ALZHEIMERS DISEASE", "CUTANEOUS MELANOMA", "PROXIMAL SPINAL MUSCULAR ATROPHY", "AMYOTROPHIC LATERAL SCLEROSIS", "CANCER", "OBSESSIVE-COMPULSIVE DISORDER"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "SEIZURES", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "NEUROPATHY", "stage": 3}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 3}, {"efo_term": "OSTEOARTHRITIS", "stage": 2}, {"efo_term": "MIGRAINE DISORDER", "stage": 2}, {"efo_term": "NEUROPATHIC PAIN", "stage": 2}, {"efo_term": "FIBROMYALGIA", "stage": 2}], "max_phase": 4, "name": "LACOSAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL58323", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY", "OSTEOARTHRITIS", "PARTIAL EPILEPSY", "MIGRAINE DISORDER", "NEUROPATHY", "NEUROPATHIC PAIN", "FIBROMYALGIA", "SEIZURES", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "COMPLEX PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 3}, {"efo_term": "FIBROMYALGIA", "stage": 2}, {"efo_term": "MIGRAINE DISORDER", "stage": 2}, {"efo_term": "BIPOLAR DISORDER", "stage": 2}], "max_phase": 4, "name": "ESLICARBAZEPINE ACETATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL87992", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY", "PARTIAL EPILEPSY", "FIBROMYALGIA", "MIGRAINE DISORDER", "BIPOLAR DISORDER", "COMPLEX PARTIAL EPILEPSY", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 3}, {"efo_term": "EATING DISORDER", "stage": 3}, {"efo_term": "SEIZURES", "stage": 3}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "ESSENTIAL TREMOR", "stage": 2}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "ZONISAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL750", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["ALCOHOL DEPENDENCE", "EPILEPSY", "PARKINSON'S DISEASE", "EATING DISORDER", "ESSENTIAL TREMOR", "SEIZURES", "NICOTINE DEPENDENCE"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "SEIZURES", "stage": 2}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "SCHIZOPHRENIA", "stage": 2}], "max_phase": 4, "name": "OXCARBAZEPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1068", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY", "SEIZURES", "PARTIAL EPILEPSY", "MULTIPLE SCLEROSIS", "SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "SEIZURES", "stage": 4}, {"efo_term": "INJURY", "stage": 2}, {"efo_term": "OPTIC NEURITIS", "stage": 2}], "max_phase": 4, "name": "PHENYTOIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL16", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY", "SEIZURES", "INJURY", "OPTIC NEURITIS"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "PARTIAL EPILEPSY", "stage": 4}, {"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "TRIGEMINAL NEURALGIA", "stage": 4}], "max_phase": 4, "name": "CARBAMAZEPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL108", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY", "PARTIAL EPILEPSY", "BIPOLAR DISORDER", "TRIGEMINAL NEURALGIA"]}, {"indications": [{"efo_term": "PRURITUS", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "CATARACT", "stage": 3}, {"efo_term": "PAIN", "stage": 2}], "max_phase": 4, "name": "TETRACAINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL698", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["CATARACT", "PAIN", "PRURITUS"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "LENNOX-GASTAUT SYNDROME", "stage": 4}, {"efo_term": "SEIZURES", "stage": 3}, {"efo_term": "PAIN", "stage": 2}], "max_phase": 4, "name": "RUFINAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201754", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["SEIZURES", "EPILEPSY", "LENNOX-GASTAUT SYNDROME", "PAIN"]}, {"indications": [{"efo_term": "HIP FRACTURE", "stage": 2}, {"efo_term": "BONE FRACTURE", "stage": 2}, {"efo_term": "INGUINAL HERNIA", "stage": 1}, {"efo_term": "PAIN", "stage": 0}], "max_phase": 4, "name": "ROPIVACAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1889140", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["PAIN", "HIP FRACTURE", "INGUINAL HERNIA", "BONE FRACTURE"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}, {"efo_term": "INGUINAL HERNIA", "stage": 2}], "max_phase": 4, "name": "BUPIVACAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200396", "mechanisms": ["Sodium channel protein type IV alpha subunit blocker"], "genes": ["SCN4A"], "type": "Small molecule", "diseases": ["INGUINAL HERNIA", "PAIN"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "STROKE", "stage": 2}], "max_phase": 4, "name": "PRIMIDONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL856", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY", "STROKE"]}, {"indications": [{"efo_term": "PAIN", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 2}], "max_phase": 3, "name": "RALFINAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107771", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["PAIN", "NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "TRIGEMINAL NEURALGIA", "stage": 2}, {"efo_term": "BIPOLAR DISORDER", "stage": 1}], "max_phase": 2, "name": "RAXATRIGINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544913", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker"], "genes": ["SCN9A"], "type": "Small molecule", "diseases": ["TRIGEMINAL NEURALGIA", "BIPOLAR DISORDER"]}, {"indications": [{"efo_term": "PAIN", "stage": 2}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 2}], "max_phase": 2, "name": "PF-05089771", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545171", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker"], "genes": ["SCN9A"], "type": "Small molecule", "diseases": ["PAIN", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "PREGNANCY", "stage": 3}], "max_phase": 4, "name": "LEVOBUPIVACAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200749", "mechanisms": ["Sodium channel protein type IV alpha subunit blocker"], "genes": ["SCN4A"], "type": "Small molecule", "diseases": ["PREGNANCY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "MEPHENYTOIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL861", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "PHENACEMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL918", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "ESLICARBAZEPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL315985", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "ETHOTOIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1095", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "DYSURIA", "stage": 3}], "max_phase": 4, "name": "PHENAZOPYRIDINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201022", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["DYSURIA"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}], "max_phase": 4, "name": "ORPHENADRINE (CHLORIDE)", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201023", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "CARDIAC ARRHYTHMIA", "stage": 4}], "max_phase": 4, "name": "QUINIDINE POLYGALACTURONATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201486", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["CARDIAC ARRHYTHMIA"]}, {"indications": [{"efo_term": "ATRIAL FIBRILLATION", "stage": 4}], "max_phase": 4, "name": "DRONEDARONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201729", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["ATRIAL FIBRILLATION"]}, {"indications": [{"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}], "max_phase": 2, "name": "NERISPIRDINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107762", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["MULTIPLE SCLEROSIS"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 2}], "max_phase": 2, "name": "NW-3509", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545207", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "NEUROPATHIC PAIN", "stage": 1}], "max_phase": 1, "name": "AZD3161", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545208", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker"], "genes": ["SCN9A"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "ATRIAL FIBRILLATION", "stage": 2}], "max_phase": 2, "name": "AZD1305", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545169", "mechanisms": ["Sodium channel protein type V alpha subunit blocker"], "genes": ["SCN5A"], "type": "Small molecule", "diseases": ["ATRIAL FIBRILLATION"]}, {"indications": [{"efo_term": "PAIN", "stage": 2}], "max_phase": 2, "name": "PF-04531083", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544951", "mechanisms": ["Sodium channel protein type X alpha subunit blocker"], "genes": ["SCN10A"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [], "max_phase": 4, "name": "PROCAINAMIDE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL605", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "IRAMPANEL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29741", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "FOSPHENYTOIN SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL919", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CHLOROPROCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL944", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PRILOCAINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1194", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PHENYTOIN SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1611", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROPOXYCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1769", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MORICIZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200334", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "INDECAINIDE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200341", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ORPHENADRINE CITRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200395", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LIDOCAINE HYDROCHLORIDE HYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200409", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "QUINIDINE GLUCONATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200437", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MEPIVACAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200440", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MERETHOXYLLINE PROCAINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200443", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROPARACAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200464", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DYCLONINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200478", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PRILOCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200586", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ETIDOCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200597", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MEXILETINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200606", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BENOXINATE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200654", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "HEXYLCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200715", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TOCAINIDE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200773", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ARTICAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200819", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200841", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DISOPYRAMIDE PHOSPHATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201020", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROPAFENONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201063", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TETRACAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1255654", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "NKTR-171", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545209", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "QUINIDINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707183", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN4A", "SCN2A", "SCN1A", "SCN3A", "SCN11A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "ELPETRIGINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29919", "mechanisms": ["Sodium channel protein type II alpha subunit blocker", "Sodium channel protein type III alpha subunit blocker"], "genes": ["SCN2A", "SCN3A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "Afacifenacin", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545165", "mechanisms": ["Sodium channel protein type XI alpha subunit  blocker", "Sodium channel protein type X alpha subunit blocker"], "genes": ["SCN11A", "SCN10A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "DSP-2230", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545012", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker", "Sodium channel protein type X alpha subunit blocker"], "genes": ["SCN9A", "SCN10A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "XEN403", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545091", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker"], "genes": ["SCN9A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "RG7893", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707353", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker"], "genes": ["SCN9A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "RG6029", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707380", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker"], "genes": ["SCN9A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIBUCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200612", "mechanisms": ["Sodium channel protein type V alpha subunit blocker", "Sodium channel protein type X alpha subunit blocker"], "genes": ["SCN5A", "SCN10A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "FLECAINIDE ACETATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200822", "mechanisms": ["Sodium channel protein type V alpha subunit blocker"], "genes": ["SCN5A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "AZD7009", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545040", "mechanisms": ["Sodium channel protein type V alpha subunit blocker"], "genes": ["SCN5A"], "type": "Small molecule", "diseases": []}], "heat": 0.7539833333333333, "nodes": [{"assoc": 1.0, "id": "ENSG00000007314", "label": "SCN4A"}, {"assoc": 1.0, "id": "ENSG00000136531", "label": "SCN2A"}, {"assoc": 1.0, "id": "ENSG00000144285", "label": "SCN1A"}, {"assoc": 0.0478, "id": "ENSG00000151150", "label": "ANK3"}, {"assoc": 1.0, "id": "ENSG00000153253", "label": "SCN3A"}, {"assoc": 1.0, "id": "ENSG00000168356", "label": "SCN11A"}, {"assoc": 1.0, "id": "ENSG00000169432", "label": "SCN9A"}, {"assoc": 1.0, "id": "ENSG00000183873", "label": "SCN5A"}, {"assoc": 1.0, "id": "ENSG00000185313", "label": "SCN10A"}, {"assoc": 1.0, "id": "ENSG00000196876", "label": "SCN8A"}, {"assoc": 0, "id": "ENSG00000161958", "label": "FGF11"}, {"assoc": 0, "id": "ENSG00000129682", "label": "FGF13"}], "size": 12}, {"diseases": [], "links": [{"source": "ENSG00000056291", "target": "ENSG00000139574", "reverse": "rev-stimulatory"}, {"source": "ENSG00000105954", "type": "stimulatory", "target": "ENSG00000148734"}, {"source": "ENSG00000122585", "target": "ENSG00000139574"}, {"source": "ENSG00000122585", "type": "stimulatory", "target": "ENSG00000185149"}, {"source": "ENSG00000122585", "type": "stimulatory", "target": "ENSG00000204174"}, {"source": "ENSG00000131096", "type": "directed", "target": "ENSG00000185149"}, {"source": "ENSG00000131096", "type": "stimulatory", "target": "ENSG00000204174"}, {"source": "ENSG00000139574", "type": "stimulatory", "target": "ENSG00000148734"}], "drugs": [{"indications": [], "max_phase": 2, "name": "TM30339", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545106", "mechanisms": ["Neuropeptide Y receptor type 4 agonist"], "genes": ["NPY4R"], "type": "Protein", "diseases": []}], "heat": 0.08803431538833749, "nodes": [{"assoc": 0.0594199381179, "id": "ENSG00000056291", "label": "NPFFR2"}, {"assoc": 0.02916028, "id": "ENSG00000105954", "label": "NPVF"}, {"assoc": 0.148502848103, "id": "ENSG00000122585", "label": "NPY"}, {"assoc": 0.195596722222, "id": "ENSG00000131096", "label": "PYY"}, {"assoc": 0.0707694292472, "id": "ENSG00000139574", "label": "NPFF"}, {"assoc": 0.0255539444444, "id": "ENSG00000148734", "label": "NPFFR1"}, {"assoc": 0.10416967875, "id": "ENSG00000185149", "label": "NPY2R"}, {"assoc": 0.0711016822222, "id": "ENSG00000204174", "label": "NPY4R"}], "size": 8}, {"diseases": ["INSOMNIA", "PAIN", "PRURITUS", "SCOLIOSIS", "SICKLE CELL ANEMIA", "TINNITUS", "EPILEPSY", "PROSTATE CARCINOMA", "ALCOHOL DEPENDENCE", "CARPAL TUNNEL SYNDROME", "NEUROPATHIC PAIN", "PREMATURE BIRTH", "FIBROMYALGIA", "LUMBAR DISC DEGENERATION", "NEOPLASM", "PARTIAL EPILEPSY", "CIRRHOSIS OF LIVER", "NICOTINE DEPENDENCE", "SPONTANEOUS ABORTION", "DRUG DEPENDENCE", "OPIOID DEPENDENCE", "VOMITING", "PSYCHOSIS", "DIABETIC NEUROPATHY", "NEUROPATHY", "RESTLESS LEGS SYNDROME", "SEIZURES", "ABNORMALITY OF REFRACTION", "GENERALIZED TONIC-CLONIC SEIZURES", "IRRITABLE BOWEL SYNDROME", "CHRONIC PANCREATITIS", "BONE FRACTURE", "DRY EYE SYNDROME", "SQUAMOUS CELL CARCINOMA", "COUGH", "GENICULATE HERPES ZOSTER", "OVERACTIVE BLADDER", "PREGNANCY", "MARIJUANA DEPENDENCE", "REFLEX SYMPATHETIC DYSTROPHY", "MIGRAINE DISORDER", "ANXIETY", "RENAL INSUFFICIENCY", "COGNITIVE IMPAIRMENT", "ALZHEIMERS DISEASE", "ESSENTIAL TREMOR", "PANIC DISORDER", "POST-TRAUMATIC STRESS DISORDER", "ALCOHOL WITHDRAWAL", "SUBARACHNOID HEMORRHAGE", "MOVEMENT DISORDER", "STROKE", "GLIOBLASTOMA MULTIFORME", "FEVER", "INFERTILITY", "CARDIOVASCULAR DISEASE", "BRAIN ANEURYSM", "ANAL FISSURE", "KIDNEY STONE", "PARKINSON'S DISEASE", "BIPOLAR DISORDER", "CONSTIPATION", "SKIN DISEASE", "ANGINA PECTORIS", "HYPERTENSION", "INTRACEREBRAL HEMORRHAGE", "CORONARY ARTERY DISEASE", "PROTEINURIA", "PRINZMETAL'S ANGINA", "MYOCARDIAL INFARCTION", "ATRIAL FIBRILLATION"], "links": [{"source": "ENSG00000067191", "target": "ENSG00000141837", "reverse": "rev-directed"}, {"source": "ENSG00000101152", "type": "directed", "target": "ENSG00000141837", "reverse": "rev-directed"}, {"source": "ENSG00000101152", "type": "inhibitory", "target": "ENSG00000148408"}, {"source": "ENSG00000141837", "type": "directed", "target": "ENSG00000165995"}, {"source": "ENSG00000141837", "type": "directed", "target": "ENSG00000167535"}, {"source": "ENSG00000141837", "type": "directed", "target": "ENSG00000182389"}, {"source": "ENSG00000148408", "type": "directed", "target": "ENSG00000165995", "reverse": "rev-directed"}, {"source": "ENSG00000148408", "type": "directed", "target": "ENSG00000167535"}, {"source": "ENSG00000151067", "type": "directed", "target": "ENSG00000167535"}], "drugs": [{"indications": [{"efo_term": "FIBROMYALGIA", "stage": 4}, {"efo_term": "SEIZURES", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "NEUROPATHIC PAIN", "stage": 4}, {"efo_term": "NEUROPATHY", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "RESTLESS LEGS SYNDROME", "stage": 3}, {"efo_term": "GENERALIZED TONIC-CLONIC SEIZURES", "stage": 3}, {"efo_term": "LUMBAR DISC DEGENERATION", "stage": 3}, {"efo_term": "BONE FRACTURE", "stage": 3}, {"efo_term": "CIRRHOSIS OF LIVER", "stage": 3}, {"efo_term": "GENICULATE HERPES ZOSTER", "stage": 3}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 3}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "IRRITABLE BOWEL SYNDROME", "stage": 2}, {"efo_term": "CHRONIC PANCREATITIS", "stage": 2}, {"efo_term": "DRY EYE SYNDROME", "stage": 2}, {"efo_term": "OVERACTIVE BLADDER", "stage": 2}, {"efo_term": "REFLEX SYMPATHETIC DYSTROPHY", "stage": 2}, {"efo_term": "ABNORMALITY OF REFRACTION", "stage": 1}, {"efo_term": "SQUAMOUS CELL CARCINOMA", "stage": 1}, {"efo_term": "COUGH", "stage": 1}, {"efo_term": "PREGNANCY", "stage": 1}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 0}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 0}], "max_phase": 4, "name": "PREGABALIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1059", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNB1", "CACNA1A", "CACNA1B", "CACNA1C", "CACNB2", "CACNB3", "CACNB4"], "type": "Small molecule", "diseases": ["FIBROMYALGIA", "NEUROPATHY", "PAIN", "PARTIAL EPILEPSY", "RESTLESS LEGS SYNDROME", "SEIZURES", "ABNORMALITY OF REFRACTION", "ALCOHOL DEPENDENCE", "EPILEPSY", "GENERALIZED TONIC-CLONIC SEIZURES", "IRRITABLE BOWEL SYNDROME", "NEUROPATHIC PAIN", "LUMBAR DISC DEGENERATION", "CHRONIC PANCREATITIS", "NICOTINE DEPENDENCE", "BONE FRACTURE", "DRY EYE SYNDROME", "SQUAMOUS CELL CARCINOMA", "CIRRHOSIS OF LIVER", "COUGH", "GENICULATE HERPES ZOSTER", "DIABETIC NEUROPATHY", "OVERACTIVE BLADDER", "PREGNANCY", "MARIJUANA DEPENDENCE", "REFLEX SYMPATHETIC DYSTROPHY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "INSOMNIA", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "SCOLIOSIS", "stage": 3}, {"efo_term": "CARPAL TUNNEL SYNDROME", "stage": 3}, {"efo_term": "FIBROMYALGIA", "stage": 3}, {"efo_term": "LUMBAR DISC DEGENERATION", "stage": 3}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "CIRRHOSIS OF LIVER", "stage": 3}, {"efo_term": "VOMITING", "stage": 3}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 3}, {"efo_term": "SICKLE CELL ANEMIA", "stage": 2}, {"efo_term": "TINNITUS", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 2}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 2}, {"efo_term": "SPONTANEOUS ABORTION", "stage": 2}, {"efo_term": "OPIOID DEPENDENCE", "stage": 2}, {"efo_term": "PRURITUS", "stage": 1}, {"efo_term": "NEUROPATHIC PAIN", "stage": 1}, {"efo_term": "PREMATURE BIRTH", "stage": 1}, {"efo_term": "DRUG DEPENDENCE", "stage": 1}, {"efo_term": "PSYCHOSIS", "stage": 1}], "max_phase": 4, "name": "GABAPENTIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL940", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNB1", "CACNA1A", "CACNA1B", "CACNA1C", "CACNB2", "CACNB3", "CACNB4"], "type": "Small molecule", "diseases": ["INSOMNIA", "PAIN", "PRURITUS", "SCOLIOSIS", "SICKLE CELL ANEMIA", "TINNITUS", "EPILEPSY", "PROSTATE CARCINOMA", "ALCOHOL DEPENDENCE", "CARPAL TUNNEL SYNDROME", "NEUROPATHIC PAIN", "PREMATURE BIRTH", "FIBROMYALGIA", "LUMBAR DISC DEGENERATION", "NEOPLASM", "PARTIAL EPILEPSY", "CIRRHOSIS OF LIVER", "NICOTINE DEPENDENCE", "SPONTANEOUS ABORTION", "DRUG DEPENDENCE", "OPIOID DEPENDENCE", "VOMITING", "PSYCHOSIS", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "SEIZURES", "stage": 4}, {"efo_term": "PANIC DISORDER", "stage": 3}, {"efo_term": "ALCOHOL WITHDRAWAL", "stage": 3}, {"efo_term": "SUBARACHNOID HEMORRHAGE", "stage": 3}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 3}, {"efo_term": "MOVEMENT DISORDER", "stage": 3}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "COGNITIVE IMPAIRMENT", "stage": 2}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 2}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "GLIOBLASTOMA MULTIFORME", "stage": 2}, {"efo_term": "ESSENTIAL TREMOR", "stage": 1}, {"efo_term": "STROKE", "stage": 1}], "max_phase": 4, "name": "LEVETIRACETAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1286", "mechanisms": ["Voltage-gated N-type calcium channel alpha-1B subunit blocker"], "genes": ["CACNA1B"], "type": "Small molecule", "diseases": ["EPILEPSY", "SEIZURES", "COGNITIVE IMPAIRMENT", "ALZHEIMERS DISEASE", "ESSENTIAL TREMOR", "PANIC DISORDER", "POST-TRAUMATIC STRESS DISORDER", "ALCOHOL WITHDRAWAL", "SUBARACHNOID HEMORRHAGE", "ALCOHOL DEPENDENCE", "MOVEMENT DISORDER", "PARTIAL EPILEPSY", "STROKE", "GLIOBLASTOMA MULTIFORME"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 4}, {"efo_term": "ANGINA PECTORIS", "stage": 4}, {"efo_term": "PRINZMETAL'S ANGINA", "stage": 4}, {"efo_term": "ANGINA PECTORIS", "stage": 4}, {"efo_term": "MYOCARDIAL INFARCTION", "stage": 4}, {"efo_term": "STROKE", "stage": 4}, {"efo_term": "PROTEINURIA", "stage": 3}], "max_phase": 4, "name": "AMLODIPINE BESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200402", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": ["HYPERTENSION", "CORONARY ARTERY DISEASE", "PROTEINURIA", "ANGINA PECTORIS", "PRINZMETAL'S ANGINA", "MYOCARDIAL INFARCTION", "STROKE"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "SUBARACHNOID HEMORRHAGE", "stage": 3}, {"efo_term": "INFERTILITY", "stage": 2}, {"efo_term": "STROKE", "stage": 2}, {"efo_term": "BRAIN ANEURYSM", "stage": 1}], "max_phase": 4, "name": "NIMODIPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1428", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": ["INFERTILITY", "CARDIOVASCULAR DISEASE", "BRAIN ANEURYSM", "STROKE", "SUBARACHNOID HEMORRHAGE"]}, {"indications": [{"efo_term": "RESTLESS LEGS SYNDROME", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "MIGRAINE DISORDER", "stage": 2}], "max_phase": 4, "name": "GABAPENTIN ENACARBIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1628502", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNB1", "CACNA1A", "CACNA1B", "CACNA1C", "CACNB2", "CACNB3", "CACNB4"], "type": "Small molecule", "diseases": ["RESTLESS LEGS SYNDROME", "EPILEPSY", "ALCOHOL DEPENDENCE", "MIGRAINE DISORDER"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "PREMATURE BIRTH", "stage": 3}, {"efo_term": "KIDNEY STONE", "stage": 3}, {"efo_term": "ANAL FISSURE", "stage": 2}], "max_phase": 4, "name": "NIFEDIPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": ["ANAL FISSURE", "PREMATURE BIRTH", "KIDNEY STONE", "CARDIOVASCULAR DISEASE"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "PARKINSON'S DISEASE", "stage": 3}, {"efo_term": "BIPOLAR DISORDER", "stage": 2}, {"efo_term": "OPIOID DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "ISRADIPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1648", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "BIPOLAR DISORDER", "CARDIOVASCULAR DISEASE", "OPIOID DEPENDENCE"]}, {"indications": [{"efo_term": "ANGINA PECTORIS", "stage": 4}, {"efo_term": "ANAL FISSURE", "stage": 3}, {"efo_term": "CONSTIPATION", "stage": 1}, {"efo_term": "SKIN DISEASE", "stage": 1}], "max_phase": 4, "name": "DILTIAZEM HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1697", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": ["CONSTIPATION", "ANAL FISSURE", "SKIN DISEASE", "ANGINA PECTORIS"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 3}, {"efo_term": "SCOLIOSIS", "stage": 2}], "max_phase": 4, "name": "CLEVIDIPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237132", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": ["HYPERTENSION", "SCOLIOSIS", "CARDIOVASCULAR DISEASE"]}, {"indications": [{"efo_term": "ANXIETY", "stage": 3}, {"efo_term": "RENAL INSUFFICIENCY", "stage": 1}], "max_phase": 3, "name": "IMAGABALIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103836", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNB1", "CACNA1A", "CACNA1B", "CACNA1C", "CACNB2", "CACNB3", "CACNB4"], "type": "Small molecule", "diseases": ["ANXIETY", "RENAL INSUFFICIENCY"]}, {"indications": [{"efo_term": "FEVER", "stage": 4}, {"efo_term": "PAIN", "stage": 4}], "max_phase": 4, "name": "ZICONOTIDE ACETATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1795072", "mechanisms": ["Voltage-gated N-type calcium channel alpha-1B subunit blocker"], "genes": ["CACNA1B"], "type": "Protein", "diseases": ["FEVER", "PAIN"]}, {"indications": [{"efo_term": "PAIN", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 2}], "max_phase": 3, "name": "RALFINAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107771", "mechanisms": ["Voltage-gated N-type calcium channel alpha-1B subunit blocker"], "genes": ["CACNA1B"], "type": "Small molecule", "diseases": ["PAIN", "NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "INTRACEREBRAL HEMORRHAGE", "stage": 3}], "max_phase": 4, "name": "NICARDIPINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200326", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": ["HYPERTENSION", "INTRACEREBRAL HEMORRHAGE"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 2}], "max_phase": 2, "name": "ATAGABALIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL593430", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNB1", "CACNA1A", "CACNA1B", "CACNA1C", "CACNB2", "CACNB3", "CACNB4"], "type": "Small molecule", "diseases": ["INSOMNIA"]}, {"indications": [{"efo_term": "DIABETIC NEUROPATHY", "stage": 2}], "max_phase": 2, "name": "CNV2197944", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545172", "mechanisms": ["Voltage-gated N-type calcium channel alpha-1B subunit blocker"], "genes": ["CACNA1B"], "type": "Small molecule", "diseases": ["DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}], "max_phase": 4, "name": "FELODIPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1480", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": ["CARDIOVASCULAR DISEASE"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}], "max_phase": 4, "name": "NISOLDIPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1726", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": ["CARDIOVASCULAR DISEASE"]}, {"indications": [{"efo_term": "ATRIAL FIBRILLATION", "stage": 4}], "max_phase": 4, "name": "DRONEDARONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201729", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": ["ATRIAL FIBRILLATION"]}, {"indications": [{"efo_term": "ATRIAL FIBRILLATION", "stage": 2}], "max_phase": 2, "name": "AZD1305", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545169", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": ["ATRIAL FIBRILLATION"]}, {"indications": [], "max_phase": 4, "name": "BEPRIDIL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200382", "mechanisms": ["Voltage-gated calcium channel blocker"], "genes": ["CACNB1", "CACNA1A", "CACNA1B", "CACNA1C", "CACNB2", "CACNB3", "CACNB4"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "ELPETRIGINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29919", "mechanisms": ["Voltage-gated P/Q-type calcium channel alpha-1A subunit blocker", "Voltage-gated N-type calcium channel alpha-1B subunit blocker", "Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1A", "CACNA1B", "CACNA1C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "Z160", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL604710", "mechanisms": ["Voltage-gated N-type calcium channel alpha-1B subunit blocker"], "genes": ["CACNA1B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "VERAPAMIL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1280", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DILTIAZEM MALATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200805", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "AMLODIPINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200984", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1C"], "type": "Small molecule", "diseases": []}], "heat": 0.882855422847225, "nodes": [{"assoc": 1.0, "id": "ENSG00000067191", "label": "CACNB1"}, {"assoc": 0.0628433827778, "id": "ENSG00000101152", "label": "DNAJC5"}, {"assoc": 1.0, "id": "ENSG00000141837", "label": "CACNA1A"}, {"assoc": 1.0, "id": "ENSG00000148408", "label": "CACNA1B"}, {"assoc": 1.0, "id": "ENSG00000151067", "label": "CACNA1C"}, {"assoc": 1.0, "id": "ENSG00000165995", "label": "CACNB2"}, {"assoc": 1.0, "id": "ENSG00000167535", "label": "CACNB3"}, {"assoc": 1.0, "id": "ENSG00000182389", "label": "CACNB4"}], "size": 8}, {"diseases": ["COCAINE DEPENDENCE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "NARCOLEPSY", "METAMPHETAMINE DEPENDENCE", "STROKE", "SCHIZOPHRENIA", "MULTIPLE SCLEROSIS", "CENTRAL NERVOUS SYSTEM CANCER", "BIPOLAR DISORDER", "CANCER", "UNIPOLAR DEPRESSION", "BRAIN NEOPLASM", "DEMENTIA", "EATING DISORDER", "POST-TRAUMATIC STRESS DISORDER", "PROSTATE CARCINOMA", "SICKLE CELL ANEMIA", "INJURY", "PARKINSON'S DISEASE", "FATIGUE", "ALZHEIMERS DISEASE", "POST-OPERATIVE SIGN OR SYMPTOM", "NICOTINE DEPENDENCE", "FIBROMYALGIA", "OBESITY", "DRUG DEPENDENCE", "PAIN", "LUNG CARCINOMA", "MOOD DISORDER", "CARDIAC ARRHYTHMIA", "DIABETIC NEUROPATHY", "COMMON COLD", "ANXIETY", "PSORIASIS", "ATOPIC ECZEMA", "GASTROPARESIS", "NEUROPATHIC PAIN", "MIGRAINE DISORDER", "EPILEPSY", "ALCOHOL DRINKING", "ALCOHOL DEPENDENCE", "CONGENITAL HEART DISEASE", "GAMBLING BEHAVIOUR", "SMOKING CESSATION", "MARIJUANA DEPENDENCE", "PRADER-WILLI SYNDROME", "CEREBRAL ISCHEMIA", "SEIZURES", "TORTICOLLIS", "ESSENTIAL TREMOR", "TINNITUS"], "links": [{"source": "ENSG00000100151", "type": "directed", "target": "ENSG00000103546"}, {"source": "ENSG00000100151", "type": "directed", "target": "ENSG00000155511", "reverse": "rev-directed"}, {"source": "ENSG00000100151", "target": "ENSG00000164418"}, {"source": "ENSG00000100151", "type": "directed", "target": "ENSG00000171189", "reverse": "rev-directed"}, {"source": "ENSG00000120251", "target": "ENSG00000155511"}, {"source": "ENSG00000149403", "target": "ENSG00000164418"}], "drugs": [{"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}, {"efo_term": "BIPOLAR DISORDER", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "BRAIN NEOPLASM", "stage": 3}, {"efo_term": "DEMENTIA", "stage": 3}, {"efo_term": "SICKLE CELL ANEMIA", "stage": 3}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 3}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "METAMPHETAMINE DEPENDENCE", "stage": 2}, {"efo_term": "EATING DISORDER", "stage": 2}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "INJURY", "stage": 2}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 2}, {"efo_term": "FATIGUE", "stage": 1}, {"efo_term": "POST-OPERATIVE SIGN OR SYMPTOM", "stage": 1}, {"efo_term": "COCAINE DEPENDENCE", "stage": 1}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 0}, {"efo_term": "PARKINSON'S DISEASE", "stage": 0}], "max_phase": 4, "name": "METHYLPHENIDATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL796", "mechanisms": ["Norepinephrine transporter inhibitor"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "BIPOLAR DISORDER", "CANCER", "METAMPHETAMINE DEPENDENCE", "UNIPOLAR DEPRESSION", "BRAIN NEOPLASM", "DEMENTIA", "EATING DISORDER", "MULTIPLE SCLEROSIS", "POST-TRAUMATIC STRESS DISORDER", "PROSTATE CARCINOMA", "SICKLE CELL ANEMIA", "INJURY", "PARKINSON'S DISEASE", "FATIGUE", "ALZHEIMERS DISEASE", "POST-OPERATIVE SIGN OR SYMPTOM", "NICOTINE DEPENDENCE", "COCAINE DEPENDENCE"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "MIGRAINE DISORDER", "stage": 3}, {"efo_term": "OBESITY", "stage": 3}, {"efo_term": "SMOKING CESSATION", "stage": 3}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 3}, {"efo_term": "PRADER-WILLI SYNDROME", "stage": 3}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "ALCOHOL DRINKING", "stage": 2}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "METAMPHETAMINE DEPENDENCE", "stage": 2}, {"efo_term": "GAMBLING BEHAVIOUR", "stage": 2}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 2}, {"efo_term": "CEREBRAL ISCHEMIA", "stage": 2}, {"efo_term": "BIPOLAR DISORDER", "stage": 1}, {"efo_term": "CONGENITAL HEART DISEASE", "stage": 1}], "max_phase": 4, "name": "TOPIRAMATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492", "mechanisms": ["Glutamate receptor ionotropic AMPA antagonist", "Glutamate receptor ionotropic kainate antagonist"], "genes": ["GRIA2", "GRIK4", "GRIA1", "GRIK2", "GRIK1"], "type": "Small molecule", "diseases": ["COCAINE DEPENDENCE", "EPILEPSY", "ALCOHOL DRINKING", "BIPOLAR DISORDER", "MIGRAINE DISORDER", "ALCOHOL DEPENDENCE", "CONGENITAL HEART DISEASE", "METAMPHETAMINE DEPENDENCE", "GAMBLING BEHAVIOUR", "OBESITY", "SMOKING CESSATION", "NICOTINE DEPENDENCE", "MARIJUANA DEPENDENCE", "PRADER-WILLI SYNDROME", "CEREBRAL ISCHEMIA"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "PARKINSON'S DISEASE", "stage": 3}, {"efo_term": "SEIZURES", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 2}, {"efo_term": "MIGRAINE DISORDER", "stage": 2}, {"efo_term": "ESSENTIAL TREMOR", "stage": 2}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 2}, {"efo_term": "TORTICOLLIS", "stage": 1}], "max_phase": 4, "name": "PERAMPANEL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1214124", "mechanisms": ["Glutamate receptor ionotropic AMPA antagonist"], "genes": ["GRIA2", "GRIA1"], "type": "Small molecule", "diseases": ["EPILEPSY", "PARKINSON'S DISEASE", "SEIZURES", "TORTICOLLIS", "NEUROPATHIC PAIN", "MIGRAINE DISORDER", "ESSENTIAL TREMOR", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}, {"efo_term": "CENTRAL NERVOUS SYSTEM CANCER", "stage": 3}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "METAMPHETAMINE DEPENDENCE", "stage": 2}, {"efo_term": "STROKE", "stage": 2}, {"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}], "max_phase": 4, "name": "DEXTROAMPHETAMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL612", "mechanisms": ["Norepinephrine transporter releasing agent"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "COCAINE DEPENDENCE", "METAMPHETAMINE DEPENDENCE", "STROKE", "SCHIZOPHRENIA", "MULTIPLE SCLEROSIS", "CENTRAL NERVOUS SYSTEM CANCER"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "BIPOLAR DISORDER", "stage": 3}, {"efo_term": "LUNG CARCINOMA", "stage": 3}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 1}, {"efo_term": "MOOD DISORDER", "stage": 1}], "max_phase": 4, "name": "BUPROPION HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1698", "mechanisms": ["Norepinephrine transporter inhibitor"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "NICOTINE DEPENDENCE", "UNIPOLAR DEPRESSION", "LUNG CARCINOMA", "MOOD DISORDER"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "ANXIETY", "stage": 2}, {"efo_term": "PAIN", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "FIBROMYALGIA", "stage": 1}], "max_phase": 4, "name": "VENLAFAXINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201066", "mechanisms": ["Norepinephrine transporter inhibitor"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION", "COCAINE DEPENDENCE", "ANXIETY", "PAIN", "PROSTATE CARCINOMA", "FIBROMYALGIA"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "EATING DISORDER", "stage": 3}], "max_phase": 4, "name": "LISDEXAMFETAMINE DIMESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201178", "mechanisms": ["Norepinephrine transporter releasing agent"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "SCHIZOPHRENIA", "UNIPOLAR DEPRESSION", "EATING DISORDER"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "NEUROPATHIC PAIN", "stage": 4}, {"efo_term": "PAIN", "stage": 4}], "max_phase": 4, "name": "TAPENTADOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201777", "mechanisms": ["Norepinephrine transporter inhibitor"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": ["PAIN", "NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "FIBROMYALGIA", "stage": 2}], "max_phase": 4, "name": "DESVENLAFAXINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1118", "mechanisms": ["Norepinephrine transporter inhibitor"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION", "FIBROMYALGIA"]}, {"indications": [{"efo_term": "MULTIPLE SCLEROSIS", "stage": 3}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 3}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 3}], "max_phase": 4, "name": "DULOXETINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200328", "mechanisms": ["Norepinephrine transporter inhibitor"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": ["MULTIPLE SCLEROSIS", "POST-TRAUMATIC STRESS DISORDER", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "GASTROPARESIS", "stage": 3}, {"efo_term": "PSORIASIS", "stage": 2}, {"efo_term": "ATOPIC ECZEMA", "stage": 1}], "max_phase": 4, "name": "NORTRIPTYLINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201156", "mechanisms": ["Norepinephrine transporter inhibitor"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": ["PSORIASIS", "ATOPIC ECZEMA", "GASTROPARESIS"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 3}], "max_phase": 4, "name": "DESVENLAFAXINE SUCCINATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201728", "mechanisms": ["Norepinephrine transporter inhibitor"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 3}, {"efo_term": "EATING DISORDER", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 3, "name": "DASOTRALINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3301595", "mechanisms": ["Monoamine transporter inhibitor"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "EATING DISORDER", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "MIGRAINE DISORDER", "stage": 2}, {"efo_term": "SEIZURES", "stage": 2}, {"efo_term": "TINNITUS", "stage": 2}], "max_phase": 2, "name": "Selurampanel", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545042", "mechanisms": ["Glutamate receptor ionotropic AMPA antagonist", "Glutamate receptor ionotropic kainate antagonist"], "genes": ["GRIA2", "GRIK4", "GRIA1", "GRIK2", "GRIK1"], "type": "Small molecule", "diseases": ["MIGRAINE DISORDER", "SEIZURES", "TINNITUS"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}], "max_phase": 4, "name": "AMPHETAMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL405", "mechanisms": ["Norepinephrine transporter releasing agent"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": ["COCAINE DEPENDENCE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}, {"efo_term": "NARCOLEPSY", "stage": 4}], "max_phase": 4, "name": "AMPHETAMINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL501", "mechanisms": ["Norepinephrine transporter releasing agent"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "NARCOLEPSY"]}, {"indications": [{"efo_term": "OBESITY", "stage": 4}, {"efo_term": "DRUG DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "PHENTERMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1574", "mechanisms": ["Norepinephrine transporter releasing agent"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": ["OBESITY", "DRUG DEPENDENCE"]}, {"indications": [{"efo_term": "PAIN", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 1}], "max_phase": 4, "name": "DESIPRAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1696", "mechanisms": ["Norepinephrine transporter inhibitor"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": ["PAIN", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}, {"efo_term": "CANCER", "stage": 2}], "max_phase": 4, "name": "METHYLPHENIDATE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1722", "mechanisms": ["Norepinephrine transporter inhibitor"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "CANCER"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}, {"efo_term": "NARCOLEPSY", "stage": 4}], "max_phase": 4, "name": "DEXTROAMPHETAMINE SACCHARATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200992", "mechanisms": ["Norepinephrine transporter releasing agent"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "NARCOLEPSY"]}, {"indications": [{"efo_term": "FIBROMYALGIA", "stage": 4}, {"efo_term": "PAIN", "stage": 3}], "max_phase": 4, "name": "MILNACIPRAN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2096626", "mechanisms": ["Norepinephrine transporter inhibitor"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": ["FIBROMYALGIA", "PAIN"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 2}], "max_phase": 3, "name": "EDIVOXETINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103857", "mechanisms": ["Norepinephrine transporter inhibitor"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}, {"efo_term": "NARCOLEPSY", "stage": 4}], "max_phase": 4, "name": "DEXTROAMPHETAMINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544971", "mechanisms": ["Norepinephrine transporter releasing agent"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "NARCOLEPSY"]}, {"indications": [{"efo_term": "OBESITY", "stage": 4}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 2}], "max_phase": 4, "name": "MAZINDOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL781", "mechanisms": ["Monoamine transporter inhibitor"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": ["OBESITY", "ATTENTION DEFICIT HYPERACTIVITY DISORDER"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "FARAMPATOR", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1276138", "mechanisms": ["Glutamate receptor ionotropic AMPA positive allosteric modulator"], "genes": ["GRIA2", "GRIA1"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "MK-8777", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707401", "mechanisms": ["Glutamate receptor ionotropic AMPA positive allosteric modulator"], "genes": ["GRIA2", "GRIA1"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}], "max_phase": 4, "name": "DEXMETHYLPHENIDATE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL904", "mechanisms": ["Norepinephrine transporter inhibitor"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}], "max_phase": 4, "name": "AMOXAPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1113", "mechanisms": ["Norepinephrine transporter inhibitor"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "FIBROMYALGIA", "stage": 3}], "max_phase": 3, "name": "ESREBOXETINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180101", "mechanisms": [" Norepinephrine transporter inhibitor"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": ["FIBROMYALGIA"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 1}], "max_phase": 4, "name": "IMIPRAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1692", "mechanisms": ["Norepinephrine transporter inhibitor"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}], "max_phase": 4, "name": "ATOMOXETINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1702", "mechanisms": ["Norepinephrine transporter inhibitor"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER"]}, {"indications": [{"efo_term": "CARDIAC ARRHYTHMIA", "stage": 4}], "max_phase": 4, "name": "BRETYLIUM TOSYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1095292", "mechanisms": ["Norepinephrine transporter substrate"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": ["CARDIAC ARRHYTHMIA"]}, {"indications": [{"efo_term": "COMMON COLD", "stage": 3}], "max_phase": 4, "name": "PSEUDOEPHEDRINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200724", "mechanisms": ["Norepinephrine transporter releasing agent"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": ["COMMON COLD"]}, {"indications": [{"efo_term": "OBESITY", "stage": 4}], "max_phase": 4, "name": "PHENTERMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200912", "mechanisms": ["Norepinephrine transporter releasing agent"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": ["OBESITY"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}], "max_phase": 4, "name": "AMITRIPTYLINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200964", "mechanisms": ["Norepinephrine transporter inhibitor"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}], "max_phase": 4, "name": "ORPHENADRINE (CHLORIDE)", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201023", "mechanisms": ["Norepinephrine transporter inhibitor"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}], "max_phase": 4, "name": "BUPROPION HYDROBROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201735", "mechanisms": ["Norepinephrine transporter inhibitor"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "TEDATIOXETINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104986", "mechanisms": ["Norepinephrine transporter inhibitor"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}], "max_phase": 4, "name": "LEVOMILNACIPRAN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105732", "mechanisms": ["Norepinephrine transporter inhibitor"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}], "max_phase": 4, "name": "DESVENLAFAXINE FUMARATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3039565", "mechanisms": ["Norepinephrine transporter inhibitor"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "OBESITY", "stage": 3}], "max_phase": 4, "name": "SIBUTRAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200765", "mechanisms": ["Monoamine transporter inhibitor"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": ["OBESITY"]}, {"indications": [{"efo_term": "METAMPHETAMINE DEPENDENCE", "stage": 0}], "max_phase": 4, "name": "METHAMPHETAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200952", "mechanisms": ["Monoamine transporter inhibitor"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": ["METAMPHETAMINE DEPENDENCE"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "LIAFENSINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2364614", "mechanisms": ["Monoamine transporter inhibitor"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "MIGRAINE DISORDER", "stage": 2}], "max_phase": 2, "name": "TEZAMPANEL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14935", "mechanisms": ["Glutamate receptor ionotropic AMPA antagonist", "Glutamate receptor ionotropic kainate antagonist"], "genes": ["GRIA2", "GRIK4", "GRIA1", "GRIK2", "GRIK1"], "type": "Small molecule", "diseases": ["MIGRAINE DISORDER"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 2}], "max_phase": 2, "name": "MIBAMPATOR", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1277001", "mechanisms": ["Glutamate receptor ionotropic AMPA positive allosteric modulator"], "genes": ["GRIA2", "GRIA1"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 2}], "max_phase": 2, "name": "PF-04958242", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707379", "mechanisms": ["Glutamate receptor ionotropic AMPA positive allosteric modulator"], "genes": ["GRIA2", "GRIA1"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [], "max_phase": 4, "name": "GUANETHIDINE MONOSULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1345", "mechanisms": ["Norepinephrine transporter substrate"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIETHYLPROPION HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1693", "mechanisms": ["Norepinephrine transporter inhibitor"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROTRIPTYLINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200332", "mechanisms": ["Norepinephrine transporter inhibitor"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "AMPHETAMINE ASPARTATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200377", "mechanisms": ["Norepinephrine transporter releasing agent"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "AMPHETAMINE ADIPATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200387", "mechanisms": ["Norepinephrine transporter releasing agent"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ORPHENADRINE CITRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200395", "mechanisms": ["Norepinephrine transporter inhibitor"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PHENMETRAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200483", "mechanisms": ["Norepinephrine transporter inhibitor"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "NEFAZODONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200492", "mechanisms": ["Norepinephrine transporter inhibitor"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "GUANADREL SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200594", "mechanisms": ["Norepinephrine transporter substrate"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "IMIPRAMINE PAMOATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200631", "mechanisms": ["Norepinephrine transporter inhibitor"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PHENYLPROPANOLAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200695", "mechanisms": ["Norepinephrine transporter releasing agent"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DEXTROAMPHETAMINE ADIPATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200782", "mechanisms": ["Norepinephrine transporter releasing agent"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PSEUDOEPHEDRINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200900", "mechanisms": ["Norepinephrine transporter releasing agent"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TRIMIPRAMINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200948", "mechanisms": ["Norepinephrine transporter inhibitor"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PHENYLPROPANOLAMINE POLISTIREX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201535", "mechanisms": ["Norepinephrine transporter releasing agent"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PSEUDOEPHEDRINE POLISTIREX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201483", "mechanisms": ["Norepinephrine transporter releasing agent"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MAPROTILINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237135", "mechanisms": ["Norepinephrine transporter inhibitor"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DOXEPIN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1628234", "mechanisms": ["Norepinephrine transporter inhibitor"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PHENDIMETRAZINE TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1898523", "mechanisms": ["Norepinephrine transporter inhibitor"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "FAXELADOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103829", "mechanisms": ["Norepinephrine transporter inhibitor"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BETHANIDINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2110368", "mechanisms": ["Norepinephrine transporter substrate"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BENZPHETAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544906", "mechanisms": ["Norepinephrine transporter releasing agent"], "genes": ["SLC6A2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "IRAMPANEL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29741", "mechanisms": ["Glutamate receptor ionotropic AMPA antagonist"], "genes": ["GRIA2", "GRIA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "ZONAMPANEL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL119625", "mechanisms": ["Glutamate receptor ionotropic AMPA antagonist"], "genes": ["GRIA2", "GRIA1"], "type": "Protein", "diseases": []}, {"indications": [], "max_phase": 0, "name": "DASOLAMPANEL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103869", "mechanisms": ["Glutamate receptor ionotropic AMPA antagonist", "Glutamate receptor ionotropic kainate 1 antagonist"], "genes": ["GRIA2", "GRIA1", "GRIK1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "BECAMPANEL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107735", "mechanisms": ["Glutamate receptor ionotropic AMPA antagonist"], "genes": ["GRIA2", "GRIA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "CX1739", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707399", "mechanisms": ["Glutamate receptor ionotropic AMPA positive allosteric modulator"], "genes": ["GRIA2", "GRIA1"], "type": "Small molecule", "diseases": []}], "heat": 0.8766794994375715, "nodes": [{"assoc": 0.136756496063, "id": "ENSG00000100151", "label": "PICK1"}, {"assoc": 1.0, "id": "ENSG00000103546", "label": "SLC6A2"}, {"assoc": 1.0, "id": "ENSG00000120251", "label": "GRIA2"}, {"assoc": 1.0, "id": "ENSG00000149403", "label": "GRIK4"}, {"assoc": 1.0, "id": "ENSG00000155511", "label": "GRIA1"}, {"assoc": 1.0, "id": "ENSG00000164418", "label": "GRIK2"}, {"assoc": 1.0, "id": "ENSG00000171189", "label": "GRIK1"}], "size": 7}, {"diseases": ["CONGESTIVE HEART FAILURE", "HYPONATREMIA", "CARCINOMA", "CIRRHOSIS OF LIVER", "HEART FAILURE", "KIDNEY DISEASE", "CHRONIC KIDNEY DISEASE", "CARDIOVASCULAR DISEASE", "LIVER DISEASE", "SEPTIC SHOCK", "UNIPOLAR DEPRESSION", "AUTISM SPECTRUM DISORDER", "SUDDEN CARDIAC ARREST", "INJURY", "ENURESIS NOCTURNA", "NOCTURIA", "INTRACEREBRAL HEMORRHAGE", "POST-OPERATIVE SIGN OR SYMPTOM", "BENIGN PROSTATIC HYPERPLASIA", "MENOPAUSE", "ALZHEIMERS DISEASE", "BREAST CARCINOMA", "NEOPLASM", "HEPATOCELLULAR CARCINOMA", "PROSTATE CARCINOMA", "CANCER", "OVARIAN CARCINOMA", "BREAST NEOPLASM", "PROSTATE ADENOCARCINOMA", "ENDOMETRIAL NEOPLASM", "PULMONARY HYPERTENSION", "PARKINSON'S DISEASE", "AMENORRHEA", "TURNER SYNDROME", "POSTMENOPAUSAL OSTEOPOROSIS", "DYSPAREUNIA", "OSTEOPOROSIS", "ANXIETY", "POST-TRAUMATIC STRESS DISORDER", "AUTISM", "HEMORRHAGE", "PRADER-WILLI SYNDROME", "PREECLAMPSIA", "SCHIZOPHRENIA", "ALCOHOL WITHDRAWAL", "CARDIAC ARRHYTHMIA", "COCAINE DEPENDENCE", "NEUROPATHIC PAIN", "FRONTOTEMPORAL DEMENTIA", "OBESITY", "SEXUAL DYSFUNCTION", "ALCOHOL DEPENDENCE", "FRAGILE X SYNDROME", "OPIOID DEPENDENCE", "OBSESSIVE-COMPULSIVE DISORDER", "PREGNANCY", "INFLAMMATION", "PAIN", "GASTROPARESIS", "MOOD DISORDER", "PREMATURE BIRTH", "INFERTILITY"], "links": [{"source": "ENSG00000101200", "type": "stimulatory", "target": "ENSG00000126895"}, {"source": "ENSG00000101200", "type": "stimulatory", "target": "ENSG00000166148"}, {"source": "ENSG00000101200", "target": "ENSG00000180914"}, {"source": "ENSG00000101200", "type": "stimulatory", "target": "ENSG00000198049"}, {"source": "ENSG00000101405", "target": "ENSG00000140009"}, {"source": "ENSG00000101405", "type": "stimulatory", "target": "ENSG00000180914"}], "drugs": [{"indications": [{"efo_term": "HEMORRHAGE", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 3}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 3}, {"efo_term": "AUTISM SPECTRUM DISORDER", "stage": 2}, {"efo_term": "PRADER-WILLI SYNDROME", "stage": 2}, {"efo_term": "AUTISM", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "NEUROPATHIC PAIN", "stage": 2}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "FRONTOTEMPORAL DEMENTIA", "stage": 2}, {"efo_term": "SEXUAL DYSFUNCTION", "stage": 2}, {"efo_term": "FRAGILE X SYNDROME", "stage": 2}, {"efo_term": "OBSESSIVE-COMPULSIVE DISORDER", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}, {"efo_term": "INFLAMMATION", "stage": 2}, {"efo_term": "PAIN", "stage": 2}, {"efo_term": "MOOD DISORDER", "stage": 2}, {"efo_term": "ALCOHOL WITHDRAWAL", "stage": 1}, {"efo_term": "OPIOID DEPENDENCE", "stage": 1}, {"efo_term": "PREGNANCY", "stage": 1}, {"efo_term": "PREECLAMPSIA", "stage": 0}, {"efo_term": "CARDIAC ARRHYTHMIA", "stage": 0}, {"efo_term": "OBESITY", "stage": 0}, {"efo_term": "GASTROPARESIS", "stage": 0}], "max_phase": 4, "name": "OXYTOCIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL395429", "mechanisms": ["Oxytocin receptor agonist"], "genes": ["OXTR"], "type": "Protein", "diseases": ["AUTISM SPECTRUM DISORDER", "HEMORRHAGE", "PRADER-WILLI SYNDROME", "PREECLAMPSIA", "SCHIZOPHRENIA", "ALCOHOL WITHDRAWAL", "AUTISM", "CARDIAC ARRHYTHMIA", "COCAINE DEPENDENCE", "NEUROPATHIC PAIN", "POST-TRAUMATIC STRESS DISORDER", "FRONTOTEMPORAL DEMENTIA", "OBESITY", "SEXUAL DYSFUNCTION", "ALCOHOL DEPENDENCE", "FRAGILE X SYNDROME", "OPIOID DEPENDENCE", "OBSESSIVE-COMPULSIVE DISORDER", "UNIPOLAR DEPRESSION", "PREGNANCY", "INFLAMMATION", "PAIN", "GASTROPARESIS", "MOOD DISORDER"]}, {"indications": [{"efo_term": "CANCER", "stage": 4}, {"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "BREAST NEOPLASM", "stage": 3}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "OVARIAN CARCINOMA", "stage": 2}, {"efo_term": "PROSTATE ADENOCARCINOMA", "stage": 2}, {"efo_term": "ENDOMETRIAL NEOPLASM", "stage": 2}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 2}], "max_phase": 4, "name": "FULVESTRANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1358", "mechanisms": ["Estrogen receptor antagonist"], "genes": ["ESR2"], "type": "Small molecule", "diseases": ["BREAST CARCINOMA", "PROSTATE CARCINOMA", "CANCER", "OVARIAN CARCINOMA", "BREAST NEOPLASM", "NEOPLASM", "PROSTATE ADENOCARCINOMA", "ENDOMETRIAL NEOPLASM", "PULMONARY HYPERTENSION"]}, {"indications": [{"efo_term": "HEART FAILURE", "stage": 4}, {"efo_term": "HYPONATREMIA", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "CIRRHOSIS OF LIVER", "stage": 3}, {"efo_term": "CARCINOMA", "stage": 2}, {"efo_term": "KIDNEY DISEASE", "stage": 2}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 2}], "max_phase": 4, "name": "TOLVAPTAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL344159", "mechanisms": ["Vasopressin V2 receptor antagonist"], "genes": ["AVPR2"], "type": "Small molecule", "diseases": ["CARCINOMA", "CIRRHOSIS OF LIVER", "HEART FAILURE", "HYPONATREMIA", "KIDNEY DISEASE", "CHRONIC KIDNEY DISEASE", "CARDIOVASCULAR DISEASE"]}, {"indications": [{"efo_term": "POSTMENOPAUSAL OSTEOPOROSIS", "stage": 4}, {"efo_term": "AMENORRHEA", "stage": 3}, {"efo_term": "TURNER SYNDROME", "stage": 3}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "INJURY", "stage": 2}, {"efo_term": "MENOPAUSE", "stage": 1}], "max_phase": 4, "name": "ESTROGENS, CONJUGATED", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201649", "mechanisms": ["Estrogen receptor agonist"], "genes": ["ESR2"], "type": "Small molecule", "diseases": ["PROSTATE CARCINOMA", "MENOPAUSE", "PARKINSON'S DISEASE", "INJURY", "AMENORRHEA", "TURNER SYNDROME", "POSTMENOPAUSAL OSTEOPOROSIS"]}, {"indications": [{"efo_term": "SEPTIC SHOCK", "stage": 3}, {"efo_term": "SUDDEN CARDIAC ARREST", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}, {"efo_term": "AUTISM SPECTRUM DISORDER", "stage": 2}, {"efo_term": "INJURY", "stage": 2}], "max_phase": 4, "name": "VASOPRESSIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL373742", "mechanisms": ["Vasopressin receptor agonist"], "genes": ["AVPR2", "AVPR1A", "AVPR1B"], "type": "Protein", "diseases": ["SEPTIC SHOCK", "UNIPOLAR DEPRESSION", "AUTISM SPECTRUM DISORDER", "SUDDEN CARDIAC ARREST", "INJURY"]}, {"indications": [{"efo_term": "ENURESIS NOCTURNA", "stage": 4}, {"efo_term": "NOCTURIA", "stage": 3}, {"efo_term": "INTRACEREBRAL HEMORRHAGE", "stage": 2}, {"efo_term": "POST-OPERATIVE SIGN OR SYMPTOM", "stage": 2}], "max_phase": 4, "name": "DESMOPRESSIN ACETATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200556", "mechanisms": ["Vasopressin receptor agonist"], "genes": ["AVPR2", "AVPR1A", "AVPR1B"], "type": "Protein", "diseases": ["ENURESIS NOCTURNA", "NOCTURIA", "INTRACEREBRAL HEMORRHAGE", "POST-OPERATIVE SIGN OR SYMPTOM"]}, {"indications": [{"efo_term": "BENIGN PROSTATIC HYPERPLASIA", "stage": 2}, {"efo_term": "MENOPAUSE", "stage": 2}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 1}, {"efo_term": "BREAST CARCINOMA", "stage": 0}], "max_phase": 2, "name": "EQUOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL198877", "mechanisms": ["Estrogen receptor beta agonist"], "genes": ["ESR2"], "type": "Small molecule", "diseases": ["BENIGN PROSTATIC HYPERPLASIA", "MENOPAUSE", "ALZHEIMERS DISEASE", "BREAST CARCINOMA"]}, {"indications": [{"efo_term": "HYPONATREMIA", "stage": 3}, {"efo_term": "CONGESTIVE HEART FAILURE", "stage": 2}], "max_phase": 3, "name": "LIXIVAPTAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL49429", "mechanisms": ["Vasopressin V2 receptor antagonist"], "genes": ["AVPR2"], "type": "Small molecule", "diseases": ["CONGESTIVE HEART FAILURE", "HYPONATREMIA"]}, {"indications": [{"efo_term": "HYPONATREMIA", "stage": 3}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 4, "name": "CONIVAPTAN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201108", "mechanisms": ["Vasopressin V2 receptor antagonist", "Vasopressin V1a receptor antagonist"], "genes": ["AVPR2", "AVPR1A"], "type": "Small molecule", "diseases": ["HYPONATREMIA", "LIVER DISEASE"]}, {"indications": [{"efo_term": "POSTMENOPAUSAL OSTEOPOROSIS", "stage": 4}, {"efo_term": "OSTEOPOROSIS", "stage": 3}], "max_phase": 4, "name": "BAZEDOXIFENE ACETATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2106615", "mechanisms": ["Estrogen receptor modulator"], "genes": ["ESR2"], "type": "Small molecule", "diseases": ["OSTEOPOROSIS", "POSTMENOPAUSAL OSTEOPOROSIS"]}, {"indications": [{"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "ANXIETY", "stage": 1}], "max_phase": 2, "name": "SRX246", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL244243", "mechanisms": ["Vasopressin V1a receptor antagonist"], "genes": ["AVPR1A"], "type": "Small molecule", "diseases": ["ANXIETY", "POST-TRAUMATIC STRESS DISORDER"]}, {"indications": [{"efo_term": "BENIGN PROSTATIC HYPERPLASIA", "stage": 2}], "max_phase": 2, "name": "ERTEBEREL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL278703", "mechanisms": ["Estrogen receptor beta agonist"], "genes": ["ESR2"], "type": "Small molecule", "diseases": ["BENIGN PROSTATIC HYPERPLASIA"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 4}], "max_phase": 4, "name": "ESTRAMUSTINE PHOSPHATE SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200721", "mechanisms": ["Estrogen receptor beta "], "genes": ["ESR2"], "type": "Small molecule", "diseases": ["NEOPLASM"]}, {"indications": [{"efo_term": "HEPATOCELLULAR CARCINOMA", "stage": 3}], "max_phase": 4, "name": "CHLOROTRIANISENE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200761", "mechanisms": ["Estrogen receptor beta modulator"], "genes": ["ESR2"], "type": "Small molecule", "diseases": ["HEPATOCELLULAR CARCINOMA"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 4}], "max_phase": 4, "name": "DIETHYLSTILBESTROL DIPHOSPHATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200598", "mechanisms": ["Estrogen receptor agonist"], "genes": ["ESR2"], "type": "Small molecule", "diseases": ["NEOPLASM"]}, {"indications": [{"efo_term": "BREAST NEOPLASM", "stage": 2}], "max_phase": 4, "name": "TOREMIFENE CITRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200675", "mechanisms": ["Estrogen receptor modulator"], "genes": ["ESR2"], "type": "Small molecule", "diseases": ["BREAST NEOPLASM"]}, {"indications": [{"efo_term": "MENOPAUSE", "stage": 2}], "max_phase": 4, "name": "ESTROGENS, ESTERIFIED", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201468", "mechanisms": ["Estrogen receptor agonist"], "genes": ["ESR2"], "type": "Small molecule", "diseases": ["MENOPAUSE"]}, {"indications": [{"efo_term": "DYSPAREUNIA", "stage": 4}], "max_phase": 4, "name": "OSPEMIFENE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105395", "mechanisms": ["Estrogen receptor modulator"], "genes": ["ESR2"], "type": "Small molecule", "diseases": ["DYSPAREUNIA"]}, {"indications": [{"efo_term": "SEPTIC SHOCK", "stage": 2}], "max_phase": 2, "name": "SELEPRESSIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1817709", "mechanisms": ["Vasopressin V1a receptor agonist"], "genes": ["AVPR1A"], "type": "Protein", "diseases": ["SEPTIC SHOCK"]}, {"indications": [{"efo_term": "AUTISM", "stage": 2}], "max_phase": 2, "name": "RG7314", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545342", "mechanisms": ["Vasopressin V1a receptor antagonist"], "genes": ["AVPR1A"], "type": "Small molecule", "diseases": ["AUTISM"]}, {"indications": [{"efo_term": "PREMATURE BIRTH", "stage": 3}], "max_phase": 3, "name": "RETOSIBAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL429736", "mechanisms": ["Oxytocin receptor antagonist"], "genes": ["OXTR"], "type": "Small molecule", "diseases": ["PREMATURE BIRTH"]}, {"indications": [{"efo_term": "INFERTILITY", "stage": 2}], "max_phase": 2, "name": "BARUSIBAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2218898", "mechanisms": ["Oxytocin receptor antagonist"], "genes": ["OXTR"], "type": "Protein", "diseases": ["INFERTILITY"]}, {"indications": [{"efo_term": "PREMATURE BIRTH", "stage": 2}], "max_phase": 2, "name": "FE 202767", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545167", "mechanisms": ["Oxytocin receptor agonist"], "genes": ["OXTR"], "type": "Protein", "diseases": ["PREMATURE BIRTH"]}, {"indications": [], "max_phase": 4, "name": "VASOPRESSIN TANNATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201528", "mechanisms": ["Vasopressin V2 receptor agonist", "Vasopressin V1a receptor agonist", "Vasopressin V1b receptor agonist"], "genes": ["AVPR2", "AVPR1A", "AVPR1B"], "type": "Protein", "diseases": []}, {"indications": [], "max_phase": 3, "name": "SATAVAPTAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107777", "mechanisms": ["Vasopressin V2 receptor antagonist"], "genes": ["AVPR2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LYPRESSIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200690", "mechanisms": ["Vasopressin receptor agonist"], "genes": ["AVPR2", "AVPR1A", "AVPR1B"], "type": "Protein", "diseases": []}, {"indications": [], "max_phase": 4, "name": "RALOXIFENE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1116", "mechanisms": ["Estrogen receptor beta modulator"], "genes": ["ESR2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "PRINABEREL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL450940", "mechanisms": ["Estrogen receptor beta agonist"], "genes": ["ESR2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "CR 1447", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545092", "mechanisms": ["Estrogen receptor beta agonist"], "genes": ["ESR2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "MF101", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545411", "mechanisms": ["Estrogen receptor beta agonist"], "genes": ["ESR2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "IDOXIFENE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6318", "mechanisms": ["Estrogen receptor modulator"], "genes": ["ESR2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "DROLOXIFENE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL487", "mechanisms": ["Estrogen receptor modulator"], "genes": ["ESR2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "AFIMOXIFENE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL10041", "mechanisms": ["Estrogen receptor modulator"], "genes": ["ESR2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "ACOLBIFENE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL68055", "mechanisms": ["Estrogen receptor modulator"], "genes": ["ESR2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "QUINESTROL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201165", "mechanisms": ["Estrogen receptor agonist"], "genes": ["ESR2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ESTROGENS, CONJUGATED SYNTHETIC A", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201466", "mechanisms": ["Estrogen receptor agonist"], "genes": ["ESR2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "SYNTHETIC CONJUGATED ESTROGENS, B", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201467", "mechanisms": ["Estrogen receptor agonist"], "genes": ["ESR2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "FISPEMIFENE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107341", "mechanisms": ["Estrogen receptor modulator"], "genes": ["ESR2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "MK-6913", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545274", "mechanisms": ["Estrogen receptor agonist"], "genes": ["ESR2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "CHF4227", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545355", "mechanisms": ["Estrogen receptor modulator"], "genes": ["ESR2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "LY2245461", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545389", "mechanisms": ["Estrogen receptor modulator"], "genes": ["ESR2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "RELCOVAPTAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL419667", "mechanisms": ["Vasopressin V1a receptor antagonist", "Oxytocin receptor antagonist"], "genes": ["AVPR1A", "OXTR"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "SRX251", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545146", "mechanisms": ["Vasopressin V1a receptor antagonist"], "genes": ["AVPR1A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "EPELSIBAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2037511", "mechanisms": ["Oxytocin receptor antagonist"], "genes": ["OXTR"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "NELIVAPTAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL582857", "mechanisms": ["Vasopressin V1b receptor antagonist"], "genes": ["AVPR1B"], "type": "Small molecule", "diseases": []}], "heat": 0.5084046411968286, "nodes": [{"assoc": 0.0848106693005, "id": "ENSG00000101200", "label": "AVP"}, {"assoc": 0.0616012672173, "id": "ENSG00000101405", "label": "OXT"}, {"assoc": 0.704205875, "id": "ENSG00000126895", "label": "AVPR2"}, {"assoc": 1.0, "id": "ENSG00000140009", "label": "ESR2"}, {"assoc": 0.709000295556, "id": "ENSG00000166148", "label": "AVPR1A"}, {"assoc": 0.299214381304, "id": "ENSG00000180914", "label": "OXTR"}, {"assoc": 0.7, "id": "ENSG00000198049", "label": "AVPR1B"}], "size": 7}, {"diseases": ["OSTEOPOROSIS", "OSTEITIS DEFORMANS", "POSTMENOPAUSAL OSTEOPOROSIS", "HYPERCALCEMIA", "OSTEOPENIA", "OSTEOARTHRITIS", "OBESITY", "TYPE I DIABETES MELLITUS", "TYPE II DIABETES MELLITUS", "MIGRAINE DISORDER"], "links": [{"source": "ENSG00000004948", "target": "ENSG00000110680", "reverse": "rev-stimulatory"}, {"source": "ENSG00000004948", "target": "ENSG00000121351", "reverse": "rev-stimulatory"}, {"source": "ENSG00000004948", "target": "ENSG00000128165", "reverse": "rev-directed"}, {"source": "ENSG00000004948", "target": "ENSG00000175868", "reverse": "rev-stimulatory"}, {"source": "ENSG00000110680", "type": "stimulatory", "target": "ENSG00000132329"}], "drugs": [{"indications": [{"efo_term": "OSTEITIS DEFORMANS", "stage": 4}, {"efo_term": "POSTMENOPAUSAL OSTEOPOROSIS", "stage": 4}, {"efo_term": "HYPERCALCEMIA", "stage": 4}, {"efo_term": "OSTEOPOROSIS", "stage": 2}, {"efo_term": "OSTEOPENIA", "stage": 2}], "max_phase": 4, "name": "CALCITONIN SALMON RECOMBINANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201661", "mechanisms": ["Calcitonin receptor agonist"], "genes": ["CALCR"], "type": "Protein", "diseases": ["OSTEOPOROSIS", "OSTEITIS DEFORMANS", "POSTMENOPAUSAL OSTEOPOROSIS", "HYPERCALCEMIA", "OSTEOPENIA"]}, {"indications": [{"efo_term": "POSTMENOPAUSAL OSTEOPOROSIS", "stage": 4}, {"efo_term": "OSTEITIS DEFORMANS", "stage": 4}, {"efo_term": "HYPERCALCEMIA", "stage": 4}], "max_phase": 4, "name": "CALCITONIN SALMON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201445", "mechanisms": ["Calcitonin receptor agonist"], "genes": ["CALCR"], "type": "Protein", "diseases": ["POSTMENOPAUSAL OSTEOPOROSIS", "OSTEITIS DEFORMANS", "HYPERCALCEMIA"]}, {"indications": [{"efo_term": "TYPE I DIABETES MELLITUS", "stage": 3}, {"efo_term": "OBESITY", "stage": 2}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 2}], "max_phase": 4, "name": "PRAMLINTIDE ACETATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3833353", "mechanisms": ["Amylin receptor AMY1, CALCR/RAMP1 agonist", "Amylin receptor AMY3; CALCR/RAMP3 agonist", "Amylin receptor AMY2; CALCR/RAMP2 agonist"], "genes": ["CALCR", "RAMP1"], "type": "Protein", "diseases": ["TYPE I DIABETES MELLITUS", "OBESITY", "TYPE II DIABETES MELLITUS"]}, {"indications": [{"efo_term": "OSTEOARTHRITIS", "stage": 3}, {"efo_term": "OSTEOPOROSIS", "stage": 3}], "max_phase": 3, "name": "SMC021", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545415", "mechanisms": ["Calcitonin receptor agonist"], "genes": ["CALCR"], "type": "Protein", "diseases": ["OSTEOARTHRITIS", "OSTEOPOROSIS"]}, {"indications": [{"efo_term": "OBESITY", "stage": 2}], "max_phase": 2, "name": "DAVALINTIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105635", "mechanisms": ["Amylin receptor AMY1, CALCR/RAMP1 agonist"], "genes": ["CALCR", "RAMP1"], "type": "Protein", "diseases": ["OBESITY"]}, {"indications": [{"efo_term": "MIGRAINE DISORDER", "stage": 3}], "max_phase": 0, "name": "EPTINEZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3833320", "mechanisms": ["Calcitonin gene-related peptide_UNCURATED inhibitor"], "genes": ["CALCB"], "type": "Antibody", "diseases": ["MIGRAINE DISORDER"]}, {"indications": [], "max_phase": 4, "name": "CALCITONIN HUMAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201614", "mechanisms": ["Calcitonin receptor agonist"], "genes": ["CALCR"], "type": "Protein", "diseases": []}], "heat": 0.22598637171383332, "nodes": [{"assoc": 0.145696697402, "id": "ENSG00000004948", "label": "CALCR"}, {"assoc": 0.104889870171, "id": "ENSG00000110680", "label": "CALCA"}, {"assoc": 0.0952891182653, "id": "ENSG00000121351", "label": "IAPP"}, {"assoc": 0.028258, "id": "ENSG00000128165", "label": "ADM2"}, {"assoc": 0.0247067666667, "id": "ENSG00000132329", "label": "RAMP1"}, {"assoc": 0.957077777778, "id": "ENSG00000175868", "label": "CALCB"}], "size": 6}, {"diseases": [], "links": [{"source": "ENSG00000106113", "target": "ENSG00000145040", "reverse": "rev-stimulatory"}, {"source": "ENSG00000106113", "target": "ENSG00000147571", "reverse": "rev-stimulatory"}, {"source": "ENSG00000106113", "target": "ENSG00000163794", "reverse": "rev-stimulatory"}, {"source": "ENSG00000106113", "target": "ENSG00000178473", "reverse": "rev-stimulatory"}, {"source": "ENSG00000163794", "target": "ENSG00000174697"}], "drugs": [], "heat": 0.09183470092891666, "nodes": [{"assoc": 0.0365834950964, "id": "ENSG00000106113", "label": "CRHR2"}, {"assoc": 0.0968960008135, "id": "ENSG00000145040", "label": "UCN2"}, {"assoc": 0.0894005739537, "id": "ENSG00000147571", "label": "CRH"}, {"assoc": 0.0422450748299, "id": "ENSG00000163794", "label": "UCN"}, {"assoc": 0.25148306088, "id": "ENSG00000174697", "label": "LEP"}, {"assoc": 0.0344, "id": "ENSG00000178473", "label": "UCN3"}], "size": 6}, {"diseases": ["PROSTATE CARCINOMA", "ATHEROSCLEROSIS", "CARDIOVASCULAR DISEASE", "DIABETIC NEPHROPATHY", "MULTIPLE SCLEROSIS", "HIV-1 INFECTION", "SCLEROSING CHOLANGITIS", "RENAL INSUFFICIENCY", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "NEUROPATHIC PAIN", "PAIN", "TYPE II DIABETES MELLITUS", "RHEUMATOID ARTHRITIS"], "links": [{"source": "ENSG00000108691", "type": "stimulatory", "target": "ENSG00000121807", "reverse": "rev-directed"}, {"source": "ENSG00000108691", "type": "stimulatory", "target": "ENSG00000163823"}, {"source": "ENSG00000121807", "target": "ENSG00000163823"}, {"source": "ENSG00000156234", "type": "stimulatory", "target": "ENSG00000160683"}, {"source": "ENSG00000160683", "target": "ENSG00000277632", "reverse": "rev-stimulatory"}, {"source": "ENSG00000163823", "target": "ENSG00000277632", "reverse": "rev-stimulatory"}], "drugs": [{"indications": [{"efo_term": "ATHEROSCLEROSIS", "stage": 2}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 2}, {"efo_term": "DIABETIC NEPHROPATHY", "stage": 2}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}], "max_phase": 2, "name": "MLN-1202", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109339", "mechanisms": ["C-C chemokine receptor type 2 antagonist"], "genes": ["CCR2"], "type": "Antibody", "diseases": ["ATHEROSCLEROSIS", "CARDIOVASCULAR DISEASE", "DIABETIC NEPHROPATHY", "MULTIPLE SCLEROSIS"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}, {"efo_term": "NEUROPATHIC PAIN", "stage": 2}, {"efo_term": "PAIN", "stage": 2}], "max_phase": 2, "name": "AZD2423", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545221", "mechanisms": ["C-C chemokine receptor type 2 antagonist"], "genes": ["CCR2"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "NEUROPATHIC PAIN", "PAIN"]}, {"indications": [{"efo_term": "HIV-1 INFECTION", "stage": 2}, {"efo_term": "SCLEROSING CHOLANGITIS", "stage": 2}], "max_phase": 2, "name": "CENICRIVIROC", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2110727", "mechanisms": ["C-C chemokine receptor type 2 antagonist"], "genes": ["CCR2"], "type": "Small molecule", "diseases": ["HIV-1 INFECTION", "SCLEROSING CHOLANGITIS"]}, {"indications": [{"efo_term": "DIABETIC NEPHROPATHY", "stage": 2}, {"efo_term": "RENAL INSUFFICIENCY", "stage": 1}], "max_phase": 2, "name": "PF-04634817", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545032", "mechanisms": ["C-C chemokine receptor type 2 antagonist"], "genes": ["CCR2"], "type": "Small molecule", "diseases": ["DIABETIC NEPHROPATHY", "RENAL INSUFFICIENCY"]}, {"indications": [{"efo_term": "PROSTATE CARCINOMA", "stage": 2}], "max_phase": 2, "name": "CARLUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1742999", "mechanisms": ["C-C motif chemokine 2 inhibitor"], "genes": ["CCL2"], "type": "Antibody", "diseases": ["PROSTATE CARCINOMA"]}, {"indications": [{"efo_term": "TYPE II DIABETES MELLITUS", "stage": 2}], "max_phase": 2, "name": "CCX140", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545286", "mechanisms": ["C-C chemokine receptor type 2 antagonist"], "genes": ["CCR2"], "type": "Small molecule", "diseases": ["TYPE II DIABETES MELLITUS"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}], "max_phase": 2, "name": "AZD4818", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2178570", "mechanisms": ["C-C chemokine receptor type 1 antagonist"], "genes": ["CCR1"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 2}], "max_phase": 2, "name": "CCX354", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545404", "mechanisms": ["C-C chemokine receptor type 1 antagonist"], "genes": ["CCR1"], "type": "Small molecule", "diseases": ["RHEUMATOID ARTHRITIS"]}], "heat": 0.17999450008749998, "nodes": [{"assoc": 0.155522584323, "id": "ENSG00000108691", "label": "CCL2"}, {"assoc": 0.28911985923, "id": "ENSG00000121807", "label": "CCR2"}, {"assoc": 0.220014821872, "id": "ENSG00000156234", "label": "CXCL13"}, {"assoc": 0.147066767183, "id": "ENSG00000160683", "label": "CXCR5"}, {"assoc": 0.161902488946, "id": "ENSG00000163823", "label": "CCR1"}, {"assoc": 0.106340478971, "id": "ENSG00000277632", "label": "CCL3"}], "size": 6}, {"diseases": ["BASAL CELL CARCINOMA", "NON-SMALL CELL LUNG CARCINOMA", "PSORIASIS", "SYSTEMIC LUPUS ERYTHEMATOSUS", "SEPSIS", "BREAST CARCINOMA", "ATOPIC ECZEMA", "TYPE I DIABETES MELLITUS", "BREAST NEOPLASM", "HYPOPARATHYROIDISM", "HYPOCALCEMIA", "OSTEOPOROSIS", "PROSTATE CARCINOMA", "HYPERTENSION", "MENOPAUSE", "ACUTE KIDNEY INJURY", "HEART FAILURE", "HEPATITIS C INFECTION", "NEUROFIBROMATOSIS TYPE 1", "SICKLE CELL ANEMIA", "TIBIA FRACTURE", "TYPE II DIABETES MELLITUS", "CHRONIC KIDNEY DISEASE", "HIV INFECTION", "PNEUMONIA", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "COLORECTAL ADENOCARCINOMA", "MULTIPLE SCLEROSIS", "VITAMIN D DEFICIENCY", "ABNORMAL GLUCOSE TOLERANCE", "CROHN'S DISEASE", "INFLUENZA INFECTION", "COLORECTAL ADENOMA", "CHRONIC LYMPHOCYTIC LEUKEMIA", "OBESITY", "INFECTION", "COGNITIVE IMPAIRMENT", "TUBERCULOSIS", "DIABETES MELLITUS", "HYPOGONADISM", "ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "AIDS", "SKIN NEOPLASM", "METABOLIC SYNDROME", "PROSTATE ADENOCARCINOMA", "IRRITABLE BOWEL SYNDROME", "NON-ALCOHOLIC FATTY LIVER DISEASE", "ALLERGIC CONJUNCTIVITIS", "ALLERGY", "PREGNANCY", "POSTMENOPAUSAL OSTEOPOROSIS", "PARKINSON'S DISEASE", "AUTISM", "AGING", "HYPERLIPIDEMIA", "HEREDITARY BREAST AND OVARIAN CANCER SYNDROME", "PREMATURE BIRTH", "OPTIC NEURITIS", "MELANOMA", "RESPIRATORY TRACT INFECTION", "CARDIOVASCULAR DISEASE", "NEOPLASM", "BONE FRACTURE", "APHTHOUS ULCER", "BLADDER CARCINOMA", "INFLAMMATORY BOWEL DISEASE", "HYPERPARATHYROIDISM", "LUNG CARCINOMA", "OSTEOPENIA", "CHRONIC HEPATITIS C INFECTION", "CUTANEOUS MELANOMA", "OSTEOARTHRITIS", "ULCERATIVE COLITIS", "SARCOPENIA", "CANCER", "POLYCYSTIC OVARY SYNDROME", "RESTLESS LEGS SYNDROME", "CYSTIC FIBROSIS", "INSULIN RESISTANCE", "CUTANEOUS LUPUS ERYTHEMATOSUS", "SECONDARY HYPERPARATHYROIDISM", "IGA GLOMERULONEPHRITIS", "PROTEINURIA", "ACNE", "SYSTEMIC SCLERODERMA", "ACUTE MYELOID LEUKEMIA", "MYOCARDIAL INFARCTION", "HIV-1 INFECTION"], "links": [{"source": "ENSG00000111424", "type": "stimulatory", "target": "ENSG00000138109"}, {"source": "ENSG00000111424", "type": "stimulatory", "target": "ENSG00000160868"}, {"source": "ENSG00000111424", "type": "stimulatory", "target": "ENSG00000197408"}, {"source": "ENSG00000160868", "target": "ENSG00000171234"}], "drugs": [{"indications": [{"efo_term": "VITAMIN D DEFICIENCY", "stage": 4}, {"efo_term": "OSTEOPOROSIS", "stage": 4}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "HEART FAILURE", "stage": 3}, {"efo_term": "HEPATITIS C INFECTION", "stage": 3}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 3}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 3}, {"efo_term": "HIV INFECTION", "stage": 3}, {"efo_term": "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "stage": 3}, {"efo_term": "INFLUENZA INFECTION", "stage": 3}, {"efo_term": "COLORECTAL ADENOMA", "stage": 3}, {"efo_term": "PROSTATE CARCINOMA", "stage": 3}, {"efo_term": "CHRONIC LYMPHOCYTIC LEUKEMIA", "stage": 3}, {"efo_term": "INFECTION", "stage": 3}, {"efo_term": "COGNITIVE IMPAIRMENT", "stage": 3}, {"efo_term": "TUBERCULOSIS", "stage": 3}, {"efo_term": "HYPOGONADISM", "stage": 3}, {"efo_term": "ASTHMA", "stage": 3}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 3}, {"efo_term": "PROSTATE ADENOCARCINOMA", "stage": 3}, {"efo_term": "PREGNANCY", "stage": 3}, {"efo_term": "POSTMENOPAUSAL OSTEOPOROSIS", "stage": 3}, {"efo_term": "MELANOMA", "stage": 3}, {"efo_term": "RESPIRATORY TRACT INFECTION", "stage": 3}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 3}, {"efo_term": "NEUROFIBROMATOSIS TYPE 1", "stage": 2}, {"efo_term": "SYSTEMIC LUPUS ERYTHEMATOSUS", "stage": 2}, {"efo_term": "COLORECTAL ADENOCARCINOMA", "stage": 2}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "ABNORMAL GLUCOSE TOLERANCE", "stage": 2}, {"efo_term": "CROHN'S DISEASE", "stage": 2}, {"efo_term": "OBESITY", "stage": 2}, {"efo_term": "DIABETES MELLITUS", "stage": 2}, {"efo_term": "AIDS", "stage": 2}, {"efo_term": "METABOLIC SYNDROME", "stage": 2}, {"efo_term": "NON-ALCOHOLIC FATTY LIVER DISEASE", "stage": 2}, {"efo_term": "ALLERGIC CONJUNCTIVITIS", "stage": 2}, {"efo_term": "ATOPIC ECZEMA", "stage": 2}, {"efo_term": "ALLERGY", "stage": 2}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "AUTISM", "stage": 2}, {"efo_term": "AGING", "stage": 2}, {"efo_term": "HEREDITARY BREAST AND OVARIAN CANCER SYNDROME", "stage": 2}, {"efo_term": "OPTIC NEURITIS", "stage": 2}, {"efo_term": "BONE FRACTURE", "stage": 2}, {"efo_term": "SICKLE CELL ANEMIA", "stage": 1}, {"efo_term": "TIBIA FRACTURE", "stage": 1}, {"efo_term": "PNEUMONIA", "stage": 1}, {"efo_term": "SKIN NEOPLASM", "stage": 1}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 1}, {"efo_term": "IRRITABLE BOWEL SYNDROME", "stage": 1}, {"efo_term": "HYPERLIPIDEMIA", "stage": 1}, {"efo_term": "NEOPLASM", "stage": 1}, {"efo_term": "PREMATURE BIRTH", "stage": 0}], "max_phase": 4, "name": "CHOLECALCIFEROL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1042", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": ["BREAST CARCINOMA", "HEART FAILURE", "HEPATITIS C INFECTION", "NEUROFIBROMATOSIS TYPE 1", "SICKLE CELL ANEMIA", "SYSTEMIC LUPUS ERYTHEMATOSUS", "TIBIA FRACTURE", "TYPE II DIABETES MELLITUS", "CHRONIC KIDNEY DISEASE", "HIV INFECTION", "PNEUMONIA", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "COLORECTAL ADENOCARCINOMA", "MULTIPLE SCLEROSIS", "VITAMIN D DEFICIENCY", "ABNORMAL GLUCOSE TOLERANCE", "CROHN'S DISEASE", "INFLUENZA INFECTION", "COLORECTAL ADENOMA", "PROSTATE CARCINOMA", "CHRONIC LYMPHOCYTIC LEUKEMIA", "OBESITY", "INFECTION", "COGNITIVE IMPAIRMENT", "TUBERCULOSIS", "DIABETES MELLITUS", "OSTEOPOROSIS", "HYPOGONADISM", "ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "AIDS", "SKIN NEOPLASM", "METABOLIC SYNDROME", "PROSTATE ADENOCARCINOMA", "TYPE I DIABETES MELLITUS", "IRRITABLE BOWEL SYNDROME", "NON-ALCOHOLIC FATTY LIVER DISEASE", "ALLERGIC CONJUNCTIVITIS", "ATOPIC ECZEMA", "ALLERGY", "PREGNANCY", "POSTMENOPAUSAL OSTEOPOROSIS", "PARKINSON'S DISEASE", "AUTISM", "AGING", "HYPERLIPIDEMIA", "HEREDITARY BREAST AND OVARIAN CANCER SYNDROME", "PREMATURE BIRTH", "OPTIC NEURITIS", "MELANOMA", "RESPIRATORY TRACT INFECTION", "CARDIOVASCULAR DISEASE", "NEOPLASM", "BONE FRACTURE"]}, {"indications": [{"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 3}, {"efo_term": "BREAST NEOPLASM", "stage": 3}, {"efo_term": "APHTHOUS ULCER", "stage": 3}, {"efo_term": "VITAMIN D DEFICIENCY", "stage": 3}, {"efo_term": "BLADDER CARCINOMA", "stage": 3}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 3}, {"efo_term": "OBESITY", "stage": 3}, {"efo_term": "CHRONIC HEPATITIS C INFECTION", "stage": 3}, {"efo_term": "CUTANEOUS MELANOMA", "stage": 3}, {"efo_term": "NON-ALCOHOLIC FATTY LIVER DISEASE", "stage": 3}, {"efo_term": "OSTEOARTHRITIS", "stage": 3}, {"efo_term": "TUBERCULOSIS", "stage": 3}, {"efo_term": "CANCER", "stage": 3}, {"efo_term": "PREGNANCY", "stage": 3}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}, {"efo_term": "PROSTATE ADENOCARCINOMA", "stage": 2}, {"efo_term": "HIV INFECTION", "stage": 2}, {"efo_term": "HEART FAILURE", "stage": 2}, {"efo_term": "SICKLE CELL ANEMIA", "stage": 2}, {"efo_term": "RESTLESS LEGS SYNDROME", "stage": 2}, {"efo_term": "OPTIC NEURITIS", "stage": 2}, {"efo_term": "CYSTIC FIBROSIS", "stage": 2}, {"efo_term": "INSULIN RESISTANCE", "stage": 2}, {"efo_term": "CUTANEOUS LUPUS ERYTHEMATOSUS", "stage": 2}, {"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "COLORECTAL ADENOCARCINOMA", "stage": 1}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 1}, {"efo_term": "INFLAMMATORY BOWEL DISEASE", "stage": 1}, {"efo_term": "HYPERPARATHYROIDISM", "stage": 1}, {"efo_term": "LUNG CARCINOMA", "stage": 1}, {"efo_term": "ULCERATIVE COLITIS", "stage": 1}, {"efo_term": "SARCOPENIA", "stage": 1}, {"efo_term": "POLYCYSTIC OVARY SYNDROME", "stage": 1}, {"efo_term": "OSTEOPENIA", "stage": 0}], "max_phase": 4, "name": "ERGOCALCIFEROL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1536", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": ["CHRONIC KIDNEY DISEASE", "BREAST NEOPLASM", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "APHTHOUS ULCER", "VITAMIN D DEFICIENCY", "BLADDER CARCINOMA", "TYPE I DIABETES MELLITUS", "BREAST CARCINOMA", "COLORECTAL ADENOCARCINOMA", "TYPE II DIABETES MELLITUS", "INFLAMMATORY BOWEL DISEASE", "MULTIPLE SCLEROSIS", "HYPERPARATHYROIDISM", "LUNG CARCINOMA", "OSTEOPENIA", "PROSTATE ADENOCARCINOMA", "OBESITY", "CHRONIC HEPATITIS C INFECTION", "CUTANEOUS MELANOMA", "HIV INFECTION", "NON-ALCOHOLIC FATTY LIVER DISEASE", "HEART FAILURE", "OSTEOARTHRITIS", "SICKLE CELL ANEMIA", "ULCERATIVE COLITIS", "SARCOPENIA", "TUBERCULOSIS", "CANCER", "POLYCYSTIC OVARY SYNDROME", "PREGNANCY", "RESTLESS LEGS SYNDROME", "OPTIC NEURITIS", "CYSTIC FIBROSIS", "INSULIN RESISTANCE", "CUTANEOUS LUPUS ERYTHEMATOSUS", "ASTHMA"]}, {"indications": [{"efo_term": "PSORIASIS", "stage": 4}, {"efo_term": "HYPOPARATHYROIDISM", "stage": 4}, {"efo_term": "HYPOCALCEMIA", "stage": 4}, {"efo_term": "OSTEOPOROSIS", "stage": 3}, {"efo_term": "BASAL CELL CARCINOMA", "stage": 2}, {"efo_term": "SYSTEMIC LUPUS ERYTHEMATOSUS", "stage": 2}, {"efo_term": "SEPSIS", "stage": 2}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "ATOPIC ECZEMA", "stage": 2}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 2}, {"efo_term": "BREAST NEOPLASM", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "HYPERTENSION", "stage": 2}, {"efo_term": "ACUTE KIDNEY INJURY", "stage": 2}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 1}, {"efo_term": "MENOPAUSE", "stage": 1}], "max_phase": 4, "name": "CALCITRIOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL846", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": ["BASAL CELL CARCINOMA", "NON-SMALL CELL LUNG CARCINOMA", "PSORIASIS", "SYSTEMIC LUPUS ERYTHEMATOSUS", "SEPSIS", "BREAST CARCINOMA", "ATOPIC ECZEMA", "TYPE I DIABETES MELLITUS", "BREAST NEOPLASM", "HYPOPARATHYROIDISM", "HYPOCALCEMIA", "OSTEOPOROSIS", "PROSTATE CARCINOMA", "HYPERTENSION", "MENOPAUSE", "ACUTE KIDNEY INJURY"]}, {"indications": [{"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 4}, {"efo_term": "SECONDARY HYPERPARATHYROIDISM", "stage": 4}, {"efo_term": "IGA GLOMERULONEPHRITIS", "stage": 3}, {"efo_term": "PROTEINURIA", "stage": 3}, {"efo_term": "HYPERPARATHYROIDISM", "stage": 3}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 2}, {"efo_term": "ALLERGY", "stage": 2}], "max_phase": 4, "name": "PARICALCITOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200622", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": ["CHRONIC KIDNEY DISEASE", "IGA GLOMERULONEPHRITIS", "PROTEINURIA", "TYPE II DIABETES MELLITUS", "SECONDARY HYPERPARATHYROIDISM", "HYPERPARATHYROIDISM", "ALLERGY"]}, {"indications": [{"efo_term": "PSORIASIS", "stage": 4}, {"efo_term": "ACNE", "stage": 2}, {"efo_term": "SYSTEMIC SCLERODERMA", "stage": 1}], "max_phase": 4, "name": "CALCIPOTRIENE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200666", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": ["PSORIASIS", "ACNE", "SYSTEMIC SCLERODERMA"]}, {"indications": [{"efo_term": "PSORIASIS", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 1}], "max_phase": 4, "name": "DOXERCALCIFEROL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200810", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": ["PSORIASIS", "NEOPLASM", "PROSTATE CARCINOMA"]}, {"indications": [{"efo_term": "HIV INFECTION", "stage": 4}, {"efo_term": "HIV-1 INFECTION", "stage": 4}, {"efo_term": "AIDS", "stage": 3}], "max_phase": 4, "name": "COBICISTAT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2095208", "mechanisms": ["Cytochrome P450 3A inhibitor"], "genes": ["CYP3A4"], "type": "Small molecule", "diseases": ["HIV INFECTION", "HIV-1 INFECTION", "AIDS"]}, {"indications": [{"efo_term": "SECONDARY HYPERPARATHYROIDISM", "stage": 2}, {"efo_term": "OSTEOPOROSIS", "stage": 2}], "max_phase": 2, "name": "DP001", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL605525", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": ["SECONDARY HYPERPARATHYROIDISM", "OSTEOPOROSIS"]}, {"indications": [{"efo_term": "MYOCARDIAL INFARCTION", "stage": 3}, {"efo_term": "ACUTE KIDNEY INJURY", "stage": 2}], "max_phase": 4, "name": "CALCIFEDIOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544909", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": ["MYOCARDIAL INFARCTION", "ACUTE KIDNEY INJURY"]}, {"indications": [{"efo_term": "PSORIASIS", "stage": 2}], "max_phase": 2, "name": "BECOCALCIDIOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104955", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": ["PSORIASIS"]}, {"indications": [{"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 2}], "max_phase": 2, "name": "INECALCITOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105107", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": ["ACUTE MYELOID LEUKEMIA"]}, {"indications": [{"efo_term": "PSORIASIS", "stage": 3}], "max_phase": 3, "name": "PEFCALCITOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3137307", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": ["PSORIASIS"]}, {"indications": [], "max_phase": 1, "name": "ILX23-7553", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL284121", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "SEOCALCITOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1908376", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "LUNACALCIPOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105705", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "Elocalcitol", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545094", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "TABIMORELIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL281764", "mechanisms": ["Cytochrome P450 3A4 inhibitor"], "genes": ["CYP3A4"], "type": "Small molecule", "diseases": []}], "heat": 0.25659763594898, "nodes": [{"assoc": 1.0, "id": "ENSG00000111424", "label": "VDR"}, {"assoc": 0.0954124509868, "id": "ENSG00000138109", "label": "CYP2C9"}, {"assoc": 0.048875474034, "id": "ENSG00000160868", "label": "CYP3A4"}, {"assoc": 0.0584402547241, "id": "ENSG00000171234", "label": "UGT2B7"}, {"assoc": 0.08026, "id": "ENSG00000197408", "label": "CYP2B6"}], "size": 5}, {"diseases": ["EPILEPSY", "LIVER DISEASE", "UNIPOLAR DEPRESSION", "PARKINSON'S DISEASE", "CANCER", "INJURY", "INFLUENZA INFECTION", "POSTENCEPHALITIC PARKINSON DISEASE", "INFECTION", "SECONDARY PARKINSON DISEASE", "CEREBRAL ATHEROSCLEROSIS", "GAMBLING BEHAVIOUR", "BIPOLAR DISORDER", "SUICIDAL IDEATION", "COCAINE DEPENDENCE", "NICOTINE DEPENDENCE", "TINNITUS", "PAIN", "NEUROPATHIC PAIN", "OBSESSIVE-COMPULSIVE DISORDER", "SCHIZOPHRENIA", "AUTISM SPECTRUM DISORDER", "DIABETIC RETINOPATHY"], "links": [{"source": "ENSG00000116032", "target": "ENSG00000183454"}, {"source": "ENSG00000176884", "target": "ENSG00000183454"}, {"source": "ENSG00000176884", "target": "ENSG00000198785"}, {"source": "ENSG00000176884", "target": "ENSG00000273079", "reverse": "rev-stimulatory"}], "drugs": [{"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}, {"efo_term": "INFLUENZA INFECTION", "stage": 4}, {"efo_term": "POSTENCEPHALITIC PARKINSON DISEASE", "stage": 4}, {"efo_term": "INFECTION", "stage": 4}, {"efo_term": "SECONDARY PARKINSON DISEASE", "stage": 4}, {"efo_term": "CEREBRAL ATHEROSCLEROSIS", "stage": 4}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "INJURY", "stage": 2}], "max_phase": 4, "name": "AMANTADINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1569", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "CANCER", "INJURY", "INFLUENZA INFECTION", "POSTENCEPHALITIC PARKINSON DISEASE", "INFECTION", "SECONDARY PARKINSON DISEASE", "CEREBRAL ATHEROSCLEROSIS"]}, {"indications": [{"efo_term": "SUICIDAL IDEATION", "stage": 3}, {"efo_term": "INJURY", "stage": 3}, {"efo_term": "BIPOLAR DISORDER", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}], "max_phase": 4, "name": "KETAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1714", "mechanisms": ["Glutamate [NMDA] receptor negative allosteric modulator"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "SUICIDAL IDEATION", "COCAINE DEPENDENCE", "INJURY"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 4, "name": "ESKETAMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL395091", "mechanisms": ["Glutamate [NMDA] receptor negative allosteric modulator"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["LIVER DISEASE", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "CANCER", "stage": 3}, {"efo_term": "GAMBLING BEHAVIOUR", "stage": 2}], "max_phase": 4, "name": "MEMANTINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1699", "mechanisms": ["Glutamate [NMDA] receptor negative allosteric modulator"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["GAMBLING BEHAVIOUR", "CANCER"]}, {"indications": [{"efo_term": "PAIN", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 2}], "max_phase": 3, "name": "RALFINAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107771", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["PAIN", "NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "OBSESSIVE-COMPULSIVE DISORDER", "stage": 2}], "max_phase": 3, "name": "RAPASTINEL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544917", "mechanisms": ["Glutamate [NMDA] receptor partial agonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Protein", "diseases": ["OBSESSIVE-COMPULSIVE DISORDER", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "NRX-1074", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545230", "mechanisms": ["Glutamate [NMDA] receptor partial agonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}, {"efo_term": "NEUROPATHIC PAIN", "stage": 1}], "max_phase": 2, "name": "AV-101", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545351", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "DIABETIC RETINOPATHY", "stage": 1}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 1}], "max_phase": 4, "name": "DEXTROMETHORPHAN HYDROBROMIDE MONOHYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256818", "mechanisms": ["Glutamate [NMDA] receptor subunit epsilon 1 antagonist"], "genes": ["GRIN2A"], "type": "Small molecule", "diseases": ["DIABETIC RETINOPATHY", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "FELBAMATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1094", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}], "max_phase": 4, "name": "ORPHENADRINE (CHLORIDE)", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201023", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "NICOTINE DEPENDENCE", "stage": 2}], "max_phase": 2, "name": "GW468816", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1207366", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["NICOTINE DEPENDENCE"]}, {"indications": [{"efo_term": "TINNITUS", "stage": 3}], "max_phase": 3, "name": "NERAMEXANE MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2106798", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["TINNITUS"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "LANICEMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107647", "mechanisms": ["Glutamate [NMDA] receptor blocker"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "PAIN", "stage": 1}], "max_phase": 4, "name": "ESKETAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2364609", "mechanisms": ["Glutamate [NMDA] receptor negative allosteric modulator"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "NEUROPATHIC PAIN", "stage": 2}], "max_phase": 2, "name": "Indantadol", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707400", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "NEUROPATHIC PAIN", "stage": 2}], "max_phase": 2, "name": "Radiprodil", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL182066", "mechanisms": ["Glutamate NMDA receptor; GRIN1/GRIN2B antagonist"], "genes": ["GRIN1", "GRIN2B"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "CERC-301", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2068839", "mechanisms": ["Glutamate NMDA receptor; GRIN1/GRIN2B antagonist"], "genes": ["GRIN1", "GRIN2B"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "AUTISM SPECTRUM DISORDER", "stage": 2}], "max_phase": 4, "name": "DEXTROMETHORPHAN POLISTIREX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201461", "mechanisms": ["Glutamate [NMDA] receptor subunit epsilon 1 antagonist"], "genes": ["GRIN2A"], "type": "Small molecule", "diseases": ["AUTISM SPECTRUM DISORDER"]}, {"indications": [], "max_phase": 0, "name": "CNS-5161", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL41306", "mechanisms": ["Glutamate [NMDA] receptor blocker"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ORPHENADRINE CITRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200395", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "NEBOGLAMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1255840", "mechanisms": ["Glutamate [NMDA] receptor positive allosteric modulator"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ACAMPROSATE CALCIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2068724", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "DELUCEMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2110814", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "AZD8108", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707355", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN3B", "GRIN1", "GRIN2A", "GRIN3A", "GRIN2B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "TRAXOPRODIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17350", "mechanisms": ["Glutamate NMDA receptor; GRIN1/GRIN2B antagonist"], "genes": ["GRIN1", "GRIN2B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "EVT-101", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545349", "mechanisms": ["Glutamate NMDA receptor; GRIN1/GRIN2B antagonist"], "genes": ["GRIN1", "GRIN2B"], "type": "Small molecule", "diseases": []}], "heat": 1.0, "nodes": [{"assoc": 1.0, "id": "ENSG00000116032", "label": "GRIN3B"}, {"assoc": 1.0, "id": "ENSG00000176884", "label": "GRIN1"}, {"assoc": 1.0, "id": "ENSG00000183454", "label": "GRIN2A"}, {"assoc": 1.0, "id": "ENSG00000198785", "label": "GRIN3A"}, {"assoc": 1.0, "id": "ENSG00000273079", "label": "GRIN2B"}], "size": 5}, {"diseases": ["NEOPLASM", "MYELODYSPLASTIC SYNDROME", "ACUTE MYELOID LEUKEMIA"], "links": [{"source": "ENSG00000110148", "target": "ENSG00000163394"}, {"source": "ENSG00000110148", "target": "ENSG00000187094", "reverse": "rev-stimulatory"}, {"source": "ENSG00000138792", "type": "inhibitory", "target": "ENSG00000187094"}, {"source": "ENSG00000163394", "target": "ENSG00000187094", "reverse": "rev-stimulatory"}], "drugs": [{"indications": [{"efo_term": "MYELODYSPLASTIC SYNDROME", "stage": 2}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 1}], "max_phase": 2, "name": "TOSEDOSTAT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103847", "mechanisms": ["Aminopeptidases inhibitor"], "genes": ["ENPEP"], "type": "Small molecule", "diseases": ["NEOPLASM", "MYELODYSPLASTIC SYNDROME", "ACUTE MYELOID LEUKEMIA"]}, {"indications": [], "max_phase": 2, "name": "Netazepide", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL324547", "mechanisms": ["Cholecystokinin B receptor antagonist"], "genes": ["CCKBR"], "type": "Protein", "diseases": []}, {"indications": [], "max_phase": 2, "name": "ITRIGLUMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256717", "mechanisms": ["Cholecystokinin B receptor antagonist"], "genes": ["CCKBR"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "CI-988", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062154", "mechanisms": ["Cholecystokinin B receptor antagonist"], "genes": ["CCKBR"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CERULETIDE DIETHYLAMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200755", "mechanisms": ["Cholecystokinin A receptor agonist"], "genes": ["CCKAR"], "type": "Protein", "diseases": []}], "heat": 0.094198779789625, "nodes": [{"assoc": 0.0457054272843, "id": "ENSG00000110148", "label": "CCKBR"}, {"assoc": 0.115034178134, "id": "ENSG00000138792", "label": "ENPEP"}, {"assoc": 0.0359675972222, "id": "ENSG00000163394", "label": "CCKAR"}, {"assoc": 0.180087916518, "id": "ENSG00000187094", "label": "CCK"}], "size": 4}, {"diseases": [], "links": [{"source": "ENSG00000140943", "type": "stimulatory", "target": "ENSG00000157613"}, {"source": "ENSG00000140943", "type": "directed", "target": "ENSG00000176697"}, {"source": "ENSG00000176697", "type": "stimulatory", "target": "ENSG00000185652", "reverse": "rev-stimulatory"}], "drugs": [], "heat": 0.130592223006425, "nodes": [{"assoc": 0.0656169265779, "id": "ENSG00000140943", "label": "MBTPS1"}, {"assoc": 0.0419857777778, "id": "ENSG00000157613", "label": "CREB3L1"}, {"assoc": 0.270248535795, "id": "ENSG00000176697", "label": "BDNF"}, {"assoc": 0.144517651875, "id": "ENSG00000185652", "label": "NTF3"}], "size": 4}, {"diseases": [], "links": [{"source": "ENSG00000151892", "target": "ENSG00000168621", "reverse": "rev-stimulatory"}, {"source": "ENSG00000151892", "target": "ENSG00000171119", "reverse": "rev-stimulatory"}, {"source": "ENSG00000168546", "target": "ENSG00000168621", "reverse": "rev-stimulatory"}, {"source": "ENSG00000168546", "target": "ENSG00000171119", "reverse": "rev-stimulatory"}], "drugs": [], "heat": 0.0975549238514, "nodes": [{"assoc": 0.07676575, "id": "ENSG00000151892", "label": "GFRA1"}, {"assoc": 0.147975674796, "id": "ENSG00000168546", "label": "GFRA2"}, {"assoc": 0.123623143804, "id": "ENSG00000168621", "label": "GDNF"}, {"assoc": 0.0418551268056, "id": "ENSG00000171119", "label": "NRTN"}], "size": 4}, {"diseases": ["ANGINA PECTORIS", "HYPERTENSION", "MYOCARDIAL INFARCTION", "MARFAN SYNDROME", "HEART DISEASE", "CARDIOVASCULAR DISEASE", "HEMANGIOMA", "GLAUCOMA", "OPEN-ANGLE GLAUCOMA", "OCULAR HYPERTENSION", "SKIN ULCER", "UNIPOLAR DEPRESSION", "ASTHMA", "SMOKING CESSATION", "PARKINSON'S DISEASE", "TYPE II DIABETES MELLITUS", "CUTANEOUS MELANOMA", "AORTIC STENOSIS", "HEART FAILURE", "CONGESTIVE HEART FAILURE", "FISH-EYE DISEASE", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "VENTRICULAR ARRHYTHMIA", "ANTERIOR ISCHEMIC OPTIC NEUROPATHY", "OVARIAN CYST", "DIABETIC FOOT", "OBESITY", "PULMONARY HYPERTENSION", "CANCER", "EPILEPSY", "ATRIAL FIBRILLATION", "POST-TRAUMATIC STRESS DISORDER", "BREAST CARCINOMA", "COCAINE DEPENDENCE", "NICOTINE DEPENDENCE", "PROSTATE CARCINOMA", "NASAL OBSTRUCTION", "SUDDEN CARDIAC ARREST", "BRONCHIOLITIS", "OBSTRUCTIVE LUNG DISEASE", "HEMORRHAGE", "SEASONAL ALLERGIC RHINITIS", "ALLERGIC RHINITIS", "URTICARIA", "ANGIOEDEMA", "SINUSITIS", "PREECLAMPSIA", "RENAL INSUFFICIENCY", "HYPOTENSION", "ORTHOSTATIC HYPOTENSION", "FIBROMYALGIA", "CHRONIC KIDNEY DISEASE", "MULTIPLE SYSTEM ATROPHY", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "PAIN", "MIGRAINE DISORDER", "NEONATAL ABSTINENCE SYNDROME", "SEPTIC SHOCK", "ANXIETY", "OPIOID DEPENDENCE", "MARIJUANA DEPENDENCE", "AUTISM SPECTRUM DISORDER", "CEREBRAL ISCHEMIA", "DIABETIC NEUROPATHY", "ALCOHOL DEPENDENCE", "HEROIN DEPENDENCE", "SPASTICITY", "BONE NEOPLASM", "RETINITIS PIGMENTOSA", "HYPEREMIA", "ROSACEA", "INCREASED INTRAOCULAR PRESSURE", "AGE-RELATED MACULAR DEGENERATION", "ALLERGIC CONJUNCTIVITIS", "INSOMNIA", "EYE DISEASE", "RHINITIS", "GRAVES OPHTHALMOPATHY"], "links": [{"source": "ENSG00000043591", "target": "ENSG00000150594"}, {"source": "ENSG00000150594", "target": "ENSG00000154277"}], "drugs": [{"indications": [{"efo_term": "HEART FAILURE", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "CONGESTIVE HEART FAILURE", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "ATRIAL FIBRILLATION", "stage": 3}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 2}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "EPILEPSY", "stage": 2}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}], "max_phase": 4, "name": "CARVEDILOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL723", "mechanisms": ["Adrenergic receptor beta antagonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": ["HEART FAILURE", "HYPERTENSION", "PULMONARY HYPERTENSION", "CANCER", "EPILEPSY", "ATRIAL FIBRILLATION", "CONGESTIVE HEART FAILURE", "POST-TRAUMATIC STRESS DISORDER", "BREAST CARCINOMA", "CARDIOVASCULAR DISEASE", "COCAINE DEPENDENCE", "NICOTINE DEPENDENCE", "PROSTATE CARCINOMA"]}, {"indications": [{"efo_term": "NASAL OBSTRUCTION", "stage": 4}, {"efo_term": "GLAUCOMA", "stage": 4}, {"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "HEMORRHAGE", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "SEASONAL ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "URTICARIA", "stage": 4}, {"efo_term": "SUDDEN CARDIAC ARREST", "stage": 4}, {"efo_term": "ANGIOEDEMA", "stage": 4}, {"efo_term": "SINUSITIS", "stage": 4}, {"efo_term": "ASTHMA", "stage": 3}, {"efo_term": "SUDDEN CARDIAC ARREST", "stage": 3}, {"efo_term": "BRONCHIOLITIS", "stage": 3}], "max_phase": 4, "name": "EPINEPHRINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL679", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB1", "ADRA2A"], "type": "Small molecule", "diseases": ["ASTHMA", "NASAL OBSTRUCTION", "SUDDEN CARDIAC ARREST", "BRONCHIOLITIS", "GLAUCOMA", "OBSTRUCTIVE LUNG DISEASE", "HEMORRHAGE", "CARDIOVASCULAR DISEASE", "SEASONAL ALLERGIC RHINITIS", "ALLERGIC RHINITIS", "URTICARIA", "ANGIOEDEMA", "SINUSITIS"]}, {"indications": [{"efo_term": "GLAUCOMA", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "MIGRAINE DISORDER", "stage": 4}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 3}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 3}, {"efo_term": "PAIN", "stage": 2}, {"efo_term": "NEONATAL ABSTINENCE SYNDROME", "stage": 2}, {"efo_term": "SEPTIC SHOCK", "stage": 2}, {"efo_term": "ANXIETY", "stage": 2}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 2}, {"efo_term": "AUTISM SPECTRUM DISORDER", "stage": 2}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 2}, {"efo_term": "OPIOID DEPENDENCE", "stage": 1}, {"efo_term": "CEREBRAL ISCHEMIA", "stage": 1}], "max_phase": 4, "name": "CLONIDINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL134", "mechanisms": ["Adrenergic receptor alpha-2 agonist"], "genes": ["ADRA2A"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "GLAUCOMA", "HYPERTENSION", "PAIN", "CARDIOVASCULAR DISEASE", "MIGRAINE DISORDER", "NEONATAL ABSTINENCE SYNDROME", "SEPTIC SHOCK", "ANXIETY", "OPIOID DEPENDENCE", "MARIJUANA DEPENDENCE", "AUTISM SPECTRUM DISORDER", "CEREBRAL ISCHEMIA", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "ANGINA PECTORIS", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "MYOCARDIAL INFARCTION", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "ANGINA PECTORIS", "stage": 4}, {"efo_term": "MARFAN SYNDROME", "stage": 3}, {"efo_term": "HEART DISEASE", "stage": 3}, {"efo_term": "HEMANGIOMA", "stage": 3}], "max_phase": 4, "name": "ATENOLOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24", "mechanisms": ["Beta-1 adrenergic receptor antagonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": ["ANGINA PECTORIS", "HYPERTENSION", "MYOCARDIAL INFARCTION", "MARFAN SYNDROME", "HEART DISEASE", "CARDIOVASCULAR DISEASE", "HEMANGIOMA"]}, {"indications": [{"efo_term": "OPEN-ANGLE GLAUCOMA", "stage": 4}, {"efo_term": "OCULAR HYPERTENSION", "stage": 4}, {"efo_term": "ROSACEA", "stage": 4}, {"efo_term": "INCREASED INTRAOCULAR PRESSURE", "stage": 4}, {"efo_term": "HYPEREMIA", "stage": 3}, {"efo_term": "AGE-RELATED MACULAR DEGENERATION", "stage": 2}, {"efo_term": "ALLERGIC CONJUNCTIVITIS", "stage": 2}, {"efo_term": "RETINITIS PIGMENTOSA", "stage": 1}], "max_phase": 4, "name": "BRIMONIDINE TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062257", "mechanisms": ["Adrenergic receptor alpha-2 agonist"], "genes": ["ADRA2A"], "type": "Small molecule", "diseases": ["OPEN-ANGLE GLAUCOMA", "RETINITIS PIGMENTOSA", "HYPEREMIA", "OCULAR HYPERTENSION", "ROSACEA", "INCREASED INTRAOCULAR PRESSURE", "AGE-RELATED MACULAR DEGENERATION", "ALLERGIC CONJUNCTIVITIS"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "HEART FAILURE", "stage": 4}, {"efo_term": "CONGESTIVE HEART FAILURE", "stage": 4}, {"efo_term": "ANGINA PECTORIS", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 3}, {"efo_term": "AORTIC STENOSIS", "stage": 2}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}], "max_phase": 4, "name": "METOPROLOL SUCCINATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200337", "mechanisms": ["Beta-1 adrenergic receptor antagonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": ["HYPERTENSION", "AORTIC STENOSIS", "HEART FAILURE", "CONGESTIVE HEART FAILURE", "FISH-EYE DISEASE", "ANGINA PECTORIS", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "ORTHOSTATIC HYPOTENSION", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "HYPOTENSION", "stage": 2}, {"efo_term": "FIBROMYALGIA", "stage": 2}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "MULTIPLE SYSTEM ATROPHY", "stage": 2}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 1}], "max_phase": 4, "name": "DROXIDOPA", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103827", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB1", "ADRA2A"], "type": "Small molecule", "diseases": ["HYPOTENSION", "ORTHOSTATIC HYPOTENSION", "FIBROMYALGIA", "CARDIOVASCULAR DISEASE", "CHRONIC KIDNEY DISEASE", "PARKINSON'S DISEASE", "MULTIPLE SYSTEM ATROPHY"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "AUTISM SPECTRUM DISORDER", "stage": 3}, {"efo_term": "HEROIN DEPENDENCE", "stage": 3}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "FIBROMYALGIA", "stage": 2}, {"efo_term": "CANCER", "stage": 2}], "max_phase": 4, "name": "MIRTAZAPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL654", "mechanisms": ["Adrenergic receptor alpha-2 antagonist"], "genes": ["ADRA2A"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION", "AUTISM SPECTRUM DISORDER", "ALCOHOL DEPENDENCE", "COCAINE DEPENDENCE", "HEROIN DEPENDENCE", "FIBROMYALGIA", "CANCER"]}, {"indications": [{"efo_term": "GLAUCOMA", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "OCULAR HYPERTENSION", "stage": 4}, {"efo_term": "OPEN-ANGLE GLAUCOMA", "stage": 2}, {"efo_term": "HEMANGIOMA", "stage": 2}, {"efo_term": "SKIN ULCER", "stage": 2}], "max_phase": 4, "name": "TIMOLOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL499", "mechanisms": ["Beta-1 adrenergic receptor antagonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": ["GLAUCOMA", "OPEN-ANGLE GLAUCOMA", "CARDIOVASCULAR DISEASE", "HEMANGIOMA", "OCULAR HYPERTENSION", "SKIN ULCER"]}, {"indications": [{"efo_term": "EYE DISEASE", "stage": 3}, {"efo_term": "RHINITIS", "stage": 3}, {"efo_term": "ROSACEA", "stage": 3}, {"efo_term": "ALLERGIC CONJUNCTIVITIS", "stage": 2}, {"efo_term": "GRAVES OPHTHALMOPATHY", "stage": 2}, {"efo_term": "ALLERGIC RHINITIS", "stage": 1}], "max_phase": 4, "name": "OXYMETAZOLINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200791", "mechanisms": ["Adrenergic receptor alpha agonist"], "genes": ["ADRA2A"], "type": "Small molecule", "diseases": ["ALLERGIC RHINITIS", "EYE DISEASE", "ALLERGIC CONJUNCTIVITIS", "RHINITIS", "ROSACEA", "GRAVES OPHTHALMOPATHY"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "HEMANGIOMA", "stage": 3}, {"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "SMOKING CESSATION", "stage": 2}], "max_phase": 4, "name": "NADOLOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL649", "mechanisms": ["Beta-1 adrenergic receptor antagonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": ["ASTHMA", "CARDIOVASCULAR DISEASE", "SMOKING CESSATION", "HEMANGIOMA"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "CUTANEOUS MELANOMA", "stage": 2}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 1}], "max_phase": 4, "name": "PROPRANOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1671", "mechanisms": ["Beta-1 adrenergic receptor antagonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": ["TYPE II DIABETES MELLITUS", "HYPERTENSION", "CUTANEOUS MELANOMA"]}, {"indications": [{"efo_term": "GLAUCOMA", "stage": 3}, {"efo_term": "HEMANGIOMA", "stage": 3}, {"efo_term": "ANTERIOR ISCHEMIC OPTIC NEUROPATHY", "stage": 1}], "max_phase": 4, "name": "TIMOLOL MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200870", "mechanisms": ["Beta-1 adrenergic receptor antagonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": ["GLAUCOMA", "HEMANGIOMA", "ANTERIOR ISCHEMIC OPTIC NEUROPATHY"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "BREAST CARCINOMA", "stage": 2}], "max_phase": 4, "name": "CARVEDILOL PHOSPHATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201167", "mechanisms": ["Adrenergic receptor beta antagonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": ["HYPERTENSION", "BREAST CARCINOMA"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 4, "name": "PINDOLOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL500", "mechanisms": ["Beta-1 adrenergic receptor partial agonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": ["CARDIOVASCULAR DISEASE", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "OPEN-ANGLE GLAUCOMA", "stage": 4}, {"efo_term": "OCULAR HYPERTENSION", "stage": 4}], "max_phase": 4, "name": "BETAXOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1691", "mechanisms": ["Beta-1 adrenergic receptor antagonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": ["OPEN-ANGLE GLAUCOMA", "OCULAR HYPERTENSION"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}], "max_phase": 4, "name": "BISOPROLOL FUMARATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200708", "mechanisms": ["Beta-1 adrenergic receptor antagonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": ["HYPERTENSION", "FISH-EYE DISEASE"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "VENTRICULAR ARRHYTHMIA", "stage": 4}], "max_phase": 4, "name": "ACEBUTOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200813", "mechanisms": ["Beta-1 adrenergic receptor antagonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": ["HYPERTENSION", "VENTRICULAR ARRHYTHMIA"]}, {"indications": [{"efo_term": "OVARIAN CYST", "stage": 1}, {"efo_term": "DIABETIC FOOT", "stage": 1}], "max_phase": 4, "name": "ESMOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201115", "mechanisms": ["Beta-1 adrenergic receptor antagonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": ["OVARIAN CYST", "DIABETIC FOOT"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "PREECLAMPSIA", "stage": 2}], "max_phase": 4, "name": "METHYLDOPA", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL459", "mechanisms": ["Adrenergic receptor alpha-2 agonist"], "genes": ["ADRA2A"], "type": "Small molecule", "diseases": ["PREECLAMPSIA", "HYPERTENSION"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 3}], "max_phase": 4, "name": "DOPAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1557", "mechanisms": ["Beta-1 adrenergic receptor agonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}], "max_phase": 4, "name": "NEBIVOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201731", "mechanisms": ["Beta-1 adrenergic receptor antagonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": ["HYPERTENSION"]}, {"indications": [{"efo_term": "MYOCARDIAL INFARCTION", "stage": 4}], "max_phase": 4, "name": "METOPROLOL TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256957", "mechanisms": ["Beta-1 adrenergic receptor antagonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": ["MYOCARDIAL INFARCTION"]}, {"indications": [{"efo_term": "OBESITY", "stage": 2}], "max_phase": 2, "name": "LY377604", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2012520", "mechanisms": ["Beta-1 adrenergic receptor antagonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": ["OBESITY"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}], "max_phase": 4, "name": "ISOPROTERENOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1711", "mechanisms": ["Adrenergic receptor beta agonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": ["ASTHMA"]}, {"indications": [{"efo_term": "OPEN-ANGLE GLAUCOMA", "stage": 4}], "max_phase": 4, "name": "CARTEOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201002", "mechanisms": ["Adrenergic receptor beta antagonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": ["OPEN-ANGLE GLAUCOMA"]}, {"indications": [{"efo_term": "PREECLAMPSIA", "stage": 2}], "max_phase": 4, "name": "LABETALOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200323", "mechanisms": ["Adrenergic receptor antagonist"], "genes": ["ADRB1", "ADRA2A"], "type": "Small molecule", "diseases": ["PREECLAMPSIA"]}, {"indications": [{"efo_term": "RENAL INSUFFICIENCY", "stage": 0}], "max_phase": 4, "name": "NORADRENALINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1356607", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB1", "ADRA2A"], "type": "Small molecule", "diseases": ["RENAL INSUFFICIENCY"]}, {"indications": [{"efo_term": "PAIN", "stage": 3}], "max_phase": 4, "name": "CLONIDINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1705", "mechanisms": ["Adrenergic receptor alpha-2 agonist"], "genes": ["ADRA2A"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "SPASTICITY", "stage": 4}], "max_phase": 4, "name": "TIZANIDINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200329", "mechanisms": ["Adrenergic receptor alpha-2 agonist"], "genes": ["ADRA2A"], "type": "Small molecule", "diseases": ["SPASTICITY"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}], "max_phase": 4, "name": "GUANFACINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200494", "mechanisms": ["Adrenergic receptor alpha-2 agonist"], "genes": ["ADRA2A"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER"]}, {"indications": [{"efo_term": "BONE NEOPLASM", "stage": 1}], "max_phase": 4, "name": "GUANABENZ ACETATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200560", "mechanisms": ["Adrenergic receptor alpha-2 agonist"], "genes": ["ADRA2A"], "type": "Small molecule", "diseases": ["BONE NEOPLASM"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 3}], "max_phase": 3, "name": "ESMIRTAZAPINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107339", "mechanisms": ["Adrenergic receptor alpha-2 antagonist"], "genes": ["ADRA2A"], "type": "Small molecule", "diseases": ["INSOMNIA"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}], "max_phase": 4, "name": "ERGOLOID MESYLATES", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2311030", "mechanisms": ["Adrenergic receptor alpha antagonist"], "genes": ["ADRA2A"], "type": "Small molecule", "diseases": ["CARDIOVASCULAR DISEASE"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}], "max_phase": 4, "name": "RAUWOLFIA SERPENTINA", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3559672", "mechanisms": ["Adrenergic receptor alpha antagonist"], "genes": ["ADRA2A"], "type": "Small molecule", "diseases": ["HYPERTENSION"]}, {"indications": [], "max_phase": 4, "name": "SOTALOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1700", "mechanisms": ["Beta-1 adrenergic receptor antagonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PENBUTOLOL SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200363", "mechanisms": ["Beta-1 adrenergic receptor antagonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DOBUTAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200418", "mechanisms": ["Beta-1 adrenergic receptor agonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "OXPRENOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200745", "mechanisms": ["Beta-1 adrenergic receptor antagonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LEVOBETAXOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200837", "mechanisms": ["Beta-1 adrenergic receptor antagonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "METOPROLOL FUMARATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200898", "mechanisms": ["Beta-1 adrenergic receptor antagonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "METIPRANOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200947", "mechanisms": ["Beta-1 adrenergic receptor antagonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROPAFENONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201063", "mechanisms": ["Beta-1 adrenergic receptor antagonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LEVOBUNOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201177", "mechanisms": ["Beta-1 adrenergic receptor antagonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ISOPROTERENOL SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200447", "mechanisms": ["Adrenergic receptor beta agonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "HYDROXYAMPHETAMINE HYDROBROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200705", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB1", "ADRA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIPIVEFRIN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200833", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB1", "ADRA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MEPHENTERMINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200996", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB1", "ADRA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "EPINEPHRINE BITARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256958", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB1", "ADRA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LEVONORDEFRIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL677", "mechanisms": ["Adrenergic receptor alpha-2 agonist"], "genes": ["ADRA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "APRACLONIDINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200379", "mechanisms": ["Adrenergic receptor alpha-2 agonist"], "genes": ["ADRA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "METHYLDOPATE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200432", "mechanisms": ["Adrenergic receptor alpha-2 agonist"], "genes": ["ADRA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DEXMEDETOMIDINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2106195", "mechanisms": ["Adrenergic receptor alpha-2 agonist"], "genes": ["ADRA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "FADOLMIDINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2106710", "mechanisms": ["Adrenergic receptor alpha-2 agonist"], "genes": ["ADRA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TOLAZOLINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1689", "mechanisms": ["Adrenergic receptor alpha antagonist"], "genes": ["ADRA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "NAPHAZOLINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1706", "mechanisms": ["Adrenergic receptor alpha agonist"], "genes": ["ADRA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TETRAHYDROZOLINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200413", "mechanisms": ["Adrenergic receptor alpha agonist"], "genes": ["ADRA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PHENOXYBENZAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200787", "mechanisms": ["Adrenergic receptor alpha antagonist"], "genes": ["ADRA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PHENTOLAMINE MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200873", "mechanisms": ["Adrenergic receptor alpha antagonist"], "genes": ["ADRA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ALSEROXYLON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201454", "mechanisms": ["Adrenergic receptor alpha antagonist"], "genes": ["ADRA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ERGOTAMINE TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062265", "mechanisms": ["Adrenergic receptor alpha agonist"], "genes": ["ADRA2A"], "type": "Small molecule", "diseases": []}], "heat": 0.6934473089067333, "nodes": [{"assoc": 1.0, "id": "ENSG00000043591", "label": "ADRB1"}, {"assoc": 1.0, "id": "ENSG00000150594", "label": "ADRA2A"}, {"assoc": 0.0803419267202, "id": "ENSG00000154277", "label": "UCHL1"}], "size": 3}, {"diseases": ["PSORIASIS", "RHEUMATOID ARTHRITIS", "MULTIPLE SCLEROSIS"], "links": [{"source": "ENSG00000049130", "target": "ENSG00000105472"}, {"source": "ENSG00000049130", "target": "ENSG00000164400", "reverse": "rev-directed"}], "drugs": [{"indications": [{"efo_term": "PSORIASIS", "stage": 2}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 1}], "max_phase": 2, "name": "NAMILUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743044", "mechanisms": ["Granulocyte-macrophage colony-stimulating factor inhibitor"], "genes": ["CSF2"], "type": "Antibody", "diseases": ["PSORIASIS", "RHEUMATOID ARTHRITIS"]}, {"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 1}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 1}], "max_phase": 2, "name": "MOR-103", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109433", "mechanisms": ["Granulocyte-macrophage colony-stimulating factor inhibitor"], "genes": ["CSF2"], "type": "Antibody", "diseases": ["RHEUMATOID ARTHRITIS", "MULTIPLE SCLEROSIS"]}, {"indications": [], "max_phase": 2, "name": "KB-003", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109431", "mechanisms": ["Granulocyte-macrophage colony-stimulating factor inhibitor"], "genes": ["CSF2"], "type": "Antibody", "diseases": []}], "heat": 0.08270356019686667, "nodes": [{"assoc": 0.0779218331066, "id": "ENSG00000049130", "label": "KITLG"}, {"assoc": 0.055428, "id": "ENSG00000105472", "label": "CLEC11A"}, {"assoc": 0.114760847484, "id": "ENSG00000164400", "label": "CSF2"}], "size": 3}, {"diseases": ["OSTEOARTHRITIS", "RHEUMATOID ARTHRITIS"], "links": [{"source": "ENSG00000089041", "target": "ENSG00000110218"}, {"source": "ENSG00000089041", "target": "ENSG00000135124"}], "drugs": [{"indications": [{"efo_term": "OSTEOARTHRITIS", "stage": 2}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 1}], "max_phase": 2, "name": "CE-224535", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1823817", "mechanisms": ["P2X purinoceptor 7 antagonist"], "genes": ["P2RX7"], "type": "Small molecule", "diseases": ["OSTEOARTHRITIS", "RHEUMATOID ARTHRITIS"]}, {"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 2}], "max_phase": 2, "name": "AZD9056", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545108", "mechanisms": ["P2X purinoceptor 7 antagonist"], "genes": ["P2RX7"], "type": "Small molecule", "diseases": ["RHEUMATOID ARTHRITIS"]}, {"indications": [], "max_phase": 1, "name": "GSK1482160", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545206", "mechanisms": ["P2X purinoceptor 7 negative allosteric modulator"], "genes": ["P2RX7"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "EVT401", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707396", "mechanisms": ["P2X purinoceptor 7 antagonist"], "genes": ["P2RX7"], "type": "Small molecule", "diseases": []}], "heat": 0.11300433117356667, "nodes": [{"assoc": 0.189593877429, "id": "ENSG00000089041", "label": "P2RX7"}, {"assoc": 0.0447761047957, "id": "ENSG00000110218", "label": "PANX1"}, {"assoc": 0.104643011296, "id": "ENSG00000135124", "label": "P2RX4"}], "size": 3}, {"diseases": ["NICOTINE DEPENDENCE", "SMOKING CESSATION", "MEMORY IMPAIRMENT", "PARKINSON'S DISEASE", "POST OPERATIVE NAUSEA AND VOMITING", "SARCOIDOSIS", "ALCOHOL DRINKING", "HEART FAILURE", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "CERVICAL CARCINOMA", "COGNITIVE IMPAIRMENT", "LUNG CARCINOMA", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "INJURY", "DRUG DEPENDENCE", "ALZHEIMERS DISEASE", "SCHIZOPHRENIA", "NEUROPATHIC PAIN", "UNIPOLAR DEPRESSION", "HYPERTENSION", "OVERACTIVE BLADDER", "GASTROPARESIS", "IRRITABLE BOWEL SYNDROME"], "links": [{"source": "ENSG00000101204", "target": "ENSG00000160716"}, {"source": "ENSG00000101204", "target": "ENSG00000163032"}], "drugs": [{"indications": [{"efo_term": "NICOTINE DEPENDENCE", "stage": 4}, {"efo_term": "SMOKING CESSATION", "stage": 3}, {"efo_term": "HEART FAILURE", "stage": 3}, {"efo_term": "CERVICAL CARCINOMA", "stage": 3}, {"efo_term": "LUNG CARCINOMA", "stage": 3}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "POST OPERATIVE NAUSEA AND VOMITING", "stage": 2}, {"efo_term": "ALCOHOL DRINKING", "stage": 2}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}, {"efo_term": "COGNITIVE IMPAIRMENT", "stage": 2}, {"efo_term": "INJURY", "stage": 2}, {"efo_term": "DRUG DEPENDENCE", "stage": 2}, {"efo_term": "MEMORY IMPAIRMENT", "stage": 1}, {"efo_term": "SARCOIDOSIS", "stage": 1}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 1}], "max_phase": 4, "name": "NICOTINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["NICOTINE DEPENDENCE", "SMOKING CESSATION", "MEMORY IMPAIRMENT", "PARKINSON'S DISEASE", "POST OPERATIVE NAUSEA AND VOMITING", "SARCOIDOSIS", "ALCOHOL DRINKING", "HEART FAILURE", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "CERVICAL CARCINOMA", "COGNITIVE IMPAIRMENT", "LUNG CARCINOMA", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "INJURY", "DRUG DEPENDENCE"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 2}, {"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 2}], "max_phase": 2, "name": "ISPRONICLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL188462", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 partial agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE", "SCHIZOPHRENIA", "ATTENTION DEFICIT HYPERACTIVITY DISORDER"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "OVERACTIVE BLADDER", "stage": 2}, {"efo_term": "HYPERTENSION", "stage": 1}], "max_phase": 3, "name": "DEXMECAMYLAMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103881", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 antagonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["HYPERTENSION", "OVERACTIVE BLADDER", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 2}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 2}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 2}], "max_phase": 2, "name": "POZANICLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL127071", "mechanisms": ["Nicotinic acetylcholine receptor alpha4/beta2/alpha5 partial agonist", "Neuronal acetylcholine receptor; alpha6/beta2 partial agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "NICOTINE DEPENDENCE"]}, {"indications": [{"efo_term": "NEUROPATHIC PAIN", "stage": 2}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 2}], "max_phase": 2, "name": "SOFINICLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL238465", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN", "ATTENTION DEFICIT HYPERACTIVITY DISORDER"]}, {"indications": [{"efo_term": "NICOTINE DEPENDENCE", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 1}], "max_phase": 4, "name": "NICOTINE POLACRILEX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201536", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["NICOTINE DEPENDENCE", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "NICOTINE DEPENDENCE", "stage": 2}, {"efo_term": "SMOKING CESSATION", "stage": 1}], "max_phase": 4, "name": "VARENICLINE TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062259", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["NICOTINE DEPENDENCE", "SMOKING CESSATION"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 2}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 2}], "max_phase": 2, "name": "AZD1446", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2179529", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER"]}, {"indications": [{"efo_term": "IRRITABLE BOWEL SYNDROME", "stage": 2}, {"efo_term": "GASTROPARESIS", "stage": 1}], "max_phase": 2, "name": "TC-6499", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545353", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["GASTROPARESIS", "IRRITABLE BOWEL SYNDROME"]}, {"indications": [], "max_phase": 2, "name": "TEBANICLINE TOSYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL430497", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "ALTINICLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL111659", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "TC-2216", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL504652", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 antagonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "CP-601927", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707250", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 partial agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "ABT-560", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707354", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 modulator"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": []}], "heat": 0.6847506666666666, "nodes": [{"assoc": 1.0, "id": "ENSG00000101204", "label": "CHRNA4"}, {"assoc": 1.0, "id": "ENSG00000160716", "label": "CHRNB2"}, {"assoc": 0.054252, "id": "ENSG00000163032", "label": "VSNL1"}], "size": 3}, {"diseases": ["PROSTATE CARCINOMA", "OSTEOPOROSIS", "BREAST CARCINOMA", "RENAL INSUFFICIENCY"], "links": [{"source": "ENSG00000106538", "target": "ENSG00000143387", "reverse": "rev-directed"}, {"source": "ENSG00000106538", "type": "stimulatory", "target": "ENSG00000174600"}], "drugs": [{"indications": [{"efo_term": "PROSTATE CARCINOMA", "stage": 3}, {"efo_term": "OSTEOPOROSIS", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "RENAL INSUFFICIENCY", "stage": 1}], "max_phase": 3, "name": "ODANACATIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL481611", "mechanisms": ["Cathepsin K inhibitor"], "genes": ["CTSK"], "type": "Small molecule", "diseases": ["PROSTATE CARCINOMA", "OSTEOPOROSIS", "BREAST CARCINOMA", "RENAL INSUFFICIENCY"]}], "heat": 0.0656858438213, "nodes": [{"assoc": 0.0988970438889, "id": "ENSG00000106538", "label": "RARRES2"}, {"assoc": 0.037792, "id": "ENSG00000143387", "label": "CTSK"}, {"assoc": 0.060368487575, "id": "ENSG00000174600", "label": "CMKLR1"}], "size": 3}, {"diseases": ["COUGH", "IDIOPATHIC PULMONARY FIBROSIS", "CHRONIC INTERSTITIAL CYSTITIS", "OSTEOARTHRITIS, KNEE", "ASTHMA"], "links": [{"source": "ENSG00000108405", "target": "ENSG00000187848"}, {"source": "ENSG00000109991", "target": "ENSG00000187848"}], "drugs": [{"indications": [{"efo_term": "COUGH", "stage": 2}, {"efo_term": "IDIOPATHIC PULMONARY FIBROSIS", "stage": 2}, {"efo_term": "CHRONIC INTERSTITIAL CYSTITIS", "stage": 2}, {"efo_term": "OSTEOARTHRITIS, KNEE", "stage": 2}, {"efo_term": "ASTHMA", "stage": 1}], "max_phase": 2, "name": "AF-219", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545041", "mechanisms": ["P2X purinoceptor 3 antagonist"], "genes": ["P2RX3"], "type": "Small molecule", "diseases": ["COUGH", "IDIOPATHIC PULMONARY FIBROSIS", "CHRONIC INTERSTITIAL CYSTITIS", "OSTEOARTHRITIS, KNEE", "ASTHMA"]}], "heat": 0.1374563321847, "nodes": [{"assoc": 0.0381342111111, "id": "ENSG00000108405", "label": "P2RX1"}, {"assoc": 0.201361147011, "id": "ENSG00000109991", "label": "P2RX3"}, {"assoc": 0.172873638432, "id": "ENSG00000187848", "label": "P2RX2"}], "size": 3}, {"diseases": ["LIVER DISEASE"], "links": [{"source": "ENSG00000108556", "target": "ENSG00000138435"}, {"source": "ENSG00000135902", "target": "ENSG00000138435"}], "drugs": [{"indications": [{"efo_term": "LIVER DISEASE", "stage": 2}], "max_phase": 4, "name": "MIVACURIUM CHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL984", "mechanisms": ["Muscle-type nicotinic acetylcholine receptor antagonist"], "genes": ["CHRNE", "CHRND", "CHRNA1"], "type": "Small molecule", "diseases": ["LIVER DISEASE"]}, {"indications": [], "max_phase": 4, "name": "SUCCINYLCHOLINE CHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL983", "mechanisms": ["Muscle-type nicotinic acetylcholine receptor agonist"], "genes": ["CHRNE", "CHRND", "CHRNA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DECAMETHONIUM BROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1134", "mechanisms": ["Muscle-type nicotinic acetylcholine receptor partial agonist"], "genes": ["CHRNE", "CHRND", "CHRNA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TUBOCURARINE CHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1687", "mechanisms": ["Muscle-type nicotinic acetylcholine receptor antagonist"], "genes": ["CHRNE", "CHRND", "CHRNA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "METOCURINE IODIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1739", "mechanisms": ["Muscle-type nicotinic acetylcholine receptor antagonist"], "genes": ["CHRNE", "CHRND", "CHRNA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ATRACURIUM BESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200527", "mechanisms": ["Muscle-type nicotinic acetylcholine receptor antagonist"], "genes": ["CHRNE", "CHRND", "CHRNA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "RAPACURONIUM BROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200549", "mechanisms": ["Muscle-type nicotinic acetylcholine receptor antagonist"], "genes": ["CHRNE", "CHRND", "CHRNA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "VECURONIUM BROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200629", "mechanisms": ["Muscle-type nicotinic acetylcholine receptor antagonist"], "genes": ["CHRNE", "CHRND", "CHRNA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CISATRACURIUM BESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200641", "mechanisms": ["Muscle-type nicotinic acetylcholine receptor antagonist"], "genes": ["CHRNE", "CHRND", "CHRNA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ROCURONIUM BROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200648", "mechanisms": ["Muscle-type nicotinic acetylcholine receptor antagonist"], "genes": ["CHRNE", "CHRND", "CHRNA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PIPECURONIUM BROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200722", "mechanisms": ["Muscle-type nicotinic acetylcholine receptor antagonist"], "genes": ["CHRNE", "CHRND", "CHRNA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PANCURONIUM BROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200757", "mechanisms": ["Muscle-type nicotinic acetylcholine receptor antagonist"], "genes": ["CHRNE", "CHRND", "CHRNA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "GALLAMINE TRIETHIODIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200993", "mechanisms": ["Muscle-type nicotinic acetylcholine receptor antagonist"], "genes": ["CHRNE", "CHRND", "CHRNA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DOXACURIUM CHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237099", "mechanisms": ["Muscle-type nicotinic acetylcholine receptor antagonist"], "genes": ["CHRNE", "CHRND", "CHRNA1"], "type": "Small molecule", "diseases": []}], "heat": 1.0, "nodes": [{"assoc": 1.0, "id": "ENSG00000108556", "label": "CHRNE"}, {"assoc": 1.0, "id": "ENSG00000135902", "label": "CHRND"}, {"assoc": 1.0, "id": "ENSG00000138435", "label": "CHRNA1"}], "size": 3}, {"diseases": [], "links": [{"source": "ENSG00000126010", "target": "ENSG00000134443", "reverse": "rev-stimulatory"}, {"source": "ENSG00000126010", "type": "stimulatory", "target": "ENSG00000170890"}], "drugs": [], "heat": 0.0436951435865, "nodes": [{"assoc": 0.0399134271707, "id": "ENSG00000126010", "label": "GRPR"}, {"assoc": 0.029312, "id": "ENSG00000134443", "label": "GRP"}, {"assoc": 0.0618600035888, "id": "ENSG00000170890", "label": "PLA2G1B"}], "size": 3}, {"diseases": ["PAIN", "OSTEOARTHRITIS", "ENDOMETRIOSIS", "CHRONIC PANCREATITIS", "PROSTATITIS", "OSTEOARTHRITIS, HIP", "CHRONIC INTERSTITIAL CYSTITIS", "DIABETIC NEUROPATHY", "GENICULATE HERPES ZOSTER", "SCIATICA", "OSTEOARTHRITIS, KNEE", "ACNE", "PERIODONTITIS", "BLEPHARITIS", "COLORECTAL ADENOCARCINOMA", "DIABETIC RETINOPATHY", "URETHRITIS", "HEMORRHAGE", "NEOPLASM OF MATURE B-CELLS", "ALZHEIMERS DISEASE", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "PLEURAL EFFUSION", "ABDOMINAL AORTIC ANEURYSM", "MARFAN SYNDROME", "PRIMARY SYSTEMIC AMYLOIDOSIS", "DRY EYE SYNDROME", "SEPTICEMIC PLAGUE", "POLYCYSTIC OVARY SYNDROME", "MYOCARDIAL INFARCTION", "PANCREATIC CARCINOMA", "SEIZURES", "DIABETIC FOOT", "AGE-RELATED MACULAR DEGENERATION", "TUBERCULOSIS"], "links": [{"source": "ENSG00000134259", "target": "ENSG00000137673", "reverse": "rev-stimulatory"}, {"source": "ENSG00000137673", "type": "stimulatory", "target": "ENSG00000196611"}], "drugs": [{"indications": [{"efo_term": "PERIODONTITIS", "stage": 3}, {"efo_term": "URETHRITIS", "stage": 3}, {"efo_term": "HEMORRHAGE", "stage": 3}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 3}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 3}, {"efo_term": "PLEURAL EFFUSION", "stage": 3}, {"efo_term": "POLYCYSTIC OVARY SYNDROME", "stage": 3}, {"efo_term": "BLEPHARITIS", "stage": 2}, {"efo_term": "COLORECTAL ADENOCARCINOMA", "stage": 2}, {"efo_term": "ACNE", "stage": 2}, {"efo_term": "DIABETIC RETINOPATHY", "stage": 2}, {"efo_term": "NEOPLASM OF MATURE B-CELLS", "stage": 2}, {"efo_term": "PAIN", "stage": 2}, {"efo_term": "ABDOMINAL AORTIC ANEURYSM", "stage": 2}, {"efo_term": "MARFAN SYNDROME", "stage": 2}, {"efo_term": "PRIMARY SYSTEMIC AMYLOIDOSIS", "stage": 2}, {"efo_term": "DRY EYE SYNDROME", "stage": 2}, {"efo_term": "SEPTICEMIC PLAGUE", "stage": 2}, {"efo_term": "MYOCARDIAL INFARCTION", "stage": 2}, {"efo_term": "PANCREATIC CARCINOMA", "stage": 2}, {"efo_term": "SEIZURES", "stage": 2}, {"efo_term": "DIABETIC FOOT", "stage": 2}, {"efo_term": "AGE-RELATED MACULAR DEGENERATION", "stage": 2}, {"efo_term": "TUBERCULOSIS", "stage": 2}], "max_phase": 4, "name": "DOXYCYCLINE HYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200699", "mechanisms": ["Matrix metalloproteinase 7 inhibitor", "Matrix metalloproteinase-1 inhibitor"], "genes": ["MMP7", "MMP1"], "type": "Small molecule", "diseases": ["BLEPHARITIS", "COLORECTAL ADENOCARCINOMA", "PERIODONTITIS", "ACNE", "DIABETIC RETINOPATHY", "URETHRITIS", "HEMORRHAGE", "NEOPLASM OF MATURE B-CELLS", "ALZHEIMERS DISEASE", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "PAIN", "PLEURAL EFFUSION", "ABDOMINAL AORTIC ANEURYSM", "MARFAN SYNDROME", "PRIMARY SYSTEMIC AMYLOIDOSIS", "DRY EYE SYNDROME", "SEPTICEMIC PLAGUE", "POLYCYSTIC OVARY SYNDROME", "MYOCARDIAL INFARCTION", "PANCREATIC CARCINOMA", "SEIZURES", "DIABETIC FOOT", "AGE-RELATED MACULAR DEGENERATION", "TUBERCULOSIS"]}, {"indications": [{"efo_term": "OSTEOARTHRITIS", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "OSTEOARTHRITIS, HIP", "stage": 3}, {"efo_term": "ENDOMETRIOSIS", "stage": 2}, {"efo_term": "CHRONIC PANCREATITIS", "stage": 2}, {"efo_term": "PROSTATITIS", "stage": 2}, {"efo_term": "CHRONIC INTERSTITIAL CYSTITIS", "stage": 2}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 2}, {"efo_term": "GENICULATE HERPES ZOSTER", "stage": 2}], "max_phase": 3, "name": "TANEZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108567", "mechanisms": ["Beta-nerve growth factor inhibitor"], "genes": ["NGF"], "type": "Antibody", "diseases": ["ENDOMETRIOSIS", "OSTEOARTHRITIS", "PAIN", "CHRONIC PANCREATITIS", "PROSTATITIS", "OSTEOARTHRITIS, HIP", "CHRONIC INTERSTITIAL CYSTITIS", "DIABETIC NEUROPATHY", "GENICULATE HERPES ZOSTER"]}, {"indications": [{"efo_term": "SCIATICA", "stage": 2}, {"efo_term": "OSTEOARTHRITIS", "stage": 2}, {"efo_term": "PAIN", "stage": 2}, {"efo_term": "OSTEOARTHRITIS, HIP", "stage": 2}, {"efo_term": "OSTEOARTHRITIS, KNEE", "stage": 1}], "max_phase": 3, "name": "Fasinumab", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109528", "mechanisms": ["Beta-nerve growth factor inhibitor"], "genes": ["NGF"], "type": "Antibody", "diseases": ["SCIATICA", "OSTEOARTHRITIS", "PAIN", "OSTEOARTHRITIS, KNEE", "OSTEOARTHRITIS, HIP"]}, {"indications": [{"efo_term": "PAIN", "stage": 2}, {"efo_term": "OSTEOARTHRITIS", "stage": 1}], "max_phase": 3, "name": "FULRANUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743023", "mechanisms": ["Beta-nerve growth factor inhibitor"], "genes": ["NGF"], "type": "Antibody", "diseases": ["PAIN", "OSTEOARTHRITIS"]}, {"indications": [{"efo_term": "ACNE", "stage": 4}, {"efo_term": "PERIODONTITIS", "stage": 3}], "max_phase": 4, "name": "DOXYCYCLINE HYCLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200567", "mechanisms": ["Matrix metalloproteinase 7 inhibitor", "Matrix metalloproteinase-1 inhibitor"], "genes": ["MMP7", "MMP1"], "type": "Small molecule", "diseases": ["ACNE", "PERIODONTITIS"]}, {"indications": [], "max_phase": 4, "name": "DOXYCYCLINE CALCIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2364574", "mechanisms": ["Matrix metalloproteinase 7 inhibitor", "Matrix metalloproteinase-1 inhibitor"], "genes": ["MMP7", "MMP1"], "type": "Small molecule", "diseases": []}], "heat": 0.2841009441103333, "nodes": [{"assoc": 0.334236800667, "id": "ENSG00000134259", "label": "NGF"}, {"assoc": 0.25, "id": "ENSG00000137673", "label": "MMP7"}, {"assoc": 0.268066031664, "id": "ENSG00000196611", "label": "MMP1"}], "size": 3}, {"diseases": [], "links": [{"source": "ENSG00000142538", "type": "stimulatory", "target": "ENSG00000144407"}, {"source": "ENSG00000144407", "target": "ENSG00000152266", "reverse": "rev-stimulatory"}], "drugs": [], "heat": 0.0525903566673, "nodes": [{"assoc": 0.0540738, "id": "ENSG00000142538", "label": "PTH2"}, {"assoc": 0.0434704444444, "id": "ENSG00000144407", "label": "PTH2R"}, {"assoc": 0.0602268255575, "id": "ENSG00000152266", "label": "PTH"}], "size": 3}], "auto_delta": "0.00279157"}